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“If you put your mind on it, you can accomplish everything”. 




“Quid est tempus? Si nemo a me quaerat, scio; si quaerenti explicare velim, nescio!” 
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m’esaltavo in racconti interminabili. Poi mi prendeva la vergogna di queste fantasticherie 
e scappavo. 
E venne il giorno in cui anche il dottor Trelawney m'abbandonò. Un mattino nel nostro 
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rada. (...). Io non avevo visto nulla. Ero nascosto nel bosco a raccontarmi storie. 
Lo seppi troppo tardi e presi a correre verso la marina, gridando: - Dottore! Dottor 
Trelawney! Mi prenda con sè! Non può lasciarmi qui, dottore! 
Ma già le navi stavano scomparendo all' orizzonte e io rimasi qui, in questo nostro mondo 
pieno di responsabilita e di fuochi fatui. 





“Bravu nin, stüdia; perché se ta stüdiat, ta podat fa ul magütt; ma se ta stüdiat mia, ta 
gh’et da fall, e basta.” 
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   Introduction 
Allenes: a bit of history 
 
 
The history of allenes in chemistry has relatively recent roots. While chemical theories lose the 
traces of their genesis in ancient Greek’s time1, chemical compounds later known as allenes kept 
nearly sleeping regardless of any scientific or historic event till 1874. At that time, Jacobus van ’t 
Hoff, a Ph. D. student in Utrecht University, accounted for the phenomenon of optical activity by 
assuming that the chemical bonds between carbon atoms and their neighbors were directed 
towards the corners of a regular tetrahedron. This three-dimensional structure perfectly 
accounted for the isomers found in nature, and van ‘t Hoff published his work on the geometry of 
science in his book La chimie dans l'espace in 1874.2 Although initially strongly criticized by the 
scientific community,3 this work was revolutionary, and later became indispensable in Science.  
However, van ‘t Hoff decided to leave the field of pure organic chemistry, going on with 
researches on chemical equilibrium and thermodynamics that would have brought to him the first 




Extract from Arrangements of Atoms in Space, 2
nd
 ed. (1898), Longmans, Greene & Co.;  
English translation of La chimie dans l’éspace 
                                                           
1
 G. Lloyd, Early Greek Science: Thales to Aristotle, 1970, London; Chatto and Windus, 45.  
2
 J. H. van ’t Hoff, La chimie dans l’espace, 1875, Rotterdam; P. M. Bazendijk, 29.  
3
 One such critic was the editor of the Journal für praktische Chemie, A. Kolbe, who stated: "A Dr. H. van ’t 
Hoff (…) has no liking, apparently, for exact chemical investigation. He has considered it more comfortable 
to mount Pegasus (…) and to proclaim in his ‘La chimie dans l’espace’ how the atoms appear to him to be 
arranged in space, when he is on the chemical Mt. Parnassus which he has reached by bold flight." 
(www.wikipedia.com) 
4
 Nobel Lectures, Chemistry 1901-1921, Elsevier Publishing Company, Amsterdam. 
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These lines were entirely predictive, van ’t Hoff lacking any experimental evidence. Indeed, he 
was the first to predict the correct core structure of a cumulated diene moiety, as well as their 
axial chirality. Such a particular atomic arrangement was immediately thought by the scientific 
community to be too extreme to be real, and it is quite interesting to note that the first synthesis 
of an allene (pentadienoic acid) was conducted to prove the nonexistence of this class of 
compounds.5 Its failure, or in other words its success, didn’t help spreading the chemical interest 
towards allenes; mainly due to the tedious methods of preparation and the mistaken belief that 
the cumulate double-bond system would prove to be relatively unstable, allenes kept being 
regarded as chemical curiosities for some decades. Moreover, at that time, with the analytical 
tools available, it was almost impossible to distinguish between allenes and the corresponding 
alkynes. Only when IR and Raman spectroscopy were introduced as tools for structural 
investigation it was possible to prove, by its characteristic allenic C-C vibration at about 1950 cm–1, 
that Burton and von Pechmann had indeed synthesized an allenic molecule.5b  
 
The new techniques permitted to turn out as incorrect many assignments of allenic structures, 
revealing them as alkynes or conjugated dienes (Semmler’s6 and Staudinger’s7 works, Figure 1); 
                                                           
5
 (a) S. B. Burton, H. von Pechmann, Chem. Ber. 1887, 20, 145. (b) E. R. H. Jones, G. H. Mansfield, M. L. H. 
Whiting, J. Chem. Soc. 1954, 3208. 
6
 (a) F. W. Semmler, Ber. Dtsch. Chem. Ges. 1906, 39, 726. (b) H. Gilman, P. R. van Ess, R. R. Burtner, J. Am. 

















Figure 2. Allenic compounds whose structure was
correctly assigned more than 50 years after their discovery.
2Flucoxantin
Peridinin2
Figure 1. Compounds misbelieved














   Introduction 
however, they were also able to confirm the allenic structures for previously discovered 
compounds in natural products (Figure 2)8, thus triggering the researches aimed at developing 
synthetic routes to allenes.  
The subsequent set up of more convenient methodologies 
to their obtention together with the proof that natural 
organisms produce “authentic” allenic compounds (the first 
one to be identified was mycocmyicin, a fungal metabolite 
with a high antibiotic activity; Figure 3)9 eventually brought allenes to light, making them reach 
the high importance they had claimed for years and they definitively gained during the past four 






Before explaining the general behavior of allenes, some words again have to be spent onto their 
peculiar geometry. Molecular orbital analysis of the allene molecule correctly state that the most 
stable bonding arrangement involves two mutually perpendicular π bonds, with the central 
carbon atom (sp-hybridized) joined in a straight line to the two terminal carbon atoms (sp2-
hybridized). As a consequence, only one end of the system projects its substituents above and 
below the plane which the rest of the molecule is comprised in (Figure 4, part a), and the two 
bonds don’t show any conjugation effect because they are not coplanar. Conversely, in a 
hypothetical coplanar arrangement, the stabilization by the bonding would be around 2.4 eV 
lower,10 and in such a molecule there would be two unpaired electrons (Figure 4, part b). From 
this point of view, allenes represent the simplest class of odd-carbon cumulenes compounds, 
which reflect this tetrahedral geometry (Figure 4, part c), while even-carbon cumulenes adopt a 
planar configuration. 
                                                                                                                                                                                
7
 (a) H. Staudinger, L. Ruzicka, Helv. Chim. Acta 1924, 7, 212. (b) L. Crombie, S. H. Harper, D. Thompson, J. 
Chem. Soc. 1951, 2906. 
8
 (a) R. Bonnett, A. A. Spark, J. L. Tee, B. C. L. Weedon, Proc. Chem. Soc. London 1964, 419. (b) H. H. Strain, 
W. A. Svec, K. Aitzetmüller, M. C. Grandolfo, J. J. Katz, H. Kjøsen, S. Norgard, S. Liaaen-Jensen, F. T. Haxo, P. 
Wegfahrt, H. Rapport, J. Am. Chem. Soc. 1971, 93, 1823. 
9
 (a) E. A. Johnson, K. L. Burdon, J. Bacteriol. 1947, 54, 281. (b) W. D. Celmer, I. A. Solomons, J. Am. Chem. 
Soc. 1952, 74, 1870. (c) W. D. Celmer, I. A. Solomons, J. Am. Chem. Soc. 1952, 74, 2245. (d) W. D. Celmer, I. 
A. Solomons, J. Am.Chem. Soc. 1952, 74, 3838. 
10








Indeed, further geometrical and thermodynamic studies have been focused much more on 
cumulenes as a class than on simple allene compounds, although confirming some general 
features already emerged from the earlier studies onto allenes, such as the decrease of the C-C 
bond length toward the asymptotic limit while the number of bonds in the cumulene chains 
increases.11 Exact dimensions for the allene molecule (C=C = bond angle = 116-118°) were in fact 
determined long ago from spectral studies and by electron diffraction,12 showing a contraction of 
the double bond, relative to that in ethylene (1.33 A), 
which has been considered to indicate the 
occurrence of hyperconjugation (σ-π overlap) 
suggesting a partial triple-bond character (Figure 5).13  
As underlined in the previous chapter, the stereochemical consequences of the bonding in allenes 
were predicted by van ‘t Hoff, who foresaw that molecular symmetry droops if the terminal 
carbon atoms bear two different substituents, leading to optical isomerism. Thus, the mirror 
images in Figure 6 differ even if X = X' and Y = Y'; they become identical only if X = Y (or X' = Y').  
 
Nevertheless, since an experimental 
proof of this prediction lacked, as 
recently as 1930 the suggestion that 
allenes adopted planar configurations 
was still being made,14 witnessing the widespread idiosyncrasy toward van ’t Hoff studies. Since 
then, however, his conclusions have been amply verified in a clear cut way by the identification 
and resolution of many asymmetric allenes. 
                                                           
11
 U. Mölder, P. Burk, I. A. Koppel J. Mol. Structure: TEOCHEM, 2004, 712, 81-89 
12
 (a) B. P. Stoicheff, Can. J. Phys. 1955, 33, 811. (b) A. Almenningen, O. Bastianen, M. Traetterberg, Acta 
Chem. Scand. 1959, 13, 1699. 
13
 (a) H. O. Pritchard, F. H. Sumner, Proc. Roy. Soc. 1956, A235, 136. (b) E. L. Allred, D. M. Grant, W. 
Goodlett, J. Am. Chem. Soc. 1965, 87, 673. 
14

















Figure 5. Hyperconjugation in allenes
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Actually, two general approaches have been adopted in the isolation of enantiomers of optically 
active allenes. The synthesis of racemic mixtures, followed by resolution by standard procedures 
as reaction with optically active acids or bases, is the most obvious and ancient one. However, a 
more direct approach is that of stereoselective synthesis, pioneered by Maitland and Mills in a 
dehydration of an unsaturated alcohol with (+)- or (-)-camphor-10-sulfonic acid, whereby they 




This second choice has obviously attracted much more attention, and nowadays stereoselective 
synthesis are conveniently able to afford many allenic natural products and pharmaceuticals; 
chirality transfer from propargylic compounds, elimination reactions of allylic compounds and 
synthesis using chiral reagents or auxiliaries are the most developed methods (for a more detailed 
discussion of synthetic methods, see subchapter.16 Some recent examples are shown in Figure 8.17  
 
 
                                                           
15
 (a) P. Maitland, W. H. Mills, Nature 1935, 135, 994. (b) P. Maitland, W. H. Mills, J. Chem. Soc. 1936, 987. 
16
 (a) A. Höffmann-Roder, N. Krause, Angew. Chem., Int. Ed. 2004, 43, 1196. (b) H. Ohno, Y. Nagaoka, K. 
Tomioka, Enantioselective Synthesis of Allenes, in Modern Allene Chemistry, 2004, Vol. 1., N. Krause, S. 
Hashmi, Weinheim, Wiley-VCH.  
17
 (a) H. Liu, D. Leow, K.-W. Huang, C.-H. Tan, J. Am. Chem. Soc. 2009, 131, 7212. (b) V. Kar-Yan Lo, C.-Y. 
Zhou, M.-K. Wong, C.-M. Che, Chem. Commun. 2010, 46, 213. 
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Even so, resolution of mixtures is still a valuable method, in the forms of fractional crystallization, 
chiral columns chromatography and kinetic resolution, although this latter has been overcome by 





As anticipated, many synthetic pathways can lead to obtain allene functionalities. Some examples 





Already at a first glance, it is inferable that the earliest preparations involved harsh conditions 
(large excesses of strong bases, hazardous reagents, high temperatures…) and were mainly based 
on the well established methods for introducing a carbon carbon double bond into an organic 
compound that already possessed a bond of this kind.5,18 However, as time went on, newer 
techniques became available which were specific to the synthesis of allenes, notably the first 
seemingly general method being the dehalogenation of gem-dihalocyclopropanes (later known as 
the Doering-Moore-Skattebøl rearrangement),19 developed together with the 1,4 additions to 
vinylacetylenes and the rearrangement of acetylenes 20. Then several other protocols were found, 
                                                           
18
 D. R. Taylor, Chem. Rev. 1967, 67, 317. 
19
 L. K. Sydnes, Chem. Rev. 2003, 103, 1133. 
20
 For selected examples: (a) A. E. Favorsky, J. Prakt. Chem. [2] 1888,382. (b) Y. I. Ginzburg, Zh. Obshch. 
Khim. 1940, 10, 513. 
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such as Claisen and sigmatropics rearrangements, homologation reactions inspired by the Wittig 
reaction or procedures involving β-elimination of suitable leaving groups.21  
Nowadays, an enormously wide plethora of methods is available to the synthetic chemist;22 
primarily, further improvements were eventually brought after the 70s by the upcoming age of 
metal promoted reaction. At first, they were applied to allene synthesis with stoichiometric 
quantities of metal, where copper, mainly involved in Gilman reagents, is the metal of choice for 
what concerns generating allenes by C-C bond forming addition and substitutions reactions of 
multiply unsaturated substrates.23 Later on, the new ability to use metals in catalytic amounts, the 
most used being palladium, opened the route to new interesting processes, where the latest 
results so far have been published by Ma.24 Transition metal catalysis seems particularly attractive 
due to the possibility to obtain axially chiral allenes from achiral precursors by simply using 
catalytic amounts of chiral metal complexes.25 We will focus now on the three methods most 
developed to synthesize allenes, namely a propargylic rearrangement, a Crabbé homologation 
reaction and a hydride transfer with LiAlH4. 
 
 
Allenes from propargyl electrophiles via LiAlH4 
 
A wide area in allene synthesis is covered by the use of aluminum reagents. The use of aluminum-
based Lewis acids for C–C bond formation processes represents the smaller part in this field; 
much more developed is the formation of C–H bonds with aluminum hydrides. Various 
propargylic electrophiles such as alcohols, ethers, halides and oxiranes can give rise to the 
corresponding allenes with the aid of lithium aluminum hydride, diisobutylaluminium hydride 
(DIBAL-H) and other aluminum hydrides. The general mechanism of this reaction claims for a 
initial coordination of the aluminum atom to an oxygen atom, eventually via deprotonation; then, 
a hydride delivery from the aluminum species to the electrophile via an SN2’ intramolecular 
reaction permits the expulsion of the leaving group and results in the formation of a new carbon-
hydrogen bond and a new carbon-carbon double bond (Figure 10).26  
                                                           
21
 For selected examples: (a) D. K. Black, S. R. Landor, J. Chem. Soc. 1965, 5225. (b) W. Oppolzer, C. Chapuis, 
Tetrahedron Lett. 1983, 24, 4665. (c) V. Mouriès, B. Delouvrié, E. Lacôte, L. Fensterbank, M. Malacria, Eur. J. 
Org. Chem. 2002, 1776. (d) Y. Zhang, H.-D. Hao, Y. Wu, Synlett 2010, 905. 
22
 (a) L. Brandsma, Synthesis of acetylenes, allenes and cumulenes: methods and techniques, 2004, Oxford, 
Elsevier. (b) K. M. Brummond, J. E. DeForrest, Synthesis 2007, 795. 
23
 A. Höffmann-Roder, N. Krause, Metal Mediated synthesis of Allenes, in Modern Allene Chemistry, 2004, 
Vol. 1., N. Krause, S. Hashmi, Weinheim, Wiley-VCH.  
24
 J. Kuang, S. Ma, J. Am. Chem. Soc. 2010, 132, 1786.  
25
 M. Ogasawara, Tetrahedron: Asymmetry 2009, 20, 259. 
26
 S. Saito, in Science of Synthesis, 2004, Vol. 7, H. Yamamoto, Stuttgart, Ed. Thieme. 
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This transformation can proceed with either syn- or anti- stereoselectivity depending on the 




Hydroxyl-directed hydride delivery with LiAlH4, since its development in 1973 by Landor and co-
workers,28 has proven to be a reliable method of allene construction from propargylic moieties 
bearing an ether as leaving group, and this methodology is still widely used today to prepare a-
hydroxyallenes. Indeed, Yoshida and coworkers recently choose this way as a step toward the 
total synthesis of enokipodin A to transform their tetrahydropyranyl propargyl ether into the 
corresponding-hydroxyallene in 83% yield (Figure 11).29  
However, this protocol is not limited to THP-protected substrates, but on the contrary it can be 
applied to other kind of ethers (silyl and methyl substituted30) and oxygenated leaving groups, 
including acetals;31 neither has oxygen necessarily to accomplish this function, since these 
reactions number propargyl chlorides as excellent substrates too. For example, propargyl 
chlorides can successfully be transformed into their allenyl counterparts with LiAlH4 in high yield 




                                                           
27
 A. Claesson, L.-L. Olsson, J. Am. Chem. Soc. 1979, 101, 7302. 
28
 J. S. Cowie, P. D. Landor, S. R. Landor, J. Chem. Soc., Perkin Trans. 1 1973, 720. 
29
 M. Yoshida, Y.Shoji, K. Shishido, Org. Lett. 2009, 11, 1441. 
30
 (a) M. Lautens, P. Delanghe, J. Am. Chem. Soc. 1994, 116, 8526. (b) M. P. VanBrunt, R. F. Standaert, Org. 
Lett. 2000, 2, 705. 
31
 R. L. Snowden, S. Linder, Helv. Chim. Acta 2005, 88, 3055. 
32
 C. J. Bungard, J. Morris, J. Org. Chem. 2002, 62, 2361. 
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More recent applications of this chemistry include the employment of hydroxyls not only as a 
directing group, but also as a suitable leaving group, provided their removal as an aluminum oxide 




This method has frequently been applied in natural product synthesis. Thus, reducing propargyl 
oxiranes with DIBAL-H allowed obtaining allenic carotinoids and terpenoids as the grasshopper 
ketone (Figure 14),34 a synthesis recently adapted by Katsumura.35 Thanks to the precoordination 
of the hydride to the oxygen, these reductions proceed with high syn-diastereoselectivity.  
 
 
                                                           
33
 (a) K. M. Brummond, M. M. Davis, C. Huang, J. Org. Chem. 2009, 74, 8314. (b) M. A. Daniel, C. J. Puglisi, D. 
L. Capone, G. M. Elsey, M. A. Sefton, J. Agric. Food Chem. 2008, 56, 9183. (c) S.-C. Hung, Y.-F. Wen, J.-W. 
Chang, C.-C. Liao, B.-J. Uang, J. Org. Chem. 2002, 67, 1308. 
34
 A. Baumeler, W. Brade, A. Haag, C. H. Eugster, Helv. Chim. Acta 1990, 73, 700. 
35
 N. Furuichi, H. Hara, T. Osaki, M. Nakano, H. Mori, S. Katsumura, J. Org. Chem. 2004, 69, 7949. 
   Introduction 
Crabbé Homologation Reaction 
 
One of the most popular methods for the synthesis of allenes is the SN2’ reaction of propargylic 
derivatives with organocopper reagents.23 Most probably a study published in 1968–69 by Rona 
and Crabbé represents the first example of the Cu(I)-mediated SN2’ reaction of propargylic 
electrophiles giving allenic products.36 Since then, many researchers have used modified 
organocopper reagents with stoichiometric or catalytic amounts of Cu(I) salt, and it was again 
Crabbé to discover a homologation reaction that would have become one of the most useful 
methods for the construction of monosubstituted allenes from terminal acetylenic precursors.37 
Its mechanism consists of a copper-catalyzed addition of a propargylic substrate onto an iminium 
ion formed in situ from a Mannich-type reaction between paraformaldehyde and 
diisopropylamine. Complexation of a cuprous halide to the acetylenic triple bond results in 
formation of a π-complex. Subsequent intramolecular hydrogen transfer from the amine moiety 
to the copper species occurs to afford a hydridocopper(I) complex. The hydride is then delivered 
























This homologation reaction is still investigated, mainly to develop efficient stereoselective 
syntheses and to improve yields and tolerance of various functional groups. Indeed, it allowed the 
preparation of a wide variety of functionalized monosubstituted allenes, such as allene-
substituted alcohols, amides, carbamates and lactams. Crews and co-workers,39 for example, 
                                                           
36
 (a) P. Rona, P. Crabbé, J. Am. Chem. Soc. 1968, 90, 4733; (b) P. Rona, P. Crabbé, J. Am. Chem. Soc. 1969, 
91, 3289. 
37
 (a) P. Crabbé, D. André, H. Fillion, Tetrahedron Lett. 1979, 20, 893. (b) P. Crabbé, H. Fillion, D. André, J.-L. 
Luche, J. Chem. Soc., Chem. Commun. 1979, 859.  
38
 S. Searles, Y. Li, B. Nassim, M.-T. R. Lopes, P. T. Tran, P. Crabbé, J. Chem. Soc., Perkin Trans. 1 1984, 747. 
39
 A. K. Mandal, J. S. Schneekloth, C. M. Crews, Org. Lett. 2005, 7, 3645. 
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recently applied this method to the synthesis of the α-allenyl alcohol in Figure 16. Similarly, 
several groups have screened in the last years different conditions (employing different amines, 








A full, atom economic way to obtain the 1,2-
diene substructure features migration of a π-
bond from a non-cumulated π-bond (Figure 17). 
The non-cumulated bond can either be an 
alkyne or a conjugated or isolated diene. Thus, if group X is a hydrogen atom, a 1,3-proton shift 
occurs through deprotonation and protonation sequence, that is what is called a prototropic 
rearrangement (different X substituents could lead to sigmatropic rearrangements). Despite being 
known from the earliest days in allene chemistry,20a this still remains the most important 
isomerization reaction leading to such products, and quite surprisingly, debates on its mechanism 
have not yet come to an end.41 Strictly speaking, equilibrium between the two forms should favor 
the alkyne,42 and indeed the opposite reaction has been fruitfully applied.43However, several 
factors can drive the reaction in both directions, such as a reaction under kinetic control, a 
stoichiometric deprotonation followed by kinetic protonation, or a change of the relative 
thermodynamic stability brought, for example, by substituents. This is what happens for allenyl 
ethers and allenylamines, which are thermodynamically more stable than their propargylic 
counterparts; consequently, a prototropic rearrangement seemed a useful way too to obtain our 
nitrogen containing allenes.  
                                                           
40
 (a) B. M. Trost, A. McClory, Org.Lett. 2006, 8, 3627. (b) J. Kuang, S. Ma, J. Org. Chem. 2009, 74, 1763. (c) H. 
Nakamura, T. Sugiishi, Y. Tanaka, Tetrahedron Lett., 2008, 49, 7230. (d) V. Kumar, A. Chipeleme, K. Chibale, 
Eur. J. Org. Chem. 2008 43. 
41
 V. B. Kobychev, N. M. Vitkovskaya, N. S. Klyba, B. A. Trofimov, Russ. Chem. Bull., Int. Ed. 2002, 51, 774. 
42
 R. Kakkar, R. Garg, P. Chadha, J. Mol. Structure: THEOCHEM 2002, 617, 141. 
43








Figure 17. Prototropic rearrangement (X = H)
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In the case of propargyl substrates substituted with a nitrogen atom, most of the examples use 
potassium tert-butoxide or n-butyllithium as base, exploiting the acidity of the hydrogen at the 
propargyl position. A number of alkyl- and aryl-substituted propargylic amines and amides have 
been in fact obtained in that way,44 occasionally also providing alkynylamines as side products. In 
some cases, such as for the compound in Figure 18, potassium hydroxide and a phase transfer 




The presence of other base-labile group, such as free hydroxyl, has been evidenced as a problem, 
although in some cases good yields have been obtained with selective deprotection (the same 
happened for competition between amides and amines). On the other hand, rare examples are 





Since our research line lies in a long lasting interest toward heterocycles, we focused our efforts 
towards allenes that could bear a heteroatom in order to afford the desired products.  
In spite of the already described synthetic potential of allenes, heteroatom-substituted allenes, 
and in particular allenamines, have received relatively little attention. Conceptually, allenamines 
are synthetically useful because the nitrogen atom can donate its lone pair toward the allenic 
moiety to render them electron-rich and readily activated in the presence of an electrophile. 
However, the same high reactivity also makes them sensitive to hydrolysis, polymerization and 
isomerization even at low temperatures, thereby creating serious difficulties in preparation and 
handling. Conversely, electron-deficient allenamines, such as allenamides, have a diminished 
donating ability. Consequently they are less reactive, but represent a more stable allenic system 
                                                           
44
 For some recent examples: (a) A. G. Lohse, R. P. Hsung, Org. Lett. 2009, 11, 3430. (b) E. Skucas, J. R. Zbieg, 
M. J. Krische, J. Am. Chem. Soc. 2009, 131, 5054. (c) Á. González-Gómez, L. Añorbe, A. Poblador, G. 
Domínguez, J. Pérez-Castells, Eur. J. Org. Chem. 2008, 1370. 
45
 J. Reisch, R. A. Salehi-Artimani, J. Heterocycl. Chem. 1989, 1803. 
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and have the potential to function as an allenamine-equivalent. For these reasons, allenamides 
have been chosen as appropriate substrates for our studies. 
In particular, since we had no specific necessity to have the nitrogen atom directly substituted 
onto the allenic moiety, we envisaged that the synthesis of not only α- but also β-allenamides 
could be useful to lead to starting materials able to undergo cyclization reactions catalyzed by 
transition-metal complexes. 
The available ways to synthesize α- and β- allenamides are basically the same previously 
described for allene synthesis, and it seems unnecessary to report here specific applications to 
allenamides. It is just worth to mention the historical value of the first examples, since both 
involve the same reactivity brought by base-induced isomerization that we adopted in some of 
our protocols, thus reasserting its efficiency unchanged through years. In fact, to repeat an earlier 
preparation of a propargyl amide en route to oxotremorine, a potent muscarinic agent, Dickinson 
reported in 1967 the first preparation of allenamide from lactam under basic conditions (MeONa 
or NaH, Figure 19).46 The first acyclic allenamide, closer to our substrates, is instead due to Corbel, 
who in 1976 reported the first example of its obtention via the isomerization of N-propargyl 







Allenic compounds are able to react in so many different ways and a complete analysis would be 
beyond the scopes of this manuscript. Moreover, in most of cases allenes behave as a double 
alkene system, thus undergoing the wide panorama of reactions typically available to 
functionalize olefinic substrates (Diels-Alder reactions, dipolar cycloadditions, electrophilic 
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attacks, nucleophilic attacks when properly 
substituted…). An overview, though 
inexhaustive, of recent reactivities of alkenes 
is depicted in Figure 21.48,49  
However, since our interest deals mainly 
with transition metal catalyzed cyclization of 
allenes with nucleophiles,49d we will focus 
directly on that subclass, evidencing the 
behavior of the metals we used to investigate such reactivity, i.e. palladium, gold and ruthenium.  
 
Transition-metal catalyzed cyclization of allenes with heteroatomic nucleophiles 
For this kind of reactions, three main and hardly distinguishable mechanisms have been put 
forward. The first one is represented in Figure 22. In the presence of an electrophilic metal 




The metal-coordinated double bond is thus activated toward intramolecular nucleophilic attack 
by a nucleophile at either coordinated carbon atom. This reactivity is analogous to that observed 
in the Wacker reaction. Thus four possible σ-complexes, two vinyl and two allyl, could be formed, 
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Figure 21. Recent overviews of allene reactivity.
General: Ref. 48
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depending on the double bond attacked, the latter couple being in equilibrium with the same η3-
complex. It is also possible that the η2-complex would react with ligands (such as halides) on the 
metal, leading to other intermediates and pathways. The final reaction products would then come 
from an evolution of the above intermediates, such as reductive elimination (if the metal has a -
bonded ligand), β-elimination, protonolysis or CO insertion. 
A second alternative foresees that the insertion of the allene might then generate an η3-allyl 
complex. This could cyclize by nucleophilic attack on either terminus. In many cases either a η2- or 




The third alternative is that the metal complex initially interacts with the nucleophilic  group; this 
is followed by insertion and reductive elimination. Insertion may involve either of the allene 





The use of palladium can enable the synthesis of a variety of heterocyclic compounds starting 
from allenyl derivatives. In all known examples, heterocyclic synthesis can be accomplished when 
allene substrates interact with a palladium(II) complex, which can be directly employed in the 
reaction environment or derive from an in situ Pd(0)-oxidation process. The former protocols can 
furthermore be divided in two subclasses: in the first case, palladium can interact with the allene 
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moiety by forming a π-allyl complex, which is then intramolecularly trapped by nitrogen, as in 
reactions developed by Bäckvall and Alcaide,50 thus giving rise to halopalladation/nucleophilic 
attack sequences (Figure 25). An oxidant is needed to bring the metal to palladium(II) oxidation 




Alternatively, nitrogen may attack one or the other Pd(II)-activated unsaturations of the allene 
moiety, which behave as isolated double bonds. These reactions historically developed before 
other allene-involving processes, and hydroamination or carbonylation processes are usually 




Walkup and Gallagher52 reported a palladium-catalyzed 5-exo regioselective cyclization of allenes 
bearing a nucleophile in γ-position in the presence of iodobenzene. This kind of reactivity has 
marked a milestone in palladium catalyzed reaction of allenes; indeed, the authors proposed a 
mechanism that for the first time was not the one historically set up by Cazes and Tsuji about 
intermolecular allenes Pd(0)-carbopalladation, that is, claiming for the formation of a π-allylic 
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complex.53 Instead, an ArPd(II) complex formed in situ is here supposed to coordinate one of the 
double bonds (namely, the internal one) and undergoes a subsequent nucleophilic attack by the 
heteroatom. A reductive elimination of the metal from the vinylpalladium intermediate 























K2CO3 KHCO3 + KI
Figure 27. Nucleophilic attack / carbopalladation sequence  
 
While in most of such reactions a clear cut evidence toward the action of a mechanism or another 
lacks, some cases and mostly the first interesting example by Hiemstra54 are example of the 
effectiveness of this idea, because a carbopalladation-amination sequence would fail to explain 
the obtention of products from the allenic lactam (Figure 28).  
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Chiral allenes have also been cyclized with chirality transfer; therefore, this mechanism has been 
indicated as effective, since chiral information would be lost in a planar π-allyl intermediate.55 
However, while this mechanism has been the first to be proposed for the intervention of non-
carbon nucleophiles, a second one analogous to Cazes and Tsuji’s well established intermolecular 
version of allene carbopalladation has been later proposed in palladium catalyzed cyclizations 
onto allenes.56 The coordination of the metal to the double bond, in fact, can also lead to a 
carbopalladation process, which only in a second instance is followed by a nucleophilic attack. In 
this case, the time order between C-C and C-X bond formation is inverted in respect to the 
mechanism described so far. That is the case of reactions developed first by Kang and successively 
mostly by Ma’s group. In particular, Kang first claimed for this mechanism in a paper where he 
was also able to show how hypervalent iodonium salts could be used as aryl moiety deliverers 




Following the same mechanistic sequence, that is with the palladation step prior to the 
nucleophile addition one, allylic halides have also been trapped in lieu of aryl moieties;57 
moreover, halides (i.e., bromides) can be also used as suitable leaving groups to form allyl 
dications from bromoallenes, yielding a reactive π-allyl intermediate able to cyclize in presence or 
absence of a Pd(0) species.58  
An interesting and not yet fully explored variation on this theme has been finally discovered by 
Liu, who described a protocol in which the palladium intermediate does not deliver neither a 
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carbon nor a halogen atom onto the central allene carbon, but instead a protonic species, leading 
to a hydroamination procedure affording alkenyl substituted pyrrolidines and piperidines.59  
 
Eventually, palladium can react with nucleophile bearing allenes also in a transmetalation fashion. 
Ma and Sha discovered in fact a curious Pd(0)-Ag(I) cocatalyzed cyclization of α-allenic acids with 
aryl and vinylic halides, where a primarily cyclized silver intermediate is believed to evolve into a 
























Figure 30. Cyclization of allenes through transmetalation mechanism.  
 
Gold 
Compared to palladium, the golden era of homogeneous catalysis was born much later, nearly at 
the end of 20th century, but could find rapidly a wide application also in allene chemistry. A series 
of five- and six-membered heterocycles can be constructed using the gold-catalyzed annulation of 
allenes with pendant nucleophiles including alcohols, esters, ketones, thiols, amines, 
sulfonamides, amides, and enamines formed in situ.  
The mechanism by which these reactions usually proceed depends on the oxidation state of the 
metal. Some authors seem to evidence the existence of processes where Au(III) or Au(I)-
complexes essentially behave in the same way, thus admitting a formal in situ conversion 
between the two states.61  
However, most of all when dealing with oxygen nucleophiles, a difference between the two states 
can be evidenced, as Au(III) behaves in a more oxophylic way while Au(I) complexes prefer to 
coordinate unsaturated carbon-carbon bonds. Figure 31 depicts a gold-catalyzed 
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cycloisomerization of a bromoallene whose selectivity depends on the oxidation state of the 
catalyst used. While AuCl3 favors the formation of 3-bromofuran likely initiated by the activation 
of the carbonyl group, the lower oxidation state catalyst Et3PAuCl interacts with allene 





Toste63a and Widenhofer63b independently reported Au(I)-catalyzed intramolecular 
enantioselective hydroamination and hydroalkoxylation of allenes. Both groups utilized chiral 
dinuclear gold–phosphine complexes, which gave excellent enantioselectivities. As in previous 
studies, Toste demonstrated the effectiveness of chiral anionic counterions in the intramolecular 
hydroalkoxylation, hydroamination, and hydrocarboxylation reactions.64 As expected, the two 
strategies can be combined, so as to obtain matched and mismatched pairing effects on the 




Despite ruthenium catalysts have been mostly used in metathesis reactions of allenes, they have 
recently created their own place also in nucleophilic cyclizations.  
Indeed, Trost and co-workers first reported a ruthenium catalyzed cycloetherification and 
subsequently applied the same protocol to a cycloamination reaction.65 For both variants, two 
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alternative pathways have been postulated. The former involves the formation of a 
vinlylruthenium species and its insertion into the enone, while the second accounts for the 
formation of a ruthenacycle which is subsequently internally trapped by the nucleophilic oxygen 
or nitrogen (Figure 32). The latest studies in this field by Trost’s group describe a similar 













































Figure 32. Trost's Ru-catalyzed pyrrolidine and piperidine formation from aminoallenes  
 
A variation on this theme involves the use of carbon monoxide in lieu of enones. Indeed, it has 
proved possible to intercept the pro-nucleophile with CO prior to cyclization, this resulting in a 
series of γ− and δ-lactones and lactams.66 The mechanism proposed in this occasion involves only 
an oxidative addition of ruthenium to the N-H bond, insertion of the allene followed by that of 
carbon monoxide and a final reductive elimination to complete the sequence (Figure 33). 
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However, in contrast to palladium and gold, ruthenium has never proven able to afford any 
hydroamination product reacting with allenes (see Figure 34). 
 
   Substrates 





Alkene Alkyne Diene Allene 
[Ru(CO)2(PPh3)(PPh2C6H5C2H3)]/NH4PF6 X   X   
[Ru3(CO)12]/NH4PF6  X  X   
[Ru3(CO)12] or CuI  X  X   
[Ru3(CO)12]/NH4PF6 X   X   
[Ru3(CO)12]/HBF4OEt2 or 
[RuH(PCy3)2(CO)(CH3CN)2]BF4 
X   X   
[Ru-CHCH-C(CH3)2(Cl)(PCy3)2(CO)]BF4 X  X  X  
[Ru(2-methylallyl)2(P-P)]/TfOH X  X    
[Ru(H)Cl(CO)(PPh3)3] X  X    
[Ru(P-P)(2-methylallyl)2] X  X    
[Ru(η6-cot)(dmfm)2] or [Ru3(CO)12]  X  X   
[RuCp(C2H4)(PPh3)2]BF4 X  X    
[Ru3(CO12)]/NH4PF6 X   X   
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Heterocycles 
Our interest toward nitrogen containing heterocycles brought us soon to investigate new 
synthetic ways toward such structures exploiting allenamides. More precisely, we chose to 
incorporate α-aminoacids or anthranilic acid to the allenamide substrate so as to end up with 
two-nitrogen containing heterocycles such as imidazoles, benzodiazepines and piperazines. A 
brief description of the above heterocyclic structures is reported here below.  
Imidazolidinones (Figure 35) – Although the industrial importance of these compounds is 




Structures of this kind are utilized for instance as structural elements in a number of molecules 
with potent anti-HIV or anti-fungal activity.67 In addition, closely related to the compounds we 
were able to synthesize is a certain class of imidazolidinone compounds (also called MacMillan 
organocatalysts) which were demonstrated to be suitable catalysts for many asymmetric 
reactions.68 These catalysts work by forming in situ an activated (low LUMO) chiral iminium ion 
with carbonyl groups of α,β-unsaturated aldehydes (enals) and enones able of transferring a high 
asymmetric induction to the final product. The catalysts have been used in Diels-Alder reactions, 
Michael additions, Friedel-Crafts alkylations, transfer hydrogenations and epoxidations, and they 
are now commercially available. 
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Piperazines (Figure 36) – Piperazines and their keto derivatives are amongst the most important 
backbones in today’s drug discovery. Owing to the high number of positive hits encountered in 
biological screening with this heterocycle and its congeners, and the presence of this moiety in 
complex natural products, the piperazine template too certainly deserves the title of "privileged 
scaffold" in medicinal and drug chemistry.69 Moreover, the ability of these scaffolds to impart 
specific conformational properties and protein-like characteristics to their derivatives, gives them 
also the role of basic skeleton for many peptidomimetic structures.70 Thus, it is no wonder that 
there is an increasing interest in the development of new synthetic methods that allow for the 




Unfortunately, public opinion has been recently interested on piperazines as they emerged as a 
new ‘family” of drugs for non-medical recreational purposes. BZP (Benzylpiperazine, A2, a.k.a. 
Frenzy or Nemesis), TFMPP (1-[3-(trifluoro-methyl)phenyl]piperazine) and mCPP (meta-
chlorophenylpiperazine, 1-(3-Chlorophenyl)- piperazine) are psychoactive drugs with stimulant 
effects comparable to amphetamines but with a lower potency and differential global scheduling 
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status. Much attention is being deserved to piperazines in Bulgaria, where they are not controlled 
by law neither banned, and they have been sold as a supposed legal alternative to ecstasy.71 
Benzodiazepines – The first benzodiazepine, 
chlordiazepoxide, was synthesized in 1955 by Leo 
Sternbach while working at Hoffmann–La Roche on the 
development of tranquilizers.72 The pharmacological 
properties of the compounds prepared initially were 
disappointing, and Sternbach abandoned the project. Two 
years later, in April 1957, co-worker Earl Reeder noticed a 
"nicely crystalline" compound left over from the discontinued project while spring cleaning in the 
lab. This compound, later named chlordiazepoxide, had not been tested in 1955 because of 
Sternbach's focus on other issues. Expecting the pharmacology results to be negative and hoping 
to publish the chemistry-related findings, researchers submitted it for a standard battery of 
animal tests. Unexpectedly, the compound showed very strong sedative, anticonvulsant and 
muscle relaxant effects. These impressive clinical findings led to its speedy introduction 
throughout the world in 1960 under the brand name Librium. Following chlordiazepoxide, 
diazepam was marketed by Hoffmann–La Roche under the brand name Valium in 1963, and for a 
while these two “mother little helpers”73 were the most commercially successful drugs. The new 
group of drugs was initially greeted with optimism by the medical profession, but gradually 
concerns arose; in particular, the risk of dependence became evident in the 1980s. However, 
although other antidepressants with anxiolytic properties have been introduced, and there is 
increasing awareness of the adverse effects of benzodiazepines, prescriptions for short term 
anxiety relief have not significantly dropped. Only for treatment of insomnia benzodiazepines are 
now less popular than nonbenzodiazepines, which include zolpidem, zaleplon and eszopiclone. In 
spite of the molecular difference between the two classes, they work on the same receptors. The 
main effect of benzodiazepines is to enhance the activity of the neurotransmitter γ-aminobutyric 
acid, which results in sedative, hypnotic (sleep-inducing), anxiolytic (anti-anxiety), anticonvulsant, 
muscle relaxant and amnesic action. These properties make benzodiazepines useful in treating 
anxiety, insomnia, agitation, seizures, muscle spasms, alcohol withdrawal and as a premedication 
for medical or dental procedures. Benzodiazepines are categorized as either short-, intermediate- 
or long-acting. Short- and intermediate-acting benzodiazepines are preferred for the treatment of 
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Figure 37 - Diazepam,
world's most famous benzodiazepine
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insomnia; longer-acting benzodiazepines are recommended for the treatment of anxiety. 
Benzodiazepines work by increasing the efficiency of a natural brain chemical, GABA, to decrease 
the excitability of certain types of brain cells called neurons. This reduces the communication 
between neurons and therefore has a calming effect on many of the functions of the brain. 
Quinazolinones (Figure 38) - The name quinazoline was first proposed for this compound by 
Weddige,74 on observing that this was isomeric with the compounds cinnoline and quinoxaline. Of 
the many derivatives of quinazoline system known so far, keto-quinazolines also called as 
quinazolinones, are the most important compounds. The quinazolinone skeleton is a frequently 
encountered heterocycle in medicinal chemistry literature with applications including 
antibacterial, antimalarial, CNS depressant, antiparkinsonism, antiviral and anticancer activities.75 
Little number of quinazolinones was also reported as potent chemotherapeutic agents in the 
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Results 
  Results 
 
1) First cyclization: behavior of aminoallenes under metal-
free conditions 
 
At first, we decided to investigate the feasibility of cyclization processes onto allenes that could 
have been built starting from α-aminoacids, that is, with a pre-introduced chiral information in 
the starting materials able to be kept till the obtention of the final enantiopure products. The 
easiness of the conversion of a carboxylic acid into an amide, and the commercial availability of 
many suitable propargyl amines apt to insert a triple bond further convertible into an allene 
group, supported the choice of these building blocks. We consequently synthesized a series of 
propargylamides 1a-d starting from N-Boc-protected commercially available L-aminoacids and 
methylpropargylamine by treatment with DCC (1.2 equiv.) and 4-(dimethylamino)pyridine (0.02 




Then, chosen propargylamide 1a as the model skeleton for our study, we envisioned a prototropic 
rearrangement as a convenient way to access the desired allene 2a. The outcome of these 
isomerizations is normally strongly dependent on the reaction time. Indeed, basic conditions are 
reported to give rise to an allene intermediate which can either regenerate the starting alkyne or 
evolve to the internal propargylic homologue, thus realizing the so-called “acetylene zipper” 
reaction. Therefore, we initially submitted 1a to different bases and reaction times in order to 
identify the best conditions to favor equilibration to the allene products. In our case, however, a 
further interesting behavior was observed. Indeed, while the formation of allene 2a effectively 
took place, a prolonged exposure to the base afforded this latter along with complex mixtures of 
five- or six-membered heterocyclic products arising from intramolecular attack of the amino 
group on one of the carbon atoms of the internal unsaturation of the allene. 
 
  Results 
 
 
With this evidence in hand, we focused our attention on this particular reactivity trying to identify 
efficient conditions to attain a synthetically useful heterocyclization procedure, and we isolated 
allene 2a for this purpose. The cleanest reaction, with limited formation of tarry products, was 
accomplished in the presence of t-BuOK (2.5 equiv. in THF at r. t. for 4 h). We obtained in this way 
the 5-methyl-3,4-dihydro-pyrazin-2-one 3a and 2-ethylydenimidazolidin-4-one 4a in 29% and 32% 




Entry Substrate R Conditions Yields (%) 
    3 4 5 
1 2a i-Pr r.t., 4h 29 32 - 
2 2a i-Pr MW irradiation, 30 min 95 - - 
3 2b i-Bu r.t., 4h 28 9 25 
4 2b i-Bu MW irradiation, 30 min 89 - - 
5 2c Bn r.t., 4h 36 8 27 
6 2c Bn MW irradiation, 30 min 72 - - 
 
The Z-configuration of compound 4a is consistent with the observed mutual NOE enhancements 
between the N-methyl group and the vinyl hydrogen atom (3.3% and 5.8%). HPLC analysis with 
chiral column of 3a and 4a, achieved in comparison to a sample of racemic mixture, proved an 
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enantiomeric purity better than 99.5%. Heterocyclization also occurred with allenes 2b,c deriving 
from L-Leucine and L-phenylalanine according to a more regioselective process.  
However, despite their structures strictly related to 2a, different ratios of five- and six-membered 
products were obtained. In fact, only small amounts of imidazolidinones 4b,c (9% and 8%, 
respectively) were obtained, while pyrazinones 3b,c were the major products besides their 
isomers 5b,c, so indicating preference for the β-C attack by the nucleophilic nitrogen (Table 1, 
entries 3 and 5). 
These reactions, carried out at room temperature, furnished the heterocyclic products in 
moderate yields, as a high amount of tarry material was also produced. Improved yields could not 
be achieved by refluxing the solution due to the thermal decomposition of the substrates. The 
heterocyclization process was also tested in a microwave reactor.77 Under these conditions, the 
reactions occurred cleanly in shorter times and higher yields giving exclusively the six-membered 
ring products 3 (Table 1, entries 2-4-6). 
Interestingly, whilst extending the scope of the cyclization, a different behavior was observed for 
allenamide 2d, arising from basic treatment of L-phenylglycine. In this case, treatment with t-
BuOK at room temperature gave rise to the formation of the racemic γ-lactam 6 as the sole 
product (Scheme 3). The observed outcome can be due to the higher acidity of the benzylic α-
aminoacidic hydrogen of 2d with respect to 2a–c. Consequently, in the presence of t-BuOK, the 
deprotonation of carbon atom instead of that of the Boc-protected amino group is operative, 
followed by nucleophilic attack of the carbanion species A on the sp-carbon. Such a mechanism 




Eventually, serendipity, as often occurs, drove us toward a further interesting result. Compound 
4a, left in an NMR-tube for some days after the requested analysis were accomplished, was found 
to be transformed to some extent into a different structure which lacked the double bond. 
Assuming this was due to the only other elements present in a deuterated chloroform solution, 
i.e. the residual acidity and traces of water, we made the hypothesis of an acid catalyzed 
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  Results 
hydration of the double bond. Indeed, treatment of 4a with catalytic amounts of p-TSA in 
THF/H2O gave smoothly and quantitatively the same compound, which was shown to be the 2-
ethyl-2-hydroxy-imidazolidin-4-one 6 (Scheme 4). This process was totally diastereoselective 
involving generation of the R-configurated new stereocenter in 2-position of the imidazolidinone 




In conclusion, we have developed a simple procedure for building monocyclic five- and six-
membered nitrogen containing heterocycles from new allenamides of L-α-aminoacids under basic 
conditions. The moderate yields of the reactions performed at ambient temperature could be 
significantly increased by applying microwave activation. Further investigations, mainly based on 
the use of transition metals, will be described in order to achieve more selective reactions and 





2) Second cyclization: a 5-exo-trig reaction through a 
carbopalladation/allylic amination sequence 
 
Although the above results deserve attention as allow a mild and metal-free way to obtain these 
cyclic structures, literature shows that transition metal-catalyzed protocols often allow cleaner 
and efficient reactions. Therefore, we went back onto our initial goal, which consisted in the 
isolation of the allenamides and test of their behavior in presence of a palladium catalyst with the 
aim of obtaining enantiopure imidazolidinone products.  
  Results 
After a thorough screening we found that the propargyl-to-allene conversion was best effected 
with reaction times as short as 1 minute. Indeed, exceeding this short time led to a mixture of the 
allenamides along with the aforementioned heterocyclic structures and other tarry products. The 
collection of substrates 1a-e78, were consequently submitted to this fast prototropic shift, yielding 




We next decided to study the palladium-catalyzed nitrogen addition onto the α-carbon of the 
allene in order to obtain imidazolidinones. As described in the introduction chapter, these 
heterocycles are the object of great interest for organic chemists. Although the TM-catalyzed 
generation of heterocyclic compounds via reactions between allene bearing a nucleophilic 
functionality and organic halides is well established, such a strategy has never been applied to 
allenamides such as 2a-e. Thus, we envisaged to obtain imidazolidinone structures through the 
set up of suitable conditions able to give rise to a pure domino79 carbopalladation-amination 




After a careful screening using 2a as the starting substrate, we found that a combination of 
Pd(PPh3)4 (2 mol%), potassium carbonate (4.0 equiv.) and iodobenzene (1.5 equiv.) in DMF, as 
reported by Kang,80 was the ideal system to promote the desired transformation.81 These 
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  Results 
conditions were totally regioselective leading to imidazolidinones 8a and 9a respectively in 55% 
and 16% yield (Scheme 7). 
 
 
The heterocyclization process occurred also with PhBr as arylating agent, although in lower yields, 
and with a Pd(II) source such as Pd(OAc)2, plausibly reduced in situ to Pd(0). The mechanism by 
which we suppose that this reaction occurs is analogous to the one depicted in Figure 29 with an 
aryl halide instead of an iodonium salt (Scheme 8).  
Once again, optimized conditions were applied to all the different allenamides 2b-e previously 




Entry R 8 (Yield %) 9 (Yield %) 
2b Me 65 12 
2c i-Bu 54 17 
2d Bn 50 19 
2e Ph 52 20 
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 On the other hand, although other bases (Et3N, Cs2CO3, t-BuOK) and solvents (acetonitrile, DMSO) also 
worked, the obtained products were contaminated by traces of byproducts possibly deriving from a 7-endo-
trig reaction. 
Table 2. Scope of the carbopalladation/amination
reaction on allenamides 2b-e
  Results 
The absolute configuration of the major and minor diastereoisomer was assigned after an X-ray 
crystal structure analysis of the minor product 9a (Image 2), which revealed a trans relationship 
between the hydrogen atoms in the stereogenic positions and indirectly proved a cis disposition 
for its diastereoisomer 8a. Analogy of the 1H NMR spectra of compounds 8a and 9a with those of 
8b-d and 9b-d, respectively, allowed the 
assignment of their absolute configuration. The 
constant presence of two rotamers in the 1H and 
13C NMR spectra of the trans diastereoisomers 
9a-e exclusively is the most peculiar feature 
allowing differentiation of the two 
diastereoisomers.  
Moreover, HPLC comparison (Chiralcel ODH 
column) of a sample of 8b with that of a racemic 
sample obtained starting from (±)-valine proved 
an enantiomeric purity better than 99.0%. The 
same analytical procedure on compound 8e 
revealed an ee of 94%.  
 
At this point, we felt that the allene structures we got in hand, combined with phenyl iodide, were 
also suitable substrates to undergo cyclization through insertion of carbon monoxide, permitting 
to achieve new different heterocycles. 
Palladium catalyzed carbonylative transformations involving allenes82 and halides83 are a useful 
tool for the preparation of several heterocycles and aromatic carbonyl compounds.  
However, much less attention has been paid to three-component reactions involving N- or O-
substituted allenes, carbon monoxide and aromatic halides (Scheme 9).84  
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 a) L. Kollár, Modern Carbonylation Methods, 2008, Weinheim, Wiley-VCH. b) R. Skoda-Földes, R., L. Kollár, 
Curr. Org. Chem. 2002, 6, 1097.   
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 a) R. D. Walkup, L. Guan, Y. Soo Kim, S. W. Kim, Tetrahedron Lett. 1995, 36, 3805. b) See ref. 80 
Image 2. ORTEP drawing of compound 9a
at 60% probability level
  Results 
 
 
As a first example, it has been reported that the carbonylation of aryl iodides or bromides in the 
presence of γ-hydroxyallenes and a palladium(0) catalyst affords aryl (tetrahydrofuran-2-yl)-vinyl 
ketones.81a This reaction was supposed to occur by addition of an initially formed aroylpalladium 
intermediate to the allenyl unit of the γ-hydroxyallene to produce a π-allylpalladium species, 
which then undergoes nucleophilic attack by the hydroxyl group to give the product. 
A similar mechanism has been claimed in an analogous reaction starting from allene substituted 
amines, previously restricted to exhibit their nucleophilicity in alkoxycarbonylation procedures.85 
A novel three component carbonylation/N-heterocyclization undergoing onto sulfonylamides 
structures was in fact reported by Kang and coworkers.81b  
However, in that case the tether between the reacting centers did not involve the presence of any 
functional group nor any further heteroatom. On the other hand, the presence of the amide 
group into our substrates represented a highly valuable goal. 
 
Accordingly, submission of 2a-c to the above optimized reaction conditions as described in 
Scheme 8 and running the reactions under CO at atmospheric pressure gave the corresponding 
enoyl imidazolidinones 10a-e. Such a result indicated, as expected, that the initially generated 
PhPd(II)I complex inserted carbon monoxide prior to undergo carbopalladation, to give the new π-
allyl complex B. Again, intramolecular allylic amination gave the final products (Scheme 10). The 
trans-configuration of 10a-e was assigned by comparing their NMR spectra with those of 
compounds 8a-e and is probably due to the bulky effect of CO group in intermediate B. The 
heterocyclization of the isopropyl-substituted substrate 2b took place giving two diastereoisomers 
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 The Pd(II)-catalyzed methoxycarbonylation of allene-substituted amines to form pyrrolidine or piperidine 
carboxylic esters was known by Gallagher et al. See: (a) T. Gallagher, I. W. Davies, S. W. Jones, D. Lathbury, 
M. F. Mahon, K. C. Molloy, R. W. Shaw, P. Vernon, J. Chem. Soc., Perkin Trans. 1 1992, 433. (b) D. N. A. Fox, 
T. Gallagher, Tetrahedron 1990 46, 4697. (c) D. N. A. Fox, D. Lathbury, M. F. Mahon, K. C. Molloy, T. 
Gallagher, J. Am. Chem. Soc. 1991, 113, 2652. (e) D. Lathbury, P. Vernon, T. Gallagher, Tetrahedron Lett. 
1986, 27, 6009. 
  Results 
in a 6:1 ratio, making possible the isolation the cis-product 11 (7%). To optimize this procedure, 
the reaction was carried out under CO pressure (20 atm), but no improvements in 




Entry R 10 (%) 
2b Me 42 
2c i-Bu 38 
2d Bn 40 
2e Ph 67 
 
Finally, we envisaged to incorporate all the reacting partners into the same reaction step, so as to 
realize a fully intramolecular carbopalladation/amination sequence. Such type of sequence is still 
rare in the literature86 and however limited to build fused-ring systems having six or more atoms 
in the formed cycles. The amination step being already intramolecular, the key point was to 
realize an intramolecular carbopalladation, which could be attained tethering the aryl iodide to 
the allenamide substrate. This was obtained by alkylation of propargylamine with o-
iodobenzylbromide to give the secondary amine 12 (more careful and efficient protocols to avoid 
the formation of overalkylated products seemed unnecessary due to the easiness and rapidity of 
this protocol as well as to the extremely low cost of the reactants). Subsequent treatment with 
the appropriate aminoacids under standard DCC conditions afforded the propargyl amides 13a-c, 
which were isomerized to the corresponding allenamides 14a-c (Scheme 11). 
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Table 3. Scope of the carbonylation
reaction on allenamides 2b-e
































Table 4. Yields of the
condensation and of the
propargylic rearrangement













Subsequent carbopalladation/amination of the latter using Pd(PPh3)4 catalyst and K2CO3 as base 
gave the expected tricyclic products 15a-c (respectively in 54%, 59% and 51% yield) and 16a,b (8% 
and 6% yield) in a 6.5:1 diastereomeric ratio. Comparison of the 1H NMR spectra of these products 
with those of 8a-e allowed assignment of a cis configuration to the former set of major isomers 
and a trans one to the minor ones, which could be isolated only in the case of substrates arising 
from valine and leucine (16a,b).  
The generation of the 1,5,10,10a-tetrahydro-2H-imidazo[1,2-b]isoquinolin-3-ones 15 and 16 can 




Boc-AA R Yields (%) 
Val i-Pr 13a (90%) 14a (95%) 
Leu i-Bu 13b (81%) 14b (93%) 
Ala Me 13c (79%) 14c (93%) 
  Results 
The initial generation of ArPd(II)I complex C by oxidative addition of the iodobenzene moiety to a 
Pd(0) species is followed by intramolecular carbopalladation of the central carbon of the allyl 
group to give the π-allyl intermediate D. At this point, the intramolecular nucleophilic attack of 
the nitrogen on the inside position of the Pd-complex generates the imidazolidinone products 
with concomitant expulsion of the Pd(0) species, able to restart the catalytic cycle.  
Inspection of molecular models of the likely equilibrating diastereomeric η3-allyl Pd complexes D1 
and D2 shows that nitrogen attack from the former one (D1) is relatively easy, whereas that from 
the latter one (D2) experiences a sever steric clash between the aminoacid residue and the allyl 
moiety. As a consequence, the higher reactivity of complex D1 over D2 well accounts for the 




In summary, we have developed a new and original approach to enantiopure imidazolidin-4-ones 
and imidazoisoquinolinones by means of a domino carbopalladation/allylic amination process, 
starting from α-amino allenamides of amino acid derivation. In all three protocols developed, the 
vinyl group present in the final products may allow further improvement of the known 
organocatalytic properties of such compounds. Moreover, the results have established the 
feasibility of the above heterocyclization process having an amide group in the tether, without 
any interference of the carbonyl oxygen. Work is now in progress to investigate the ability of the 
newly obtained imidazolidin-4-ones as building blocks for more complex structures87 and as 
organocatalysts in reactions involving R-unsaturated aldehydes.88 
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  Results 
3) Shifting towards the obtention of 7-membered heterocycles 
 
This part of my thesis has been spent in the laboratories of professor Poli’s group at Université 
Pierre et Marie Curie, in Paris, in the frame of a cooperation agreement. The main goal we 
intended to achieve was a palladium-catalyzed synthesis of benzodiazepines using allene 
substrates. In particular, our interest was devoted to 1,4-benzodiazepin-5-ones, a subset of many 
biologically and pharmacologically active compounds.89 Thus, synthesis of new analogues of this 
structure is highly desirable as it might allow obtaining new compounds showing better 
pharmaceutical activity. Interestingly, the synthesis of simple bicyclic skeletons, which have 
captivated interest as simplified forerunners of active tricyclic systems,90 has not been extensively 
reported as compared to that of other 1,4-benzodiazepinone derivatives. 
In fact, known methods to access these compounds start from substrates such as benzamides91 or 
anilines,92 and require appropriate pre-functionalizations or harsh conditions, or lack in atom 
economy. Aryne nucleophilic substitutions93 also hide limited diversity as a drawback. Better 
results are obtained with supported and solid synthesis.94 More appealing transition-metal 
catalyzed processes have also been developed. However, although some of these reactions have 
been reported to form tricyclic 1,4-benzodiazepin-5-ones,95 just one Pd(II)-catalyzed 
intramolecular route to bicyclic structures is known.96 
To widen this research area, we envisioned allenes as suitable substrates, and herein we 
developed the first synthesis of bicyclic 1,4-benzodiazepin-5-ones via a pure domino Pd(0) 
catalyzed carbopalladation/allylic amination process involving allenes. To the best of our 
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  Results 
knowledge, such reactivity has never been explored in reactions leading to 7-membered nitrogen 
containing cycles. To obtain such a goal, we forcedly needed an interatomic distance of 6 atoms 
between the two reacting centers, since the new bond we wanted to build would have 
represented the seventh bond of the azepinic ring. The ideal substrate to fruitfully accomplish this 
condition was identified with compound 23a, whose synthesis was projected to undergo in seven 
steps starting from the propargylic alcohol 17. 
Part of the synthesis followed a way already developed into professor Poli’s laboratory for a 
different work on a carbopalladation/alkylation protocol on allenes.97 Namely, the motivation 
leading to the three steps toward compound 19 are completely described into doctor Kammerer’s 




A significant change was brought in the transformation of 19. Previously adopted protections (i.e., 
benzyl carbonate, benzoate and acetate) all showed some limitations in yield (carbonate) or 
handling (very low volatility of the two ester groups). Since the yields obtained with the two ester 
groups were however higher than what observed with the carbonate protection, we consequently 
chose a different and heavier residue on the ester protection in order to avoid the volatility issue. 
To our delight, the ester 20 resulting from condensation between phenacetyl chloride and allene 
19 was obtained in high yields and did not evaporate to any observable extent at atmospheric 
pressure (Scheme 15).  
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  Results 
 
 
The last reaction was a palladium-catalyzed nucleophilic substitution. Amine 21, previously 
identified as the best partner, efficiently reacted with compound 20 to yield amide 22. After 
deprotection we obtained the desired allenamine 22. Eventually, a simple condensation reaction 
with tosyl-protected anthranilic acid98 afforded the allenyl anthranilic amide 23a with an overall 
yield of 17% after 7 steps (Scheme 16). This latter and 4-iodotoluene (1.2 equiv.) were chosen as 




The system Pd(OAc)2/NaH gave a modest conversion (Table 5, entry 1). On the other hand, the 
use of phosphine-free conditions as previously reported by us95 was more successful (Table 5, 
entry 2). The active species was generated dissolving Pd(CH3CN)2Cl2 (5 mol%) as precatalyst in 
DMSO in the presence of BuLi (10%), 4-iodotoluene (1.2 equiv.) and TBAB (20%); then a solution 
of sodium amidate (obtained through deprotonation of amide 23a by NaH) in DMSO was added. 
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  Results 
When the same experiment was repeated at 90 °C, the yield of 24a could be raised to 82% (Table 
5, entry 3). On the other hand, switching to a carbonate as the base (entries 4, 5 and 6) or 




Chosen the best conditions for 
the reaction, we then 
investigated the reactivity of 
different protecting group on 
the nucleophilic nitrogen. This 
was aimed to obtain 
unprotected 
benzodiazepinones, in order to 
identify another site on the 
vinyl-substituted products that 
could lead to further 
functionalizations. Results are 
summarized in Table 6. 





1 Pd(OAc)2 (5%) NaH (1.2 eq) 50 - CH3CN 75 27 
2 Pd(CH3CN)2Cl2 (5%), BuLi (10%) NaH (1.2 eq)  r.t.->50 TBAB (20%) DMSO 84 46 
3 Pd(CH3CN)2Cl2 (5%), BuLi (10%) NaH (1.2 eq) 50
 
->90 TBAB (20%) DMSO 100 82 
4 Pd(CH3CN)2Cl2 (5%), BuLi (10%) Cs2CO3 (2 eq) 50 TBAB (20%) DMSO 6 n.i. 
5 Pd(CH3CN)2Cl2 (5%), BuLi (10%) K2CO3 (2 eq) 50 TBAB (20%) DMSO 20 n.i. 
6 Pd(CH3CN)2Cl2 (5%), BuLi (10%) K2CO3 (2 eq) 90 TBAB (20%) DMSO 20 n.i. 













1 SES  - - - - 
2 BOC  58% (23b) 48% (24b) - 











Obtained product 26. See discussion in the text and 
notes below Scheme 16 
a) Isolated yield. Deprotection conditions: b) PhSH (1 eq), K2CO3 (1 eq), DMF, r.t., 
4h. c) PhSH (1 eq), K2CO3 (1 eq), DMF, 50°C, 24h d) TBAF, THF, reflux e) Mg, 
MeOH, reflux, 2h f) HCl, microwaves, EtOH/AcOH/H2O. 








  Results 
While N-SES protection of anthranilic acid failed (entry 1), the N-Boc protected analogues were 
discarded due to the low cyclization yield (entry 2). Other sulfonyl groups gave better results, due 
to their higher nucleophilicity (entries 3, 4), and they were subsequently studied in the 
deprotection reaction. However, deprotection of the tosyl group failed and that of the nosyl gave 
product 25 only in 13% yield (entry 3). This result was considered far from satisfactory.  
Finally, we decided to remove BOC group from allenylamide 23b to test the cyclization on an 
unprotected substrate. 1H-NMR of the crude product obtained from treatment of 23b with 
TMSCl/NaI revealed the presence of the desired NH2 group. Much to our surprise, purification 
over a silica gel column (entry 5) gave a spontaneous intramolecular hydroamination affording 
product 26. Although literature reports intramolecular hydroamination of allenes promoted by 
bases or metals, such a behavior is unprecedented. As we suspected that the hydroamination 
reaction was triggered by the acidity of silica gel, other acidic conditions were tested. After a few 
trials we found that treatment of the crude product from 23b with p-TSA (1 equiv.) in DMF at r.t. 




The above results indicated that the tosyl group was the protecting group of choice to extend our 
protocol (Scheme 18). Thus, using the optimized phosphine-free conditions, the scope of the 
domino sequence was next examined on a 0.1 mmol scale with various aryl iodides.   
Electron-rich 4-, 3- and 2-iodoanisoles all reacted smoothly, affording the expected corresponding 
benzodiazepinones 24d-f in 63%, 63% and 73% respectively. The effect of electron-withdrawing 
substituents was next investigated. Reactions of 4-methoxycarbonyl, 4-nitro and 4-acetyl 
iodobenzene gave satisfactory yields of 61%, 71% and 68% (24g-i).  
  Results 
The use of simple iodobenzene led to the benzodiazepinone 24j, which was isolated in 67% yield. 
Heteroaromatic iodides also gave good yields, as 3-iodopyridine afforded the expected product 
24k in 70% yield. The same protocol was also shown to be able to sustain substitutions onto the 
aromatic ring, since the 3-methyl anthranilic allenylamide 23l afforded the corresponding 































































BuLi (10%), TBAB (20%),
ArI (1.2 eq.), DMSO, 90 °C,
2h
1) NaH (1.2 eq.), DMSO,
50 °C, 10 min.
23a,j 24a-j
24g (61%)











The formation of 1,4-benzodiazepin-5-ones can be rationalized according to the mechanistic 
proposal depicted in Scheme 19. At first, a Pd(0) complex is generated in DMSO from 
Pd(CH3CN)2Cl2, by using BuLi as an in situ reducing agent.
99 The generation of PhPd(II)I by 
oxidative addition of iodobenzene to Pd(0)-species follows, involving a carbopalladation of the 
central carbon of the allyl moiety that gives π-allyl complex E. The nucleophilic attack of the 
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  Results 
nitrogen atom on the internal carbon atom closes the pure domino sequence, with generation of 
the benzodiazepinone products and Pd(0)-species, able to restart the catalytic cycle.  
In all the cases studied, the carbopalladation/amination sequence was totally regioselective, 
yielding the desired 1,4-benzodiazepin-5-ones as the sole products. Such an outcome is probably 













































We have in this way developed a new and original approach to 1,4-benzodiazepin-5-ones via a 
pure domino carbopalladation/allylic amination process starting from allenylamides of anthranilic 
acid. These results represent the first example of synthesis of 7-membered heterocycles starting 
from allene via carbopalladation. Besides their intrinsic pharmacological interest, the obtained 
scaffolds are an interesting DOS-compatible platform,100 amenable to modular synthesis (via the 
use of differently substituted anthranilic acids), orthogonal protections and easy modifications of 
the vinylic moiety (use of different iodides), still susceptible of further functionalizations. 
Furthermore, this study reports the first example of Brønsted-acid catalyzed intramolecular 
hydroamination of allenes. 
                                                           
100
 DOS: Diversity oriented Organic Synthesis: S. L. Schreiber, Science 2000, 287, 1964. 
























4) Exploiting the anthranilic scaffold, back to allenamides – 
A) a 6-exo trig carbopalladation/amination reaction 
 
In view of our previous studies using allenamides 2 and using the anthranilic acid fragment as the 
nucleophilic partner for our cyclizations, we logically thought to combine these two moieties so as 
to study the cyclization behavior of anthranilic enamides of type 27. In this case, a 6-exo-dig, a 7-
exo or endo-dig or an 8-endo-dig process would generate quinazolinones, benzodiazepinones or 


































Accordingly, anthranilic acid was N-Boc protected,101 then transformed into propargyl amide 28a. 
Subsequent base-promoted prototropic rearrangement gave the corresponding desired 
allenamide 27a (Scheme 21). Following a similar protocol, a series of additional 6 anthranilic acid 
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 T. Vilaivan, Tetrahedron Lett. 2006, 47, 6739. 
















With these precursors in hand, their submission to the previously mentioned optimized 
conditions (Pd(PPh3)4 (5 mol%), aryl iodide (1.5 equiv.), potassium carbonate (4 equiv.), DMF, 100 




As depicted, we obtained a large variety of quinazolinonic products, arising from a 6-exo-dig 
cyclization process. This was achieved by using: 
R Yields (%) R Yields (%) 



















Benzyl 28d (50%) 27d (47%)    




































  Results 
i) differently substituted aryl iodides; 
ii) substrates bearing different substitutions on the amidic nitrogen;  
iii) substrates bearing different substitutions on the aromatic ring. 
 
Conversely to what observed in the cyclization of 2, the nature of the halogen atom is crucial to 
attain the formation of styrylquinazolinones, as the replacement of iodine for a less reactive 
bromine atom led only to the recovery of unreacted starting material. The mechanism is expected 





4)  Exploiting the anthranilic scaffold, back to allenamides – 
B) a 6-exo trig hydroamination reaction 
All the cyclized products presented so far show an interesting double bond susceptible of further 
functionalizations. However, the constant presence of a phenyl ring into the vinyl appendage 
somewhat reduces the possibility of obtaining highly differentiated compounds. As a 
consequence, we turned our attention toward variations of this cyclization that allow the 
formation of a vinyl appendage as opposed to a less interesting styryl moiety.  
  Results 
The first envisaged strategy, inspired from recent results of our group,102 was based on a Pd(0)-
catalyzed hydroamination process. However, a preliminary test using allenamide 27a indicated 
that such a process was not satisfactory (Table 9).  
 
 
Entry Conditions Solvent T (°C) Time Outcome 
1 Pd(PPh3)4 (5 mol%), MW Toluene 25-150 °C 2h 30a (10%) 
2 Pd(PPh3)4 (5 mol%), K2CO3 (2 equiv.), MW Toluene 25-120 °C 25 min n. r. + degradation 
3 Pd(PPh3)4 (5 mol%), MW CH3CN 25-100 °C 45 min n. r. + degradation 





Alternatively, a hydroamination reaction of allenes can also be accomplished under a palladium(II) 
catalysis in presence of an oxidant system, as recently demonstrated in studies by Liu and 
coworkers.59 However, also in this case we did not obtain clear cut results, as 
allenes 27 reacted to some extent, but unfortunately were only transformed into 
a compound whose structure is supposed to be 31, although in too low yields to 
be isolated and characterized.103 Therefore, we abandoned palladium catalysis 
shifting to other transition metals.  
Platinum was soon discarded after few trials in light of the unsatisfactory ratio observed between 
the not enthusiastic yields and the cost of the catalyst; on the other hand, prompted by the good 
results obtained by another branch of our group onto gold-catalyzed allene hydroamination 
reactions, 104 we submitted allene 27a to some gold-catalyzed protocols obtaining results 
described in Table 10.  
                                                           
102
 E. M. Beccalli, A. Bernasconi, E. Borsini, G. Broggini, M. Rigamonti, G. Zecchi, J. Org. Chem. 2010, 75, 
6923. 
103
 Allenes 2 were also unable to give any cyclization product when submitted to Pd(II)-catalyzed reactions. 
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  Results 
 
Entry Reagents Solvent T (°C) Time Outcome 
1 AuCl3 (5 mol%) MeCN Reflux 12h Starting material 
2 AuCl3 (5 mol%), AgOSO2CF3 (10 mol%) CH2Cl2 r.t. 12h Starting material 
3 Au(PPh3)Cl (5 mol%), K2CO3 (1.5 equiv.) MeCN Reflux 12h Starting material 
4 AuCl3 (10 mol%), MW toluene 25 to 110 2 h Starting material 
4 AuCl3 (5 mol%) MeCN Reflux 12h 30a (45%) 
5 
Au(PPh3)Cl (7.5 mol%), K2CO3 (1.5 
equiv.) 
MeCN Reflux 12 h Starting material 





20 h Starting material 
6 
AuCl(PPh3) (7.5 mol%), AgOAc (22.5 
mol%), CuCl2 (5 equiv.) 




No cyclized product was obtained either in the presence of gold(I) catalyst or in combination with 
an oxidant. The reaction proceeded only in presence of an Au(III) catalyst (entry 4) and in 
moderate yields. Acetonitrile at reflux was necessary for the cyclization. Once identified the best 
protocol, we applied it to a number of different compound, obtaining the cyclized products 
depicted in Scheme 23. 
 
 
  Results 
Despite the promising results obtained under gold catalysis, we decided to continue our study 
switching to Ru catalysis. This choice was motivated by the low cost of RuCl3 and by the fact that 
Ru-catalyzed hydroaminations of allenes is, to the best of our knowledge, still unknown. Our 
results are shown in Table 11. 
 
 
Entry Catalytic System Solvent T (°C) Time Products 
1 
RuCl3·2.4H2O (1 mol%), dppp (1 mol%), 
K2CO3 (2 equiv.), allylacetate (4 equiv.) 
MeCN 80 °C 20 h 
30a (26%) + 
starting material 
2 
RuCl3·2.4H2O (1 mol%), dppp (1 mol%), 
K2CO3 (2 equiv.), allylacetate (4 equiv.) 
dioxane 




30a (5%) + starting 
material 
3 
RuCl3·2.4H2O (1 mol%), dppp (1 mol%), 
K2CO3 (2 equiv.), allylacetate (4 equiv.) 
N-Me-
morpholine 




RuCl3·2.4H2O (1 mol%), dppp (1 mol%), 
K2CO3 (2 equiv.), allylacetate (4 equiv.),  
MeCN 80 °C 48 h 
30a (40%) + 
starting material 
5 
RuCl3·2.4H2O (1 mol%), dppe (1 mol%), 
K2CO3 (2 equiv.), allylacetate (4 equiv.) 
MeCN 60 °C 2 h 30a (80%) 
6 
dppe (1 mol%), 
K2CO3 (2 equiv.), allylacetate (4 equiv.) 
MeCN 60 °C 24 h Starting material 
7 
RuCl3·2.4H2O (1 mol%), K2CO3 (2 equiv.), 
allylacetate (4 equiv.) 
MeCN 60 °C 24 h 30a (tracce) 
8 
RuCl3·2.4H2O (1 mol%), Bu4NCl (1 
mol%), K2CO3 (2 equiv.), allylacetate (4 
equiv.) 
MeCN 60 °C 24 h Starting material 
9 
RuCl3·2.4H2O (1 mol%), dppe (1 mol%), 
K2CO3 (2 equiv.) 
MeCN 60 °C 24 h Starting material 
10 
RuCl3·2.4H2O (1 mol%), dppe (1 mol%), 
K2CO3 (2 equiv.), BQ (4 equiv.) 
MeCN 60 °C 24 h Starting material 
11 
RuCl3·2.4H2O (1 mol%), dppe (1 mol%), 
K2CO3 (2 equiv.), O2 
MeCN 60 °C 24 h 30a (20%) 
12 
RuCl3·2.4H2O (1 mol%), dppe (1 mol%), 
K2CO3 (2 equiv.), CuCl2 (5 mol% equiv.), 
O2 
MeCN 60 °C 24 h 30a (5%) 
13 
RuCl3·2.4H2O (1 mol%), dppe (1 mol%), 
K2CO3 (2 equiv.), CuCl2 (1 equiv) 
MeCN 60 °C 2 h 30a (90%) 
 
  Results 
The conditions reported by Kondo for intramolecular amination reactions on olefins105 furnished 
the hint for undergoing the investigation on our allene substrates We initially screened the 
influence of different solvents (entries 1-3). While dioxane and N-Me-morpholine didn’t give 
satisfactory results, acetonitrile brought to the desired product in a 26% yield. This was 
consequently chosen as the ideal solvent. Prolonging reaction the yield increased (entry 4), 
although conversion was not total yet. This latter condition was accomplished by using a different 
phosphine ligand, which afforded the vinyl quinazolinone 29a in 80% yield. Substitution of allyl 
acetate with copper chloride as oxidant (entries 12 and 13) slightly improved the yield up to 90%; 
the use of several ligands able to stabilize in a different way the ruthenium complex or to 
intervene somehow in the reaction mechanism has not brought so far to better results than the 
ones obtained with entry 5. These results prompt us to look for better conditions; indeed, the 
reaction is still under investigation, as well as its mechanistic pathway, still unclear. However, it is 
possible to infer some key features of this reaction from experimental evidences, that is: a) an 
oxidant is surely needed, as its absence inhibits the cyclization process (entry 9), and b) critical for 
the reaction success are phosphines as ligands for whatever may be the ruthenium species 
involved in the reaction.
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We have developed six strategies resulting in the synthesis of novel diheteroatomic nitrogen 
containing heterocyclic scaffolds, exploiting the reactivity of allene compounds. 
 
The first strategy provided useful piperazinonic structures through a metal-free base-catalyzed 
cyclization reaction. The use of a metal, namely palladium, was instead investigated in three 
different protocols which led to the obtention of imidazolidinones, benzodiazepinones and styryl-
substituted quinazolinones. Finally, gold and ruthenium were able to promote an intramolecular 
hydroamination process able to yield vinyl-substituted quinazolinones.  
 
The main reaction which we focused our attention on has been the carbopalladation/allylic 
amination sequence, which has been extensively exploited and applied under different conditions 
(carbonylative conditions, fully intramolecular protocols, phosphine-free catalytic systems). On 
the other hand, the ruthenium catalyzed cyclization, which is still under investigation, is worth of 





AA: aminoacid I.R.: Infra-Red 
Ac.: acetyl L: ligand 
Bn: benzyl LG: leaving group 
Boc: tert-butoxycarbonyl Me: methyl 
i-Bu: iso-butyl min: minute 
t-Bu: tert-butyl m.p.: melting point 
Cat.: catalytic nOe: nuclear Overhauser effect 
Cy: cyclohexyle NMP: N-methylpyrrolidinone 
DCC: dicyclohexylcarbodiimide NMR: Nucelar Magnetic Resonance 
DCM: dichloromethane Ns: Nosyl 
DMAP: 4,4’-dimethylaminopyridine Nu: nucleophile 
DMF: N,N-dimethylformamide PG: protecting group 
dppb: 1,4-bis(diphenylphosphino)butane Ph: phenyl 
dppe: 1,2-bis(diphenylphosphino)ethane PTSA: para-toluenesulfonic acid 
dppf: 1,1’-bis(diphenylphosphino)ferrocene i-Pr: iso-propyl 
d.r.: diastereomeric ratio r.t.: room temperature 
e.e.: enantiomeric excess SES: trimethylsilylethanesulfonyl 
equiv.: equivalent TBAB: tetrabutyl ammonium bromide 
Et: ethyl TBDMS: tert-butyldimetylsilyl 
EWG: electron withdrawing group THF: tetrahydrofuran 
h: hour TLC: thin layer chromatography 
HPLC: High liquid pressure chromatography Ts: tosyl 
Experimental Section
 




 Experimental Section  












DCC (10 mmol), N-methyl-propargyl amine (8.3 mmol) and DMAP (0.125 mmol) in anhydrous 
CH2Cl2 (60 mL), cooled at 0 °C, were slowly added to a solution of the appropriate Boc-protected 
α-aminoacid (10 mmol). The resulting solution was stirred at r.t. for 48 h, then filtered on a path 
of silica gel. The solvent was evaporated under reduced pressure and the crude residue was 








Colorless oil.  
IR (nujol): 3304, 3298, 2119, 1703, 1651 cm-1;  
[α]23D = +29.5 (c = 0.80, CHCl3); 
Rotamers ratio 2.5:1 
 
1H NMR (400 MHz, CDCl3)  
δ: 0.92 (3H, d, J = 6.6 Hz), 0.99 (3H, d, J = 6.6 Hz), 1.45 (9H, s), 1.90-2.05 (1H, m), 2.24 (1H, d, J = 
2.3 Hz), 2.93 (3H, s), 3.75-3.85 (1H, m), 4.15-4.30 (2H, m), 5.33 (1H, d, J = 8.9 Hz) (major rotamer); 
0.66 (3H, d, J = 6.7 Hz), 0.72 (3H, d, J = 6.7 Hz), 1.18 (9H, s), 1.70-1.80 (1H, m), 2.22 (1H, d, J = 2.3 
Hz), 2.76 (3H, s), 3.75-3.85 (1H, m), 4.15-4.30 (2H, m), 5.33 (1H, d, J = 8.9 Hz) (minor rotamer). 
 
13C NMR (100 MHz, CDCl3)  
δ:17.6 (q), 19.5 (q), 28.5 (q), 31.5 (d), 34.7 (q), 36.7 (t), 55.2 (d), 72.6 (d), 78.5 (s), 79.3 (s), 156.0 
(s), 172.3 (s) (major rotamer);  
17.7 (q), 19.8 (q), 28.5 (q), 31.4 (d), 34.7 (q), 39.5 (t), 55.4 (d), 73.6 (d), 78.5 (s), 79.4 (s), 
155.9 (s), 172.4 (s) (minor rotamer).  
 









Colorless oil.  
IR: 3310, 3282, 2112, 1708, 1649 cm-1. 
[α]23D = +17.5 (c = 0.69, CHCl3)  
Rotamers ratio 2.5:1. 
 
1H NMR (400 MHz, CDCl3)  
δ: 0.95 (3H, d, J = 6.8 Hz), 1.02 (3H, d, J = 6.8 Hz), 1.34-1.51, (11H, m), 1.70-1.80 (1H, m), 2.24 (1H, 
d, J = 2.5 Hz), 3.16 (3H, s), 4.16 (1H, d, J = 17.2 Hz), 4.26, (1H, d, J = 17.2 Hz), 4.60-4.68 (1H, m), 
5.29 (1H, d, J = 8.0 Hz) (major rotamer);  
0.95 (3H, d, J = 6.8 Hz), 1.02 (3H, d, J = 6.8 Hz), 1.34-1.51 (11H, m), 1.70-1.80 (1H, m), 2.34 (1H, d, J 
= 2.5 Hz), 3.03 (3H, s), 3.99 (1H, d, J = 17.2 Hz), 4.46 (1H, d, J = 17.2 Hz), 4.60-4.68 (1H, m), 5.23 
(1H, d, J = 8.0 Hz) (minor rotamer).  
 
13C NMR (100 MHz, CDCl3)  
δ: 22.1 (q), 23.8 (q), 25.0 (d), 28.7 (q), 34.5 (q), 37.0 (t), 42.8 (t), 49.1 (d), 72.6 (d), 78.6 (s), 79.8 (s), 
156.0 (s), 173.1 (s) (major rotamer);  
22.1 (q), 23.8 (q), 25.0 (d), 28.7 (q), 33.9 (q), 39.6 (t), 42.4 (t), 49.0 (d), 73.6 (d), 78.2 (s), 80.6 (s), 
156.0 (s), 173.1 (s)(minor rotamer).  
 









Colorless oil.  
IR: 3306, 3295, 2121, 1705, 1650 cm-1  
[α]23D = +38.8 (c = 0.40, CHCl3)  
Rotamers ratio 3:1  
 
1H NMR (400 MHz, CDCl3)  
δ: 1.43 (9H, s), 2.22 (1H, d, J = 2.4 Hz), 2.73 (3H, s), 2.80-3.20 (2H, m), 4.02 (1H, d, J = 17.2 Hz), 
4.21 (1H, d, J = 17.2 Hz), 4.80-4.85 (1H, m), 5.41 (1H, d, J = 7.9 Hz), 7.19-7.30 (5H, m) (major 
rotamer);  
 Experimental Section  
1.41 (9H, s), 2.27 (1H, d, J = 2.4 Hz), 2.80-3.20 (5H, m), 3.82 (1H, d, J = 17.2 Hz), 3.97 (1H, d, J = 
17.2 Hz), 4.80-4.85 (1H, m), 5.30-5.40 (1H, m), 7.19-7.30 (5H, m) (minor rotamer).  
 
13C NMR (100 MHz, CDCl3) δ: 28.7 (q), 34.4 (q), 36.9 (t), 40.4 (t), 51.9 (d), 72.6 (d), 78.4 (s), 80.0 (s), 
127.3 (d), 128.8 (d), 129.9 (d), 136.6 (s), 155.4 (s), 171.8 (s) (major rotamer); 
28.7 (q), 33.8 (q), 39.4 (t), 40.0 (t), 51.9 (d), 73.7 (d), 78.4 (s), 80.2 (s), 127.3 (d), 129.0 (d), 129.6 
(d), 136.9 (s), 155.4 (s), 171.8 (s) (minor rotamer).  
 









White solid.  
M. p. 78-80 °C.  
IR: 3306, 3289, 2115, 1710, 1648 cm-1 
[α]23D = +152.2 (c = 0.94, CHCl3)  
Rotamers ratio 2.7:1  
 
1H NMR (400 MHz, CDCl3)  
δ: 1.43 (9H, s), 2.22 (1H, d, J = 2.5 Hz), 2.95 (3H, s), 4.15-4.40 (2H, m), 5.58 (1H, d, J = 7.9 Hz), 5.97 
(1H, d, J = 7.9 Hz), 7.30-7.40 (5H, m) (major rotamer);  
1.42 (9H, s), 2.22 (1H, d, J = 2.5 Hz), 3.05 (3H, s), 3.82 (1H, d, J = 17.5 Hz), 4.12 (1H, d, J = 17.5 Hz), 
5.60-5.65 (1H, m), 6.00-6.05 (1H, m), 7.30-7.40 (5H, m) (minor rotamer).  
 
13C NMR (100 MHz, CDCl3) δ: 28.7 (q), 34.6 (q), 37.4 (t), 55.7 (d), 72.7 (d), 78.3 (s), 80.1 (s), 128.1 
(d), 128.7 (d), 129.4 (d), 137.9 (s), 155.4 (s), 170.3 (s) (major rotamer);  
28.7 (q), 34.0 (q), 39.3 (t), 55.d (q), 73.8 (d), 78.3 (s), 80.1 (s), 128.1 (d), 128.7 (d), 129.4 (s), 137.9 
(s), 155.4 (s), 170.3 (s) (minor rotamer).  
 
MS: m/z 302 (M+). Anal. calcd for C17H22N2O3: C, 67.53; H, 7.33; N, 9.26. Found C, 67.42; 







Yield: 96%.  
Colorless oil.  
 Experimental Section  
IR: 3306, 3291, 2122, 1705, 1649 cm-1 
[α]23D = +9.7 (c = 1.13, CHCl3) 
Rotamers ratio 2.3:1. 
 
1H- NMR (400 MHz, CDCl3)  
δ: 1.33 (3H, d, J = 7.2 Hz), 1.45 (9H, s), 2.24 (1H, d, J = 2.0 Hz), 3.15 (3H, s), 4.20 (1H, d, J = 17.0 Hz), 
4.37 (1H, d, J = 17.0 Hz), 4.64 (1H, dq, J = 7.2, 7.2 Hz), 5.48 (1H, d, J = 7.2 Hz) (major rotamer);  
1.37 (3H, d, J = 7.2 Hz), 1.45 (9H, s), 2.34 (1H, d, J = 2.0 Hz), 3.04 (3H, s), 3.96 (1H, d, J = 17.0 Hz), 
4.40 (1H, d, J = 17.0 Hz), 4.64 (1H, dq, J = 7.2, 7.2 Hz), 5.41 (1H, d, J = 7.2 Hz) (minor rotamer);  
 
13C NMR (100 MHz, CDCl3)  
δ: 19.1 (q), 28.7 (q), 34.5 (d), 37.1 (t), 46.8 (q), 72.7 (d), 77.8 (s), 79.4 (s), 155.6 (s), 173.1 (s) (major 
rotamer);  
19.5 (q), 28.7 (q), 34.5 (d), 39.5 (t), 46.8 (q), 73.6 (d), 77.8 (s), 79.4 (s), 155.6 (s), 173.1 (s) (minor 
rotamer).  
 









Thermal heating: A solution of 2a (100 mg, 0.4 mmol) and t-BuOK (112 mg, 1.0 mmol) in THF (8 
mL) was stirred for 4 h at room temperature. The solution was filtered off through a short silica 
gel path (hexane/AcOEt 4:1 as eluent), and the solvent was evaporated under reduced pressure 
affording 3a (29 mg, 29%) and 4a (32 mg, 32%). 
 
Microwave irradiation: A solution of 2a (100 mg, 0.4 mmol) and t-BuOK (112 mg, 1.0 mmol) in THF 
(5 mL) was heated for 30 min at 50 °C and 250 Watt in a CEM Discover microwave reactor. The 
solution was filtered off through a short silica gel path (hexane/AcOEt 4:1 as eluent), and the 
solvent was evaporated under reduced pressure affording 3a as a colorless oil (95 mg, 95%). 
 
 




Yield: 29% (thermal), 95% (MW). 
Colorless oil.  
IR (Nujol): 1684, 1706 cm-1. 
[α]23D = +103.0 (c = 0.70, CHCl3). 
 Experimental Section  
1H NMR (400 MHz, CDCl3) 
δ: 0.92 (3H, d, J = 6.7 Hz),0.98 (3H, d, J = 6.7 Hz), 1.47 (9H, s), 1.83 (1H, m), 2.06 (3H, s), 3.02 (3H, 
s), 4.34 (1H, m), 5.47 (1H, s).  
 
13C NMR (100 MHz, CDCl3)  
δ: 18.0 (q), 19.4 (d), 28.3 (q), 28.6 (q), 33.2 (q), 63.8 (d), 81.8 (s), 117.8 (d), 119.7 (s), 153.4 (s), 
166.1 (s).  
 








Yield: 28% (thermal), 89% (MW). 
Colorless oil.  
IR (CH2Cl2): 1681, 1705 cm
-1. 
[α]23D = +203.7 (c = 0.23, CHCl3). 
 
1H NMR (400 MHz, CDCl3) 
δ: 0.95 (3H, d, J = 6.6 Hz),0.99 (3H, d, J = 6.6 Hz), 1.26-1.35 (2H, m) 1.47 (s, 9H), 1.60-1.65 (1H, m), 
2.06 (3H, s), 3.03 (s, 3H), 4.78 (1H, s br), 5.55 (1H, s).  
 
13C NMR (100 MHz, CDCl3)  
δ: 18.0 (q), 19.4 (d), 20.0 (t), 28.3 (q), 28.6 (q), 33.2 (q), 63.8 (d), 81.8 (s), 117.8 (d), 119.7 (s), 153.4 
(s), 166.1 (s).  
 








Yield: 36% (thermal), 72% (MW). 
Yellow oil.  
IR (CH2Cl2): 1680, 1708 cm
-1. 
[α]23D = +123.4 (c = 0.87, CHCl3). 
 
 Experimental Section  
1H NMR (400 MHz, CDCl3) 
δ: 1.23 (9H, s),2.12 (3H, s br), 2.78 (1H, dd, J = 13.4, 10.9 Hz) 2.93 (1H, dd, J = 13.4, 2.9 Hz), 3.07 
(3H, s), 4.98-5.02 (1H, m), 5.46 (1H, s br), 7.18-7.31 (5H, m) 
  
13C NMR (100 MHz, CDCl3)  
δ: 18.0 (q), 28.2 (q), 33.3 (q), 35.3 (t), 59.9 (d), 81.7 (s), 116.6 (d), 119.3 (s), 127.1 (d), 128.6 (d), 
130.1 (d), 137.1 (s), 152.6 (s), 166.6 (s). 
 








Yield: 32% (thermal) 
Pale yellow oil.  
IR (Nujol): 1685, 1710 cm-1.  
[α]23D = +3.7 (c 0.03, CHCl3). 
 
1H NMR (400 MHz, CDCl3)  
δ = 0.89 (3H, d, J = 6.9 Hz), 1.01 (3H, d, J = 6.9 Hz), 1.51 (9H, s), 1.71 (3H, d, J = 7.1 Hz), 2.26 (1H, 
dqq, J = 3.5 Hz, 6.9 Hz, 6.9 Hz), 2.96 (3H, s), 4.26 (1H, d, J = 3.5 Hz), 4.44 (1H, q, 
J = 7.1 Hz).  
 
13C NMR (100 MHz, CDCl3)  
δ: 13.3 (q), 17.3 (q), 19.2 (q), 26.2 (q), 28.6 (q), 32.8 (d), 66.7 (d), 82.3 (s), 89.2 (d), 138.6 (s), 152.7 
(s), 170.5 (s).  
 








Yield: 9% (thermal) 
Pale yellow oil.  
IR (Nujol): 1683, 1709 cm-1.  
[α]23D = +13.4 (c 0.05, CHCl3). 
 
1H NMR (400 MHz, CDCl3)  
 Experimental Section  
δ = 0.97 (3H, d, J = 6.7 Hz), 1.01 (3H, d, J = 6.7 Hz), 1.26-1.35 (2H, m), 1.51 (9H, s), 1.65-1.67 (1H, 
m), 1.73 (3H, d, J = 7.0 Hz), 2.98 (3H, s), 4.28-4.32 (1H, m), 4.48 (1H, q, J = 7.0 Hz).  
 
13C NMR (100 MHz, CDCl3)  
δ: 13.1 (q), 17.2 (t), 17.4 (q), 26.2 (d), 28.6 (q), 29.3 (q), 33.5 (q), 66.7 (d), 82.3 (s), 89.2 (d), 138.6 
(s), 152.7 (s), 170.5 (s).  
 















Yield: 8% (thermal) 
Pale yellow oil.  
IR (Nujol): 1688, 1709 cm-1.  
[α]23D = +10.6 (c 0.04, CHCl3). 
 
1H NMR (400 MHz, CDCl3)  
δ = 1.53 (9H, s), 1.79 (3H, d, J = 7.2 Hz), 2.65-2.81 (2H, m), 3.01 (3H, s), 4.28-4.32 (1H, m), 4.45 (1H, 
q, J = 7.2 Hz), 7.12-7.55 (5H, m). 
 
13C NMR (100 MHz, CDCl3)  
δ: 19.2 (q), 24.5 (t), 26.2 (q), 28.6 (q), 32.8 (q), 66.7 (d), 82.3 (s), 89.2 (d), 127.3 (d), 127.5 (d), 
127.7 (d), 130.4 (s), 138.6 (s), 152.7 (s), 170.5 (s).  
 








Yield: 25% (thermal). 
Colorless oil.  
IR (CH2Cl2): 1680, 1703 cm
-1. 
[α]23D = +153.7 (c = 0.14, CHCl3). 
 
1H NMR (400 MHz, CDCl3) 
 Experimental Section  
δ: 0.91 (3H, d, J = 6.6 Hz),0.96 (3H, d, J = 6.6 Hz), 1.47 (s, 9H), 1.50-1.58 (1H, m), 1.90-1.95 (2H, m), 
3.03 (s, 3H), 3.88-3.90 (2H, m), 4.43 (1H, s), 4.59 (1H, s), 4.73-4.77 (1H, m).  
 
13C NMR (100 MHz, CDCl3)  
δ: 18.0 (q), 22.4 (q), 24.8 (d), 28.3 (q), 31.1 (t), 36.2 (q), 62.9 (d), 82.8 (s), 86.8 (d), 142.7 (s), 153.5 
(s), 170.1 (s).  
 








Yield: 27% (thermal). 
Colorless oil.  
IR (CH2Cl2): 1686, 1703 cm
-1. 
[α]23D = +166.4 (c = 0.25, CHCl3). 
 
1H NMR (400 MHz, CDCl3) 
δ: 1.48 (s, 9H), 3.03 (s, 3H), 3.20-3.38 (2H, m), 3.88-3.90 (2H, m), 4.43 (1H, s), 4.60 (1H, s), 4.83-
4.90 (1H, m), 7.29-7.40 (5H, m).  
 
13C NMR (100 MHz, CDCl3)  
δ: 28.3 (q), 35.1 (t), 36.2 (q), 62.9 (d), 82.8 (s), 86.8 (d), 127.2 (d), 127.4 (d), 127.6 (d), 130.1 (s), 
142.7 (s), 153.5 (s), 170.1 (s).  
 




tert-butyl 1,4-dimethyl-2-oxo-3-phenyl-2,3-dihydro-1H-pyrrol-3-ylcarbamate (6) 
 
 
Yield: 73%.  
Pale yellow oil.  
IR (Nujol): 1697, 1712 cm-1. 
 
1H NMR (400 MHz, CDCl3)  
δ: 1.42 (9H, s), 1.74 (3H, d, J = 1.6 Hz), 3.01 (3H, s), 5.24 (1H, s br, missing after deuteration), 6.24 
(1H, q, J = 1.6 Hz), 7.37 (5H, m).  
 
 Experimental Section  
13C NMR (100 MHz, CDCl3):  
δ: 10.9 (q), 24.3 (q), 29.8 (q), 68.1 (s), 80.8 (s), 119.6 (s), 126.2 (d), 129.0 (d), 129.3 (d), 129.5 (d), 
137.5 (s), 154.4 (s), 177.8 (s).  
 


















White solid. M.p. 121–122 °C.  
IR (Nujol): 1680, 1709, 3380 cm-1.  
[α]23D = +7.1 (c = 0.03, CHCl3). 
 
1H NMR (400 MHz, CDCl3) 
δ: 0.93 (3H, X part of ABX3 system, J = 7.5 Hz), 1.00 (3H, d, J = 6.9 Hz), 1.17 (3H, d, J = 6.9 Hz), 1.52 
(9H, s), 2.07 (1H, A part of ABX3 system, J = 14.9 Hz, 7.5 Hz), 2.28 (1H, m), 2.51 (1H, B part of ABX3 
system, J = 14.9 Hz, 7.5 Hz), 2.87 (3H, s), 3.97 (1H, d, J = 4.1 Hz), 4.58 (1H, s br, missing after 
deuteriation).  
 
13C NMR (100 MHz, CDCl3) 
δ: 9.8 (q), 17.5 (q), 20.2 (d), 24.8 (q), 28.7 (q), 30.9 (t), 31.5 (d), 63.6 (d), 82.4 (s), 
100.6 (s), 154.7 (s), 170.6 (s).  
 
MS: m/z 302 (M+). Anal. calcd for C18H26N2O4: C, 64.65; H, 7.84; N, 8.68. Found C, 64.63; H, 7.81; 
N, 8.74. 
 
 Experimental Section  
2) Second cyclization: a 5-exo-trig reaction through a 











t-BuOK (2.5 mmol) in THF (10 mL) was added to a solution of 3 (1 mmol). The resulting solution 
was stirred at r.t. for 1 min, then filtered on silica gel (AcOEt). The solvent was evaporated under 













Yield: 98%.  
Colorless oil.  
IR: 3301, 1947, 1719, 1648 cm-1  
[α]23D = +55.4 (c = 0.94, CHCl3)  
Rotamers ratio 1.1:1  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.92 (3H, d, J = 6.8 Hz), 1.00 (3H, d, J = 6.8 Hz), 1.45 (9H, s), 1.90-2.10 (1H, m), 3.14 (3H, s), 4.50-
4.65 (1H, m), 5.25-5.35 (1H, m), 5.43 (2H, d, J = 6.4, Hz), 7.54 (1H, dd, J = 6.4, 6.4 Hz) (major 
rotamer);  
0.90 (3H, d, J = 6.8 Hz), 1.00 (3H, d, J = 6.8 Hz), 1.45, (9H, s), 1.90-2.10 (1H, m), 3.04 (3H, s), 4.50-
4.65 (1H, m), 5.25-5.35 (1H, m), 5.43 (2H, d, J = 6.4 Hz), 6.97 (1H, dd, J = 6.4, 6.4 Hz) (minor 
rotamer);  
 
13C NMR (100 MHz, CDCl3) δ: 17.5 (q), 19.9 (q), 28.8 (q), 31.9 (q), 33.5 (d), 55.7 (d), 80.0 (s), 87.4 
(t), 100.1 (d), 156.2 (s), 171.1 (s), 201.6 (s) (major rotamer);  
17.6 (q), 20.0 (q), 28.8 (q), 31.9 (q), 33.5 (d), 56.1 (d), 80.0 (s), 87.8 (t), 101.3 (d), 156.2 (s), 171.1 
(s), 203.0 (s) (minor rotamer).  
 Experimental Section  








Yield: 92%.  
Yellow oil.  
IR: 3302, 1938, 1709, 1640 cm-1 
[α]23D = +45.8 (c = 0.72, CHCl3)  
Rotamers ratio 1.1:1.  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.94 (3H, d, J = 6.7 Hz), 1.00 (3H, d, J = 6.7 Hz), 1.44 (9H, s), 1.45-1.55 (2H, m), 1.70-1.80 (1H, m), 
3.11 (3H, s), 4.68-4.78 (1H, m), 5.24-5.26 (1H, m), 5.41 (2H, d, J = 6.4 Hz), 7.49 (1H, dd, J = 6.4, 6.4 
Hz) (major rotamer);  
0.94 (3H, d, J = 6.7 Hz), 1.00 (3H, d, J = 6.7 Hz), 1.44 (9H, s), 1.45-1.55 (2H, m), 1.70-1.80 (1H, m), 
3.11 (3H, s), 4.68-4.78 (1H, m), 5.24-5.26 (1H, m), 5.41 (2H, d, J = 6.4 Hz), 6.93 (1H, dd, J = 6.4, 6.4 
Hz) (minor rotamer).  
 
13C NMR (100 MHz, CDCl3)  
δ: 22.1 (q), 23.7 (q), 25.1 (d), 28.7 (q), 32.0 (q), 43.0 (t), 49.8 (d), 80.0 (s), 87.8 (t), 100.2 (d), 156.0 
(s), 171.9 (s), 202.9 (s) (major rotamer);  
22.1 (q), 23.7 (q), 25.9 (d), 28.7 (q), 33.0 (q), 43.0 (t), 49.4 (d), 80.0 (d), 87.3 (t), 100.9 (d), 155.9 (s), 
171.9 (s), 201.7 (s) (minor rotamer).  
 








Yield: 95%.  
Yellow oil.  
IR: 3306, 1942, 1701, 1650 cm-1  
[α]23D = +56.7 (c = 0.63, CHCl3)  
Rotamers ratio 1.4:1  
 
 Experimental Section  
1H NMR (400 MHz, CDCl3)  
δ: 1.36 (9H, s), 2.72 (3H, s), 2.90-3.06 (2H, m), 4.83-4.90 (1H, m), 5.30 (2H, d, J = 6.3 Hz), 5.62-5.69 
(1H, m), 7.08-7.35 (5H, m), 7.44 (1H, dd, J = 6.3, 6.3 Hz) (major rotamer);  
1.36 (9H, s), 2.91 (3H, s), 2.90-3.06 (2H, m), 4.90-4.97 (1H, m), 5.25 (2H, d, J = 6.3 Hz), 5.62-5.69 
(1H, m), 6.79 (1H, dd, J = 6.3, 6.3 Hz), 7.08-7.35 (5H, m) (minor rotamer);  
 
13C NMR (100 MHz, CDCl3)  
δ: 28.7 (q), 33.0 (q), 40.2 (t), 52.6 (d), 80.0 (s), 87.6 (t), 100.0 (d), 127.3 (d), 128.8 (d), 129.8 (d), 
136.6 (s), 155.5 (s), 170.6 (s), 202.9 (s) (major rotamer);  
28.7 (q), 32.0 (q), 39.8 (t), 52.2 (d), 80.0 (s), 87.0 (t), 100.9 (d), 127.1 (d), 128.7 (d), 129.8 (d), 136.6 
(s), 155.5 (s), 170.4 (s), 201.7 (s) (minor rotamer).  
 
MS: m/z 316 (M+). Anal. calcd for C18H24N2O3: C, 68.33; H, 7.65; N, 8.85. Found C, 







Yield: 95%.  
Yellow oil.  
IR: 3306, 1946, 1704, 1644 cm-1  
[α]23D = +51.3 (c = 0.89, CHCl3) 
Rotamers ratio 1.5:1.  
1H NMR (400 MHz, CDCl3)  
δ: 1.43 (9H, s), 2.91 (3H, s), 5.27-5.42 (2H, m), 5.64 (1H, d, J = 8.0 Hz), 5.95 (1H, d, J = 8.0 Hz), 6.77 
(1H, dd, J = 6.4, 6.4 Hz), 7.25-7.75 (5H, m) (major rotamer);  
1.43 (9H, s), 3.03 (3H, s), 5.27-5.42 (2H, m), 5.70 (1H, d, J = 8.0 Hz), 5.95 (1H, dd, J = 8.0, 8.0 Hz), 
7.25-7.75 (6H, m) (minor rotamer);  
 
13C NMR (100 MHz, CDCl3) δ: 28.7 (q), 33.0 (q), 56.3 (d), 80.3 (s), 88.0 (t), 100.7 (d), 128.1 (d), 
128.8 (d), 129.5 (d), 137.6 (s), 155.4 (s), 168.9 (s), 202.7 (s) (major rotamer);  
28.7 (q), 32.2 (q), 55.8 (d), 80.3 (s), 87.3 (t), 100.2 (d), 128.1 (d), 128.8 (d), 129.5 (d), 137.9 (s), 
154.3 (s), 168.9 (s), 201.6 (s) (minor rotamer).  
 








 Experimental Section  
Yield: 94%. 
Colorless oil.  
IR: 3306, 1940, 1705, 1649 cm-1 
[α]23D = +54.5 (c = 1.80, CHCl3)  
Rotamers ratio 1.1:1.  
 
1H NMR (400 MHz, CDCl3)  
δ: 1.37 (3H, d, J = 5.7 Hz), 1.45 (9H, s), 3.11 (3H, s), 4.73 (1H, dq, J = 5.7, 5.7 Hz), 5.40-5.50 (3H, m), 
7.49-7.52 (1H, m) (major rotamer);  
1.35 (3H, d, J = 5.7 Hz), 1.45 (9H, s), 3.04 (3H, s), 4.73 (1H, dq, J = 5.7, 5.7 Hz), 5.40-5.50 (3H, m), 
6.85-6.88 (1H, m) (minor rotamer);  
 
13C NMR (100 MHz, CDCl3)  
δ: 19.4 (q), 28.7 (q), 31.9 (q), 47.3 (d), 79.9 (s), 87.8 (t), 100.1 (d), 155.5 (s), 171.5 (s), 201.6 (s) 
(major rotamer);  
19.2 (q), 28.7 (q), 33.0 (q), 46.9 (d), 79.9 (s), 87.3 (t), 100.9 (d), 155.5 (s), 171.5 (s), 202.8 (s) (minor 
rotamer). 
 







General procedure for the carbopalladation/amination of allenamides 2a-e: synthesis of 




K2CO3 (4 mmol), iodobenzene (1.5 mmol) and Pd(PPh3)4 (2%) in DMF (10 mL) were added to a 
solution of 2 (1 mmol). The resulting solution was heated at 100 °C for 2 h, then was cooled, 
diluted with brine and extracted with AcOEt (3 x 20 mL). The resulting crude was purified by flash 








Yield: 55%.  
Colorless oil.  
IR: 1708, 1671 cm-1 
[α]23D = +4.9 (c = 0.35, CHCl3)  
 
 Experimental Section  
1H NMR (400 MHz, CDCl3)  
δ: 0.72 (3H, d, J = 6.9 Hz), 0.77 (3H, d, J = 6.9 Hz), 1.43 (9H, s), 2.00-2.20 (1H, m), 2.85 (3H, s), 3.76-
3.78 (1H, m), 5.37-5.51 (3H, m), 7.12-7.29 (5H, m). 
13C NMR (100 MHz, CDCl3) δ: 18.5 (q), 20.4 (q), 27.6 (q), 28.6 (q), 32.4 (d), 64.3 (d), 78.8 (d), 81.7 
(s), 120.7 (t), 128.3 (d), 128.5 (d), 128.7 (d), 138.6 (s), 146.3 (s), 155.1 (d), 170.8 (d).  
 









Yield: 16%.  
Yellow oil.  
IR: 1710, 1658 cm-1  
[α]23D = +33.7 (c = 0.81, CHCl3).  
Rotamers ratio 1.1:1.  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.86 (3H, d, J = 6.9 Hz), 1.14 (3H, d, J = 6.9 Hz), 1.41 (9H, s), 2.60-2.78 (1H, m), 2.90 (3H, s), 3.91-
3.94 (1H, m), 5.44-5.54 (3H, m), 7.12-7.33 (5H, m) (major rotamer);  
0.86 (3H, d, J = 6.9 Hz), 1.11 (3H, d, J = 6.9 Hz), 1.33 (9H, s), 2.25-2.50 (1H, m), 2.80 (3H, s), 3.64-
3.68 (1H, m), 5.44-5.54 (3H, m), 7.12-7.33 (5H, m) (minor rotamer).  
 
13C NMR (100 MHz, CDCl3)  
δ: 16.4 (q), 18.4 (q), 26.7 (q), 28.6 (q), 28.8 (d), 63.6 (d), 79.1 (d), 81.1 (s), 120.7 (t), 121.2 (d), 
127.6 (d), 128.4 (d), 137.5 (s), 145.3 (s), 152.3 (s), 169.5 (s) (major rotamer);  
16.6 (q), 18.5 (q), 28.5 (q), 28.6 (q), 31.1 (d), 63.7 (d), 79.4 (d), 81.7 (s), 121.2 (t), 128.0 (d), 
128.7 (d), 129.1 (d), 137.5 (s), 146.1 (s), 152.3 (s), 169.8 (s) (minor rotamer).  
 









Yield: 65%.  
 Experimental Section  
Yellow oil.  
IR: 1703, 1664 cm-1;  
[α]23D = +10.4 (c = 0.46, CHCl3)  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.84 (3H, d, J = 6.7 Hz), 1.47 (9H, s), 2.90 (3H, s), 3.99-4.03 (1H, m), 5.41 (1H, s), 5.49 (1H, s), 
5.52 (1H, s) 7.08-7.11 (2H, m), 7.28-7.30 (3H, m)  
 
13C NMR (100 MHz, CDCl3) 
δ: 17.2 (q), 27.0 (q), 28.6 (q), 55.2 (d), 79.2 (d), 81.3 (s), 120.7 (t), 128.3 (d), 128.5 (d), 128.7 (d), 
138.2 (s), 146.2 (s), 153.4 (s), 171.3 (s).  
 









Yield: 12%.  
Pale yellow oil.  
IR: 1710, 1658 cm-1  
[α]23D = +41.1 (c = 0.25, CHCl3). 
Rotamers ratio: 1.2:1  
 
1H NMR (400 MHz, CDCl3)  
δ: 1.35-1.55 (12 H, m), 2.93 (3H, s), 3.50-3.60 (1H, m), 5.45-5.56 (3H, m), 7.09-7.33 (5H, m) (major 
rotamer);  
1.35-1.55 (12H, m), 2.85 (3H, s), 3.70-3.90 (1H, m), 5.45-5.56 (3H, m), 7.09-7.33 (5H, m) (minor 
rotamer).  
 
13C NMR (100 MHz, CDCl3)  
δ: 18.3 (q), 27.1 (q), 28.7 (q), 55.0 (d), 78.8 (d), 81.2 (s), 121.3 (t), 127.8 (d), 128.5 (d), 128.8 (d), 
137.8 (s), 145.1 (s), 152.6 (s), 171.6 (s) (major rotamer);  
17.1 (q), 27.1 (q), 28.7 (q), 55.0 (d), 78.8 (d), 81.6 (s), 120.9 (t), 128.2 (d), 128.7 (d), 129.1 (d), 
137.6 (s), 146.0 (s), 152.3 (s), 171.5 (s) (minor rotamer).  
 













Yield: 54%.  
Pale yellow oil.  
IR: 1702, 1653 cm-1 
[α]23D = +11.3 (c = 1.13, CHCl3). 
 
1H NMR (400 MHz, CDCl3)  
δ: 0.70-0.95 (8H, m), 1.49 (9H, s), 1.81-1.86 (1H, m), 2.90 (3H, s), 3.95-4.05 (1H, m), 5.40 (1H, s), 
5.49-5.55 (2H, m), 7.07-7.09 (2H, m), 7.31-7.33 (3H, m).  
 
13C NMR (100 MHz, CDCl3) 
δ: 22.3 (q), 23.4 (d), 24.6 (q), 27.2 (q), 28.7 (q), 43.2 (t), 57.0 (d), 79.2 (d), 81.5 (s), 120.9 (t), 128.4 
(d), 128.5 (d), 129.0 (d), 138.1 (s), 145.9 (s), 153.8 (s), 171.4 (s). 
 









Yield: 17%.  
Colorless oil.  
IR: 1710, 1658 cm-1  
[α]23D = +50.9 (c = 0.44, CHCl3). 
Rotamers ratio 1.3:1  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.82-0.94 (6H, m), 1.05-2.03 (12H, m), 2.90 (3H, s), 3.60-3.65 (1H, m), 5.44-5.54 (3H, m), 7.09-
7.16 (2H, m), 7.25-7.29 (3H, m) (major rotamer);  
0.82-0.94 (6H, m), 1.05-2.03 (12H, m), 2.82 (3H, s), 3.90-3.93 (1H, m), 5.44-5.54 (3H, m), 7.09-7.16 
(2H, m), 7.25-7.29 (3H, m) (minor rotamer).  
 
13C NMR (100 MHz, CDCl3) δ: 22.6 (q), 23.3 (d), 24.2 (q), 24.6 (q), 27.0 (q), 39.8 (t), 58.0 (d), 79.0 
(d), 81.2 (s), 121.2 (t), 127.6 (d), 128.4 (d), 129.0 (d), 137.9 (s), 146.0 (s), 152.4 (s), 171.9 (s) (major 
rotamer);  
23.1 (q), 23.8 (d), 24.4 (q), 25.1 (q), 27.0 (q), 38.0 (t), 57.9 (d), 79.0 (d), 81.2 (s), 120.8 (t), 128.1 (d), 
128.7 (d), 129.0 (d), 137.6 (s), 145.2 (s), 152.0 (s), 171.9 (s) (minor rotamer).  
 Experimental Section  








Yield: 50%.  
Colorless oil.  
IR: 1711, 1650 cm-1 
[α]23D = -5.2 (c = 0.85, CHCl3).  
 
1H NMR (400 MHz, CDCl3)  
δ: 1.38 (9H, s), 2.30-2.40 (2H, m), 2.90 (3H, s), 4.20-4.25 (1H, m), 5.00-5.50 (2H, m), 5.55 (1H, s), 
7.08-7.38 (10H, m).  
 
13C NMR (100 MHz, CDCl3)  
δ: 27.3 (q), 28.6 (q), 38.8 (t), 60.6 (d), 78.5 (d), 81.8 (s), 120.8 (t), 126.8 (d), 128.6 (d), 130.1 (d), 
138.1 (s), 138.7 (s), 145.7 (s), 153.9 (s), 170.2 (s).  
 
MS: m/z 392 (M+). Anal. calcd for C24H28N2O3: C, 73.44; H, 7.19; N, 7.14. Found 








Yield: 19%.  
Yellow oil.  
IR: 1710, 1658 cm-1  
[α]23D = +101.6 (c = 0.42, CHCl3). 
Rotamers ratio 1.5:1  
 
1H NMR (400 MHz, CDCl3)  
δ: 1.47 (9H, s), 2.60 (3H, s), 3.13-3.15 (1H, m), 3.68-3.70 (1H, m), 4.22-4.24 (1H, m), 4.65 (1H, s), 
5.24 (1H, d, J = 1.6 Hz) 5.43 (1H, d, J = 1.6 Hz), 7.05-7.30 (10H, m) (major rotamer); 
1.45 (9H, s), 2.60 (3H, s), 3.13-3.15 (1H, m), 3.25-3.30 (1H, m), 4.00-4.04 (1H, m), 4.68 (1H, s), 5.24 
(1H, d, J = 1.6 Hz) 5.43 (1H, d, J = 1.6 Hz), 7.05-7.30 (10H, m). 
 
 Experimental Section  
13C NMR (100 MHz, CDCl3) δ: 26.7 (q), 28.8 (q), 34.5 (t), 60.4 (d), 79.0 (d), 81.6 (s), 120.9 (t), 127.2 
(d), 127.7 (d), 128.3 (d), 128.6 (d), 129.0 (d), 130.3 (d), 136.5 (s), 137.6 (s), 145.6 (s), 152.3 (s), 
169.8 (s) (major rotamer);  
26.7 (q), 28.7 (q), 36.3 (t), 60.6 (d), 79.0 (d), 121.0 (t), 127.3 (d), 128.1 (d), 128.5 (d), 128.7 (d) 
129.7 (d), 130.2 (s), 136.0 (s), 137.9 (s), 145.1 (s), 152.0 (s), 169.8 (s) (minor rotamer). 
 









Yield: 52%.  
Yellow oil.  
IR: 1706, 1649 cm-1;  
[α]23D = +66.5 (c = 1.20, CHCl3).  
 
1H NMR (400 MHz, CDCl3)  
δ: 1.31 (9H, br s), 2.99 (3H, s), 5.11 (1H, br s), 5.51 (1H, s), 5.52-5.66 (2H, m), 7.02-7.37 (10H, m).  
 
13C NMR (100 MHz, CDCl3) δ: 27.6 (q), 28.4 (q), 62.9 (d), 79.0 (d), 81.2 (s), 121.4 (t), 127.2 (d), 
127.5 (d), 128.0 (d), 128.4 (d), 128.7 (d), 129.4 (d), 136.7 (s), 138.5 (s), 146.3 (s), 154.1 (s), 168.9 
(s).  
 









Yield: 20%.  
Yellow solid. M. p. 155-157 °C.  
IR: 1703, 1646 cm-1  
[α]23D = +207.5 (c = 0.26, CHCl3).  
Rotamers ratio 3:1  
 
 
 Experimental Section  
1H NMR (400 MHz, CDCl3)  
δ: 1.08 (9H, s), 2.97 (3H, s), 4.53 (1H, s), 5.57 (1H, s), 5.67 (1H, s), 5.84 (1H, s), 7.20-7.37 (10H, m) 
(major rotamer);  
1.40 (9H, s), 2.88 (3H, s), 4.86 (1H, s), 5.57 (1H, s), 5.67 (1H, s), 5.84 (1H, s), 7.20-7.37 (10H, m) 
(minor rotamer). 
 
13C NMR (100 MHz, CDCl3)  
δ: 27.4 (q), 28.2 (q), 63.5 (d), 79.4 (d), 81.2 (s), 121.9 (t), 126.6 (d), 127.0 (d), 127.8. (d), 128.4 (d), 
128.6 (d), 128.9 (d), 137.8 (s), 138.9 (s), 145.1 (s), 152.3 (s), 169.3 (s) (major rotamer);  
27.4 (q), 28.6 (q), 63.2 (d), 79.4 (d), 81.2 (s), 121.4 (t), 126.6 (d), 127.0 (d), 127.8 (d), 128.4 (d), 
128.6 (d),128.9 (d), 137.8 (s), 138.9 (s), 145.1 (s), 152.3 (s), 169.3 (s).  
 









Pd(PPh3)4 (2%), iodobenzene (1.5 mmol) and K2CO3 (4 mmol) were added to a solution of 2 (1 
mmol) in DMF (10 mL) under CO atmosphere (balloon). The suspension was stirred at 60 °C for 4 
h, then cooled, diluted with brine and extracted with AcOEt (3 x 20 mL). The organic phase was 
dried over Na2SO4 and the solvent evaporated under reduced pressure. The crude mixture was 
















Yield: 52%.  
Pale yellow solid. M. p. 130-132 °C.  
IR: 1701, 1675, 1644 cm-1 
[α]23D = +113.4 (c = 0.28, CHCl3).  
Rotamers ratio 3:1  
 
1H NMR (400 MHz, CDCl3) 
δ: 0.91 (3H, d, J = 7.2 Hz), 1.18 (3H, d, J = 7.2 Hz), 1.38 (9H, s), 2.40-2.50 (1H, m), 2.88 (3H, s), 4.08-
4.10 (1H, m), 5.69 (1H, s), 5.85 (1H, d, J = 4.2 Hz), 6.02 (1H, d, J = 4.2 Hz), 7.42-7.85 (5H, m) (major 
rotamer);  
 Experimental Section  
0.88 (3H, d, J = 7.2 Hz), 1.21 (3H, d, J = 7.2 Hz), 1.31 (9H, s), 2.40-2.50 (1H, m), 2.82 (3H, s), 4.20-
4.30 (1H, m), 5.68 (1H, s), 5.85 (1H, d, J = 4.2 Hz), 6.02 (1H, d, J = 4.2 Hz), 7.42-7.85 (5H, m) (minor 
rotamer).  
 
13C NMR (100 MHz, CDCl3) δ: 16.7 (q), 18.4 (d), 18.6 (q), 28.5 (q), 31.0 (q), 63.8 (d), 75.3 (d), 81.5 
(s), 128.0 (t), 128.5 (d), 128.8 (d), 130.3 (d), 137.2 (s), 144.5 (s), 153.0 (s), 170.1 (s), 196.3 (s) 
(major rotamer);  
16.1 (q), 18.4 (d), 18.6 (q), 28.5 (q), 31.0 (q), 63.5 (d), 72.5 (d), 82.2 (s), 128.0 (t), 128.5 (d), 128.8 
(d), 130.3 (d), 136.6 (s), 144.4 (s), 153.2 (s), 169.7 (s), 195.2 (s) (minor rotamer).  
 
MS: m/z 372 (M+). Anal. calcd for C21H28N2O4: C, 67.72; H, 7.58; N, 7.52. Found C, 67.74; 
















Yield: 42%.  
Pale yellow oil.  
IR: 1703, 1670, 1646 cm-1 
[α]23D = +153.5 (c = 0.31, CHCl3).  
Rotamers ratio 3:1 
 
1H NMR (400 MHz, CDCl3)  
δ: 1.24 (3H, d, J = 6.3 Hz), 1.37 (9H, s), 2.83 (3H, s), 4.07-4.13 (1H, m), 5.67 (1H, s), 5.84 (1H, s), 
6.06 (1H, s), 7.28-7.82 (5H, m) (major rotamer);  
1.22 (3H, d, J = 6.3 Hz), 1.30 (9H, s), 2.79 (3H, s), 4.15-4.22 (1H, m), 5.67 (1H, s), 5.81 (1H, s), 6.04 
(1H, s), 7.28-7.82 (5H, m) (minor rotamer).  
 
13C NMR (100 MHz, CDCl3) 
δ: 18.3 (q), 26.0 (q), 27.1 (q), 55.0 (d), 75.2 (d), 81.5 (s), 128.6 (t), 128.7 (d), 130.1 (d), 133.2 (d), 
137.3 (s), 143.8 (s), 153.0 (s), 171.9 (s), 196.5 (s) (major rotamer);  
17.3 (q), 26.0 (q), 27.1 (q), 55.2 (d), 72.9 (d), 82.1 (s), 128.6 (t), 128.8 (d), 130.3 (d), 133.6 (d), 
136.6 (s), 143.8 (s), 153.0 (s), 171.9 (s), 196.5 (s) (minor rotamer).  
 
MS: m/z 344 (M+). Anal. calcd for C19H24N2O4: C, 66.26; H, 7.02; N, 8.13. Found C, 





















Yield: 38%. Pale yellow oil.  
IR: 1700, 1673, 1648 cm-1  
[α]23D = +93.7 (c = 0.31, CHCl3).  
Rotamers ratio 3:1  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.79 (3H, d, J = 5.6 Hz), 1.09 (3H, d, J = 5.6 Hz), 1.37 (9H, s), 1.81-2.03 (3H, m), 2.82 (3H, s), 4.10-
4.20 (1H, m), 5.64 (1H, s), 5.84 (1H, s), 6.04 (1H, s), 7.28-7.56 (3H, m), 7.81-7.83 (2H, m) (major 
rotamer);  
0.79 (3H, d, J = 5.6 Hz), 1.09 (3H, d, J = 5.6 Hz), 1.29 (9H, s), 2.40-2.50 (3H, m), 2.79 (3H, s), 4.27-
4.30 (1H, m), 5.64 (1H, s), 5.81 (1H, s), 6.01 (1H, s), 7.28-7.56 (3H, m), 7.81-7.83 (2H, m) (minor 
rotamer).  
 
13C NMR (100 MHz, CDCl3) δ: 23.1 (q), 24.2 (q), 26.9 (d), 28.7 (q), 40.1 (t), 57.9 (d), 75.2 (d), 81.5 
(s), 128.3 (t), 128.5 (d), 130.2 (d), 133.2 (d), 137.3 (s), 144.1 (s), 153.0 (s), 171.6 (s), 196.5 (s) 
(major rotamer); 
22.6 (q), 23.9 (q), 26.9 (d), 28.6 (q), 38.1 (t), 56.9 (d), 72.8 (d), 81.8 (s), 128.0 (t), 128.5 (d), 128.8 
(d), 130.3 (d), 133.6 (s), 144.4 (s), 153.0 (s), 171.6 (s), 196.5 (s) (minor rotamer).  
 

















Yield: 40%.  
Pale yellow oil.  
IR: 1702, 1678, 1646 cm-1  
[α]23D = +78.7 (c = 0.46, CHCl3).  
Rotamers ratio 3:1  
 
 Experimental Section  
1H NMR (400 MHz, CDCl3)  
δ: 1.48 (9H, s), 2.58 (3H, s), 3.19-3.23 (1H, m), 3.42-3.48 (1H, m), 4.46-4.60 (1H, m), 4.85 (1H, s), 
5.77-5.97 (2H, m), 7.13-7.81 (10H, m) (major rotamer);  
1.34 (9H, s), 2.57 (3H, s), 3.19-3.23 (1H, m), 3.69-3.75 (1H, m), 4.46-4.60 (1H, m), 5.02 (1H, s), 
5.77-5.97 (2H, m), 7.13-7.81 (10H, m) (minor rotamer).  
 
13C NMR (100 MHz, CDCl3)  
δ: 24.2 (q), 28.7 (q), 36.3 (t), 60.6 (d), 75.2 (d), 81.9 (s), 127.3 (t), 128.1 (d), 128.5 (d), 128.8 (d), 
130.2 (d), 130.4 (d), 133.2 (d), 136.1 (s), 137.2 (s), 144.0 (s), 152.7 (s), 170.1 (s), 196.3 (s) (major 
rotamer);  
24.2 (q), 28.5 (q), 34.6 (t), 60.4 (d), 72.9 (d), 82.2 (s), 127.3 (t), 128.1 (d), 128.6 (d), 128.7 
(d), 130.1 (d), 130.3 (d), 133.6 (d), 136.2 (s), 137.2 (s), 144.0 (s), 152.0 (s), 170.0 (d), 195.1 (d) 
(minor rotamer).  
 
MS: m/z 420 (M+). Anal. calcd for C25H28N2O4: C, 71.41; H, 6.71; N, 6.66. Found C, 71.56; 
















Yield: 67%.  
Pale yellow solid. M. p.: 182-184 °C.  
IR: 1708, 1673, 1656 cm-1 
[α]23D = +131.5 (c = 0.80, CHCl3).  
Rotamers ratio 3:1  
 
1H NMR (400 MHz, CDCl3) 
δ: 0.95 (9H, s), 2.76 (3H, s), 4.89 (1H, s), 5.91 (1H, s), 6.04 (1H, s), 6.37 (1H, s), 7.28-7.80 (10H, m) 
(major rotamer);  
1.26 (9H, s), 2.70 (3H, s), 5.02 (1H, s), 5.75 (1H, s), 6.14 (1H, s), 6.47 (1H, s), 7.28-7.80 (10H, m) 
(minor rotamer).  
 
13C NMR (100 MHz, CDCl3) δ: 27.3 (q), 28.3 (q), 63.7 (d), 77.1 (d), 81.6 (s), 128.4 (d), 128.7 (d), 
128.9 (d), 129.2 (d), 129.6 (t) 130.3 (d), 133.4 (d), 137.5 (s), 138.9 (s), 143.4 (s), 157.8 (s), 169.8 (s), 
196.7 (s) (major rotamer); too weak signals for the minor rotamer.  
 




















Yield: 7%.  
Pale yellow oil.  
IR: 1701, 1683, 1657 cm-1  
[α]23D = -30.4 (c = 0.28, CHCl3).  
 
1H NMR (400 MHz, CDCl3)  
δ: 1.10 (6H, d, J = 6.8 Hz), 1.38 (9H, s), 2.18-2.25 (1H, m), 2.86 (3H, s), 4.00-4.10 (1H, m), 5.76 (1H, 
s), 5.85 (1H, s), 5.91 (1H, s), 7.28-7.90 (5H, m). 
 
13C NMR (100 MHz, CDCl3)  
δ: 16.8 (q), 18.5 (d), 18.7 (q), 28.6 (q), 31.0 (q), 63.9 (d), 75.5 (d), 81.2 (s), 128.0 (t), 128.5 (d), 
128.8 (d), 130.1 (d), 137.2 (s), 144.6 (s), 153.0 (s), 170.2 (s), 196.3 (s).  
 
















DCC (10 mmol), 12106 (8.3 mmol) and DMAP (0.125 mmol) were slowly added to a solution of the 
appropriate Boc-protected α-aminoacid (10 mmol) in anhydrous CH2Cl2 (60 mL) cooled at 0 °C. 
The resulting solution was stirred at r.t. for 48 h, then filtered on silica gel and the solvent was 
evaporated under reduced pressure. The crude residue was purified by flash chromatography 
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Yield: 90%.  
Colorless oil.  
IR: 2924, 1659 cm-1  
[α]23D = -3.7 (c = 0.25, CHCl3).  
Rotamers ratio 3:2  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.93 (3H, d, J = 6.8 Hz), 0.96 (3H, d, J = 6.8 Hz), 1.42 (9H, s), 1.92-2.01 (1H, m), 2.31 (1H, dd, J = 
2.1, 2.2 Hz), 3.79-3.91 (1H, m), 4.38-4.46 (1H, m), 4.51, 4.87 (2H, AB system, J = 15.9 Hz), 4.54-4.62 
(1H, m), 5.22-5.34 (1H, m), 6.92 (1H, dd, J = 7.4, 7.7 Hz), 7.06 (1H, d, J = 7.7 Hz), 7.22 (1H, dd, J = 
7.4, 7.6 Hz), 7.79 (1H, d, J = 7.6 Hz) (major rotamer);  
0.88 (3H, d, J = 6.8 Hz), 1.00 (3H, d, J = 6.8 Hz), 1.37 (9H, s), 2.04-2.13 (1H, m), 2.21 (1H, br s), 3.79-
3.91 (1H, m), 4.38-4.46 (2H, m), 4.68, 4.71 (2H, AB system, J = 17.1 Hz), 5.22-5.34 (1H, m), 6.97 
(1H, dd, J = 7.5, 7.7 Hz), 7.06 (1H, d, J = 7.7 Hz), 7.29 (1H, dd, J = 7.5 , 7.9 Hz), 7.83 (1H, d, J = 7.9 
Hz) (minor rotamer).  
 
13CNMR (100 MHz, CDCl3) δ: 17.8 (q), 19.8 (q), 28.3 (q), 31.2 (d), 37.2 (t), 53.7 (t), 55.6 (d), 73.3 (d), 
78.3 (s), 79.8 (s), 98.7 (s), 128.0 (d), 128.5 (d), 129.1 (d), 138.2 (s), 139.6 (d), 156.0 (s), 173.0 (s) 
(major rotamer);  
17.8 (q), 19.6 (q), 28.3 (q), 31.5 (d), 34.6 (t), 55.4 (d), 55.5 (t), 72.4 (d), 78.2 (s), 79.5 (s), 98.0 (s), 
127.5 (d), 128.6 (d), 129.6 (d), 137.3 (s), 140.0 (d), 155.5 (s), 172.8 (s) (minor rotamer). 
 








Yield: 81%.  
Colorless oil.  
IR: 2926, 1655 cm-1 
[α]23D = -3.2 (c = 0.29, CHCl3).  
Rotamers ratio 3:2 
 
 
 Experimental Section  
1H NMR (400 MHz, CDCl3)  
δ: 0.98 (3H, d, J = 6.6 Hz), 1.03 (3H, d, J = 6.6 Hz), 1.46 (9H, s), 1.55-1.86 (3H, m), 2.33 (1H, dd, J = 
2.4, 2.4 Hz), 3.85-3.89 (1H, m), 4.52, 4.92 (2H, AB system, J = 15.9 Hz), 4.55-4.82 (2H, m), 5.13 (1H, 
d, J = 9.1 Hz), 6.97 (1H, dd, J = 7.1, 7.8 Hz), 7.12 (1H, d, J = 7.1 Hz), 7.29 (1H, dd, J = 7.8, 8.2 Hz), 
7.84 (1H, d, J = 8.2 Hz) (major rotamer);  
0.86 (3H, d, J = 6.9 Hz), 0.92 (3H, d, J = 6.9 Hz), 1.41 (9H, s), 1.55-1.86 (3H, m), 2.24 (1H, dd, J = 2.5, 
2.5 Hz), 3.81-3.85 (1H, m), 3.99, 4.42 (2H, AB system, J = 17.3 Hz), 4.55-4.82 (2H, m), 5.17 (1H, d, J 
= 8.8 Hz), 7.02 (1H, dd, J = 6.9, 7.6 Hz), 7.12 (1H, d, J = 6.9 Hz), 7.35 (1H, dd, J = 7.6 , 7.7 Hz), 7.88 
(1H, d, J = 7.7 Hz).  
 
13CNMR (100 MHz, CDCl3)  
δ: 21.8 (q), 23.5 (q), 24.7 (d), 28.3 (q), 37.0 (t), 41.9 (t), 48.9 (d), 54.0 (t),73.4 (d), 78.1 (s), 79.8 (s), 
98.7 (s), 127.4 (d), 128.6 (d), 129.1 (d), 138.1 (s), 139.9 (d), 155.4 (s), 173.6 (s) (major rotamer);  
21.6 (q), 23.4 (q), 24.5 (d), 30.9 (q), 35.0 (t), 42.8 (t), 49.1 (d), 55.4 (t), 72.5 (d), 
78.1 (s), 79.8 (s), 97.8 (s), 127.7 (d), 128.1 (d), 129.5 (d), 138.1 (s), 139.6 (d), 154.8 (s), 173.6 
(s)(minor rotamer).  
 
MS: m/z 484 (M+). Anal. calcd for C21H29IN2O3: C, 52.07; H, 6.03; N, 5.78. Found C, 








Colorless oil.  
IR: 2927, 1651 cm-1 
[α]23D = -4.4 (c = 0.19, CHCl3).  
Rotamers ratio 3:2 
 
1H NMR (400 MHz, CDCl3)  
δ: 1.30 (3H, d, J = 6.7 Hz), 1.44 (9H, s), 2.33 (1H, dd, J = 2.4, 2.4 Hz), 3.88, 4.41 (2H, AB system, J = 
18.5 Hz), 4.53-4.76 (2H, m), 4.88 (1H, d, J = 15.9 Hz), 5.39 (1H, d, J = 7.9 Hz), 6.96 (1H, dd, J = 7.4 , 
7.5 Hz), 7.12 (1H, d, J = 7.5 Hz), 7.28 (1H, d, J = 7.7 Hz), 7.82 (1H, d, J = 7.7 Hz) (major rotamer);  
1.30 (3H, d, J = 6.7 Hz), 1.42 (9H, s), 2.23 (1H, br s), 4.04, 4.32 (2H, AB system, J = 17.3 Hz), 4.53-
4.76 (3H, m), 5.43 (1H, d, J = 7.6 Hz), 7.01 (1H, dd, J = 7.5, 7.7 Hz), 7.07 (1H, d, J =7.7 Hz), 7.34 (1H, 
dd, J = 7.5, 7.8 Hz), 7.86 (1H, d, J = 7.8 Hz) (minor rotamer).  
 
13C-NMR (100 MHz, CDCl3)  
δ: 18.9 (q), 28.3 (q), 37.0 (t), 46.4 (d), 53.9 (t), 73.4 (d), 78.0 (s), 79.8 (s), 98.7 (s), 128.2 (d), 128.5 
(d), 129.2 (d), 138.1 (s), 139.7 (d), 155.3 (s), 173.6 (s) (major rotamer); 19.4 (q), 28.3 (q), 34.8 (t), 
46.7 (d), 55.3 (t), 72.6 (d), 77.9 (s), 79.6 (s), 98.7 (s), 127.1 (d), 128.6 (d), 129.6 (d), 137.1 (s), 140.0 
(d), 154.8 (s), 173.4 (s) (minor rotamer).  
 
MS: m/z 442 (M+). Anal. calcd for C18H23IN2O3: C, 48.88; H, 5.24; N, 6.33. Found C, 48.98; H, 4.99; 
N, 6.48. 
 Experimental Section  




To a solution of 10 (1 mmol) in THF (10 mL) t-BuOK (2.5 mmol) was added. The resulting solution 
was stirred at r.t. for 1 min, then filtered on silica gel (AcOEt). The solvent was evaporated under 








Yield: 95%.  
Colorless oil.  
IR: 3321, 1650 cm-1 
[α]23D = +30.8 (c = 0.27, CHCl3).  
Rotamers ratio 1:1  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.94 (6H, d, J = 6.7 Hz), 1.04 (6H, d, J = 6.7 Hz), 1.45 (18H, s), 2.10-2.21 (2H, m), 4.59-4.83 (6H, 
m), 5.05-5.45 (6H, m), 6.87-7.03 (4H, m), 7.24 (2H, dd, J = 7.5, 7.9 Hz), 7.56-7.63 (1H, m). 7.79 (2H, 
d, J = 7.9 Hz), 7.77-7.85 (1H, m).  
 
13C-NMR (100 MHz, CDCl3)  
δ: 17.4 (q), 17.6 (q), 19.6 (q), 28.7 (q), 31.6 (d), 31.9 (d), 54.0 (t), 55.2 (t), 56.1 (d), 56.4 (d), 80.0 (s), 
80.1 (s), 87.7 (t), 88.1 (t), 97.5 (s), 98.3 (s), 99.0 (d), 100.2 (d), 126.8 (d), 126.9 (d), 128.7 (d), 129.0 
(d), 129.4 (d), 129.7 (d), 138.2 (s), 138.7 (s), 139.9 (d), 140,1 (d), 155.7 (s), 156.4 (s), 171.5 (s), 
201.9 (s), 202.8 (s).  
 








 Experimental Section  
Yield: 93%.  
Colorless oil.  
IR: 3319, 1655 cm-1 
[α]23D = -6.1 (c = 0.15, CHCl3).  
Rotamers ratio 1:1 
 
1H NMR (400 MHz, CDCl3)  
δ: 0.98 (6H, d, J = 6.6 Hz), 1.02 (6H, d, J = 6.5 Hz), 1.26 (18H, s), 1.55-1.83 (6H, m), 4.41-4.81 (4H, 
m), 4.51, 4.93 (2H, AB system, J =15.9 Hz), 5.12-5.21 (2H, m), 5.37 (4H, dd, J = 4.9, 4.9 Hz), 6.97 
(1H, dd, J = 6.8, 7.4 Hz), 7.02 (1H, dd, J = 7.4, 7.5 Hz), 7.07-7.19 (2H, m), 7.21-7.53 (4H, m), 7.84 
(1H, d, J = 7.9 Hz), 7.87 (1H, d, J = 7.8 Hz).  
 
13C-NMR (100 MHz, CDCl3)  
δ: 21.8 (q), 23.5 (q), 24.7 (d), 28.3 (q), 35.0 (t), 37.1 (t), 48.9 (d), 54.0 (t), 55.4 (t), 79.8 (s), 87.6 (t), 
98.7 (s), 100.1 (d), 128.1 (d), 128.6 (d), 129.1 (d), 129.5 (d), 129.8 (d), 130.0 (d), 137.3 (s), 138.1 
(s), 139.6 (d), 140.0 (d), 155.9 (s), 173.7 (s), 206.9 (s).  
 








Yield: 93%.  
Colorless oil.  
IR: 3326, 1655 cm-1  
[α]23D = +13.6 (c = 0.30, CHCl3).  
Rotamers ratio 1:1 
 
1H NMR (400 MHz, CDCl3)  
δ: 1.19-1.27 (6H, m), 1.43 (18H, s), 4.39-4.87 (6H, m), 5.13-5.22 (4H, m), 5.41 (1H, br s), 5.54 (1H, 
br s), 6.82-7.01 (5H, m), 7.18-7.31 (2H, m), 7.51-7.62 (1H, m), 7.76 (1H, d, J = 7.9 Hz), 7.79 (1H, d, J 
= 7.6 Hz).  
 
13C-NMR (100 MHz, CDCl3)  
δ: 18.9 (q), 28.3 (q), 46.9 (d), 47.1 (d), 53.6 (t), 54.7 (t), 79.8 (s), 87.3 (t), 98.7 (s), 99.2 (d), 126.4 
(d), 128.3 (d), 128.6 (d), 129.3 (d), 129.6 (d), 137.8 (s), 138.2 (s), 139.4 (d), 139.5 (d), 155.3 (s), 
172.5 (s), 201.5 (s), 202.4 (s).  
 






 Experimental Section  




K2CO3 (4 mmol) and Pd(PPh3)4 (2%) were added to a solution of 14 (1 mmol) in DMF (10 mL). The 
resulting suspension was heated at 100 °C for 2 h, then cooled, diluted with brine and extracted 
with AcOEt (3 x 20 mL). The resulting crude mixture was purified by flash chromatography to 









Yield: 54%.  
White solid. M. p.: 112-115 °C.  
IR: 1703,1648 cm-1 
[α]23D = -30.6 (c = 0.21, CHCl3).  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.99 (3H, d, J = 6.9 Hz), 1.03 (3H, d, J = 7.0 Hz), 1.53 (9H, s), 2.10-2.27 (1H, m), 4.23-4.30 (1H, m), 
4.39, 5.16 (2H, AB system, J = 17.4 Hz), 5.35 (1H, d, J = 1.5 Hz), 5.69 (1H, s), 5.77 (1H, d, J = 1.5 Hz), 
7.19 (1H, d, J = 7.1 Hz), 7.25-7.40 (2H, m), 7.66 (1H, d, J = 7.3 Hz).  
 
13C-NMR (100 MHz, CDCl3) δ: 18.9 (q), 19.6 (q), 28.7 (q), 32.2 (d), 42.2 (t), 65.3 (d), 70.7 (d), 82.0 
(s), 110.1 (t), 126.1 (d), 126.8 (d), 127.8 (d), 129.1 (d), 130.7 (s), 131.7 (s), 139.4 (s), 155.6 (s), 
168.8 (s).  
 









Yield: 8%.  
 Experimental Section  
Colorless oil.  
IR: 1708, 1655 cm-1  
[α]23D =+26.2 (c = 0.28, CHCl3).  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.92 (3H, d, J = 6.9 Hz), 1.25 (3H, d, J = 7.1 Hz), 1.45-1.60 (9H, m), 1.98-2.30 (1H, m), 4.03-4.18 
(1H, m), 4.40, 5.22 (2H, AB system, J = 17.6 Hz), 5.10 (1H, br s), 5.47 (1H, s), 5.63-5.70 (1H, m), 
7.19 (1H, d, J = 7.4 Hz), 7.27-7.48 (2H, m), 7.50 (1H, d, J = 7.6 Hz).  
 
13C-NMR (100 MHz, CDCl3)  
δ: 16.0 (q), 18.7 (q), 28.7 (q), 32.8 (d), 42.2 (t), 63.6 (d), 70.3 (d), 81.2 (s), 108.9 (t), 126.2 (d), 126.4 
(d), 127.8 (d), 129.2 (d), 130.2 (s), 133.3 (s), 139.4 (s), 155.6 (s), 168.8 (s).  
 
MS: m/z 342 (M+). Anal. calcd for C20H26N2O3: C, 70.15; H, 7.65; N, 8.18. Found 








Yield: 59%.  
White solid. M. p.: 108-110 °C.  
IR: 1710, 1659 cm-1 
[α]23D = -52.2 (c = 0.56, CHCl3). 
 
1H NMR (400 MHz, CDCl3)  
δ: 0.95 (3H, d, J = 6.6 Hz), 0.98 (3H, d, J = 6.6 Hz), 1.50-1.70 (2H, m), 1.53 (9H, s), 1.95-2.08 (1H, m), 
4.30-4.52 (1H, m), 4.40, 5.17 (2H, AB system, J = 17.4 Hz), 5.28 (1H, d, J = 1.7 Hz), 5.65 (1H, d, J = 
1.7 Hz), 5.75 (1H, s), 7.18 (1H, d, J = 7.4 Hz), 7.24-7.36 (2H, m), 7.61 (1H, d, J = 7.5 Hz).  
 
13C-NMR (100 MHz, CDCl3)  
δ: 22.6 (q), 22.8 (q), 24.3 (d), 28.4 (q), 32.8 (t), 42.0 (t), 57.8 (d), 70.0 (d), 81.6 (s), 109.0 (t), 125.8 
(d), 126.3 (d), 127.3 (d), 128.8 (d), 130.4 (s), 131.3 (s), 139.6 (s), 154.6 (s), 169.9 (s).  
 
















Yield: 6%.  
Colorless oil.  
IR: 1704, 1658 cm-1  
[α]23D = +33.0 (c = 0.17, CHCl3).  
 
1H NMR (400 MHz, CDCl3)  
δ: 0.70-2.08 (18H, m), 4.15-4.19 (1H, m), 4.38, 5.22 (2H, AB system, J = 17.4 Hz), 5.15 (1H, d, J = 
1.2 Hz), 5.53 (1H, d, J = 1.2 Hz), 5.65 (1H, s), 7.12-7.65 (4H, m).  
 
13C-NMR (100 MHz, CDCl3)  
δ: 22.4 (q), 22.5 (q), 25.5 (d), 28.0 (q), 31.0 (t), 42.8 (t), 58.2 (d), 71.2 (d), 81.6 (s), 108.0 (t), 125.7 
(d), 126.5 (d), 128.3 (d), 129.4 (d), 131.5 (s), 133.0 (s), 134.7 (s), 152.0 (s), 164.0 (s).  
 









Yield: 51%.  
Yellow oil.  
IR: 1705, 1655 cm-1 
[α]23D = -8.8 (c = 0.40, CHCl3). 
  
1H NMR (400 MHz, CDCl3)  
δ: 1.15-1.25 (3H, m), 1.43 (9H, s), 4.27-4.41 (1H, m), 4.40, 5.19 (2H, AB system, J = 17.4 Hz), 5.29 
(1H, d, J = 1.6 Hz), 5.61 (1H, d, J = 1.6 Hz), 5.69 (1H, s), 7.18 (1H, d, J = 7.2 Hz), 7.24-7.37 (2H, m), 
7.59 (1H, d, J = 7.7 Hz).  
 
13C-NMR (100 MHz, CDCl3)  
δ: 19.4 (q), 28.3 (q), 41.2 (t), 56.7 (d), 69.7 (d), 81.4 (s), 109.1 (t), 128.1 (d), 128.9 (d), 130.7 (d), 
131.1 (s), 132.9 (s), 139.6 (d), 140.6 (s), 154.6 (s), 169.9 (s).  
 
 Experimental Section  
MS: m/z 314 (M+). Anal. calcd for C18H22N2O3: C, 68.77; H, 7.05; N, 8.91. Found C, 68.48; H, 6.91; N, 
9.17. 
 Experimental Section  











Triethylamine (10.7 mL, 76.4 mmol, 3 equiv.) is added to a solution of 18 (2.5 g, 25.5 mmol, 1 
equiv.) in dichloromethane (130 mL). Freshly distilled phenacyl chloride (10.1 mL, 76.4 mmol, 3 
equiv.) is introduced dropwise at 0 °C and the resulting solution is stirred for 16h at r.t. The 
reaction is quenched with saturated NH4Cl and the organic phase is extracted with CH2Cl2. The 
organic phases are washed with saturated NaHCO3, dried over MgSO4 and concentrated under 




Pale yellow oil. 
IR (neat): 2984, 2940, 2912, 1972, 1739, 1218 cm-1 
 
1H NMR (400 MHz, CDCl3)  
δ = 1.68 (6H, d, J= 3.0 Hz), 3.64 (2H s), 4.53 (d, 2H, J= 7.0 Hz), 5.08 (1H, m), 7.28-7.32 (5H, m) 
 
13C NMR (100 MHz, CDCl3) 
δ = 20.5 (q), 41.7 (t), 63.9 (t), 85.1 (d), 97.7 (s), 127.4 (d), 129.0 (d), 129.8 (d), 134.4 (s), 171.6 (s), 
203.6 (s). 
 
HRMS (ESI+) Calcd. for C14H16O2Na (M+Na








To a solution of allenyl amine (187 mg, 1 mmol, 1 equiv.) in THF (9.3 mL, 0,1 M) were rapidly 
added under argon atmosphere the appropriate N-protected-anthranylic acid (1.2 equiv.), DCC 
(248 mg, 1.2 equiv.) and DMAP (6.1 mg, 0.05 equiv.). The resulting mixture was stirred at room 
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 Experimental Section  
temperature overnight. The completion of the reaction was verified by TLC. Cyclohexane (28 mL) 
was then added, the mixture was filtered over a celite pad and then concentrated in vacuo. The 











Yield: 70%.  
White solid. M.p.: 107-109 °C.  
IR (neat) 1620, 1597, 1337, 1164, 737 cm-1. 
Rotamers ratio 3.1:1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.75 (6H, s), 2.20-2.50 (3H, m), 3.13 (2H, s br), 4.64 (2H, s br), 4.73-4.90 (1H, m), 6.70-7.80 (13H, 
m), 8.41 (1H, s br) (major rotamer);  
1.75 (6H, s), 2.20-2.50 (3H, m), 3.96 (2H, s br), 4.17 (2H, s br), 4.85-5.10 (1H, m), 6.70-7.80 (13H, 
m), 8.57 (1H, s br) (minor rotamer). 
 
13C-NMR (100 MHz, CDCl3) 
δ: 20.6 (q), 21.6 (q), 47.0 (t), 47.4 (t), 85.1 (d), 98.7 (s), 124.3 (d), 126.2 (d), 126.9 (s), 127.3 (d), 
127.8 (d), 128.1 (d), 129.1 (d), 129.7 (d), 130.2 (d), 131.3 (d), 134.9 (s), 136.6 (s), 143.7 (s), 153.8 
(s), 170.1 (s), 203.2 (s) (major rotamer);  
20.6 (q), 21.9 (q), 47.0 (t), 47.4 (t), 85.1 (d), 98.7 (s), 123.9 (d), 126.2 (d), 126.9 (s), 127.3 (d), 127.8 
(d), 128.2 (d), 129.1 (d), 129.7 (d), 130.2 (d), 131.5 (d), 134.9 (s), 136.4 (s), 144.8 (s), 153.8 (s), 
167.6 (s), 203.2 (s) (minor rotamer).  
 
HRMS (ESI +): Calcd. for C27H28N2NaO3S (M+Na
+): 483.17128, found: 483.17051. 
 
 








Yield: 58%.  
White solid (M.p.: 98-100 °C).  
IR (neat) 1728, 1626, 1516, 1157 cm-1.  
Rotamers ratio: 2:1.  
 Experimental Section  
1H-NMR: (400 MHz, CDCl3) 
δ: 1.52 (9H, s), 1.75 (6H, s), 3.74 (2H, s br), 4.80 (2H, s br), 4.85-5.00 (1H, m), 6.80-7.40 (8H, m), 
7.70-8.25 (2H, m) (major rotamer);  
1.52 (9H, s), 1.75 (6H, s), 4.04 (2H, s br), 4.57 (2H, s br), 5.00-5.20 (1H, m), 6.80-7.40 (8H, m), 7.70-
8.25 (2H, m) (minor rotamer).  
 
13C-NMR (100 MHz, CDCl3) 
δ: 20.7 (q), 28.7 (q), 47.4 (t), 48.0 (t), 80.7 (s), 85.4 (d), 98.6 (s), 121.4 (d), 122.3 (d), 124.6 (s), 
126.9 (d), 127.9 (d), 128.4 (s), 129.0 (d), 130.9 (d), 137.2 (s), 153.2 (s), 170.8 (s), 203.0 (s).  
 
HRMS (ESI +): Calcd. for C25H30N2NaO3S (M+Na











Yield: 62%.  
Yellow solid. M.p.: 70-72 °C.  
IR (neat) 1619, 1531, 1348, 1170 cm-1.  
Rogtamers ratio: 3.9:1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.75 (6H, s br), 3.20 (2H, s br), 4.62 (2H, s br), 4.70-4.90 (1H, m), 7.00-8.40 (13H, m), 8.80 (1H, s 
br) (major rotamer);  
1.75 (6H, s br), 3.96 (2H, s br), 4.29 (2H, s br), 4.85-5.05 (1H, m), 7.00-8.40 (13H, m), 9.0 (1H, s br) 
(minor rotamer).  
 
13C-NMR (100 MHz, CDCl3) 
δ: 20.6 (q), 47.0 (t), 47.6 (t), 84.8 (d), 99.4 (s), 124.2 (d), 124.6 (d), 125.1 (d), 126.9 (s), 127.6 (d), 
128.6 (d), 129.3 (d), 130.0 (d), 131.7 (d), 134.6 (d), 135.6 (s), 136.6 (s), 145.2 (s), 150.2 (s), 169.7 
(s), 203.3 (s).  
HRMS (ESI +): Calcd. for C26H25N3NaO5S (M+Na













 Experimental Section  
White oil. 
IR (neat) 1614, 1451, 1164 cm-1. 
Rotamers ratio 2.5:1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.74 (6H, d, J = 2.7 Hz), 2.30 (3H, s), 2.33 (3H, s), 3.45 (2H, d, J = 4.7), 4.62 (2H, s), 4.92 (1H, 
dddd, J = 4.7, 4.7, 2.7, 2.7 Hz),7.00 (2H, d, J = 8.0 Hz), 7.01-7.50(m, 8H), 7.54 (2H, d, J = 8.0 Hz), 
7.96 (1H, s br) (major rotamer);  
1.65 (6H, d, J = 2.5 Hz), 2.29 (3H, s), 2.46 (3H, s), 3.96 (2H, d, J = 5.8 Hz), 4.38 (2H, s), 4.99-5.09 (1H, 
m), 7.01-7.50 (m, 10H), 7.75 (2H, d, J = 8.0 Hz), 7.86 (1H, s br) (minor rotamer). 
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.6 (q), 20.9 (q), 21.7 (q), 47.9 (t), 48.3 (t), 85.5 (d), 98.2 (s), 125.4 (d), 126.6 (d),127.2 (d), 
127.9 (d), 128.9 (d), 129.6 (d), 129.7 (d), 133.6 (d), 133.7 (s), 134.0 (s), 136.9 (s), 137.4 (s), 139.8 
(s), 143.7 (s), 170.8 (s), 203.3 (s) (major rotamer); 
19.6 (q), 20.6 (q), 21.9 (q), 45.5 (t), 52.7 (t), 84.6 (d), 96.5 (s), 124.6 (d), 126.9 (d), 127.2 (d), 127.9 
(d), 129.2 (d), 129.6 (d), 129.9 (d), 133.6 (d), 133.7 (s), 134.0 (s), 136.9 (s), 137.4 (s), 139.8 (s), 
144.0 (s), 171.3 (s), 203.7 (s) (minor rotamer).  
 
HRMS (ESI +): Calcd. for C28H30N2NaO3S (M+Na














NaH (4.8 mg, 0.12 mmol, 1.2 equiv., 60% dispersion in mineral oil) was added to a solution of the 
appropriate N-protected allenyl amide (0.1 mmol, 1 equiv.) in freshly distilled DMSO (1.6 mL) 
under argon atmosphere. The resulting mixture was stirred at 50°C for 10 min. In another flask, 
BuLi (10 mL, 0.02 mmol, 20 mol%, 2.0 M solution in hexane) was added dropwise to a solution of 
PdCl2(CH3CN)2 in freshly distilled DMSO under Ar. The resulting solution, initially yellow, became 
dark orange. The appropriate aromatic iodide (0.12 mmol, 1.2 equiv.) and TBAB (6.4 mg, 0.02 
mmol, 20 mol%) were added, and the solution containing the deprotonated amide was added via 
cannula. The resulting mixture was stirred at 90 °C. The completion was monitored by TLC (about 
2 h) and the reaction was quenched with saturated NH4Cl. The aqueous layer was extracted with 
CH2Cl2. The organic layers were washed with saturated NaCl, dried on MgSO4 and concentrated in 
vacuo. The crude product was purified by flash chromatography (cyclohexane/AcOEt 8:2).  
 
 










Yield: 82%.  
Colorless oil.  
IR (neat) 1650, 1351, 1161, 716, 660 cm-1. 
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.41 (3H, s), 1.80 (3H, s), 2.33 (3H, s), 2.43 (3H, s), 3.06 (1H, dd, J = 15.3, 4.3), 3.33 (1H, dd, J = 
15.3, 12.5), 3.74 (1H, A part of AB system, J = 14.7 Hz), 3.81 (3H, s), 4.62 (1H, B part of AB system, 
J = 14.7 Hz),5.38 (1H, dd, J = 12.5, 4.3), 6.33 (1H, d, J = 8.0, 0.9 Hz), 6.60-6.95 (1H, m), 7.03 (1H, 
ddd, J = 8.0, 7.8, 1.7 Hz), 7.10-7.17 (2H, m), 7.22 (1H, ddd, J = 7.8, 7.8, 0.9 Hz), 7.27-7.37 (7H, m), 
7.42-7.47 (2H, m), 7.54 (1H, dd, J = 7.8, 1.7 Hz), 7.67-7.87 (1H, m); 
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.4 (q), 21.4 (q), 21.9 (q), 22.8 (q), 48.9 (t), 49.5 (t), 64.3 (d), 127.6 (d), 128.2 (d), 128.3 (d), 
128.8 (d), 129.2 (d), 129.8 (d), 130.1 (d), 131.1 (d), 131.3 (s), 133.6 (d), 133.7 (s), 134.1 (s), 134.2 
(s), 136.6 (s), 136.7 (s), 137.0 (s), 143.9 (s), 168.0 (s). 
 
HRMS (ESI +): Calcd. for C34H34N2NaO3S (M+H













Colorless oil.  
IR (neat) 1725, 1630, 1156 cm-1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.33 (9H, s), 1.49 (3H, s), 1.69 (3H, s), 2.34 (3H, s), 3.19-3.24 (1H, m), 3.41-3.49 (1H, m), 4.70 
(1H, A part of AB system, J = 14.2 Hz), 5.03 (1H, B part of AB system, J = 14.2 Hz), 5.35-5.42 (1H, 
m), 5.52-5.60 (1H, m), 6.30-6.40 (1H, m), 6.70-7.50 (10H, m), 7.55-7.61 (1H, m). 
 Experimental Section  
 
13C-NMR: (100 MHz, CDCl3) 
δ: 21.4 (q), 22.7 (q), 28.5 (q), 49.5 (t), 50.4 (t), 63.1 (d), 80.8 (s), 126.6 (d), 128.2 (d), 128.6 (d), 
128.7 (d), 129.1 (d), 129.2 (d), 130.0 (d), 130.6 (d), 133.4 (s), 136.7 (s), 137.5 (s), 147.5 (s), 156.1 
(s), 168.0 (s).  
 
HRMS: Calcd. For C32H36N2NaO3 (M+Na












Yield: 80%.  
Colorless oil.  
IR (neat) 1652, 1530, 1350, 1176, 668, 616 cm-1. 
  
1H-NMR: (400 MHz, CDCl3) 
δ: 1.44 (3H, s), 1.87 (3H, s), 2.35 (3H, s), 3.14 (1H, dd, J = 15.5, 4.4 Hz), 3.36 (1H, dd, J = 15.5, 12.3 
Hz), 3.88 (1H, A part of AB system, J = 14.5 Hz), 4.64 (B part of AB system, J = 14.5 Hz), 5.48 (1H, 
dd, J = 12.3, 4.4 Hz), 6.31 (1H, dd, J = 8.1, 1.0 Hz), 6.25-6.50 (1H, s br), 6.60-6.90 (1H, s br), 6.56 
(1H, d, J = 9.0 Hz), 7.06 (1H, ddd, J = 8.1, , 7.8, 1.7 Hz), 7.13-7.18 (2H, m), 7.23-7.41 (6H, m), 7.50 
(1H, dd, J = 7.8, 1.7 Hz), 15.2 (2H, d, J = 8.9 Hz), 8.28 (2H, d, J = 8.9 Hz).  
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.5 (q), 21.4 (q), 22.8 (q), 49.0 (t), 49.8 (t), 65.5 (d), 124.7 (d), 128.4 (d), 128.6 (d), 128.8 (d), 
129.0 (d), 129.3 (d), 129.9 (d), 131.3 (d), 132.2 (s), 132.9 (s), 133.2 (d), 134.2 (s), 136.3 (s), 136.6 
(s), 136.9 (s), 144.7 (s), 150.4 (s), 167.5 (s).  
 
HRMS (ESI +): Calcd. for C33H31N3NaO5S (M+Na













 Experimental Section  
Yield: 63%.  
Colorless oil.  
IR (neat) 1651, 1466, 1351, 1159, 718, 658 cm-1.  
Rotamers ratio 1.1:1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.43 (3H, s), 1.80 (3H, s ), 2.43 (3H, s), 3.07 (1H, dd, J = 15.3, 4.0 Hz), 3.34 (1H, dd, J = 15.3, 12.5 
Hz), 3.52 (3H, s br, minor rotamer) 3.70-3.85 (1H, m), 3.94 (3H, s br, major rotamer), 4.63 (1H, d, J 
= 14.7 Hz),5.39 (1H, dd, J = 12.5, 4.0 Hz) 5.90-6.10 (1H, m), 6.35-6.40 (1H, m), 6.78 (1H, dd, J = 7.8, 
1.8 Hz), 7.00-7.25 (5H, m), 7.27-7.57 (9H, m) 
 
13C-NMR (100 MHz, CDCl3):  
δ: 19.3 (q), 21.9 (q), 22.8 (q), 48.9 (t), 49.5 (t), 55.5 (q, minor rotamer), 55.8 (q), major rotamer), 
64.1 (d), 127.6 (d), 128.2 (d), 128.4 (d), 128.8 (d), 129.2 (d), 129.8 (d), 130.1 (d), 131.2 (d), 131.3 
(s), 133.5 (d), 133.6 (d), 134.0 (s), 134.1 (s), 136.6 (s), 137.0 (s), 141.0 (s), 144.0 (s), 168.0 (s).  
 
HRMS (ESI +): Calcd. for C34H34N2NaO4S (M+Na













Yield: 63%.  
Colorless oil.  
IR (neat) 1651, 1351, 1159, 718, 658 cm-1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.40 (3H, s), 1.80 (3H, s), 2.42 (3H, s), 3.11 (1H, dd, J = 15.8, 4.5 Hz), 3.15 (3H, s), 3.49 (1H, dd, J 
= 15.8, 12.3 Hz), 3.66 (1H, A part of AB system, J = 14.7 Hz), 4.56 (B part of AB system, J = 14.7 Hz), 
5.40 (1H, dd, J = 12.3, 4.5 Hz), 6.09 (1H, d, J = 8.1), 6.56 (1H, d, J = 9.0 Hz), 6.90-7.50 (m, 14H), 7.56 
(1H, d, J = 7.6 Hz).  
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.5 (q), 21.9 (q), 22.8 (q), 48.9 (t), 49.5 (t), 54.8 (q), 64.6 (d), 110.6 (d), 121.4 (d), 127.6 (d), 
128.1 (d), 128.3 (d), 128.5 (s), 128.7 (d), 128.9 (d), 129.1 (d), 129.7 (d), 130.1 (d), 130.5 (s), 131.1 
(d), 131.3 (s), 133.7 (d), 134.1 (s), 134.6 (d), 134.7 (s), 136.9 (s), 137.2 (s), 143.8 (s), 157.3 (s), 
168.2 (s).  
 
HRMS (ESI +): Calcd. for C34H34N2NaO4S (M+Na
+): 589.21315, found: 589.21202. 
 
 











Yield: 73%.  
Colorless oil. 
IR (neat) 1651, 1509, 1350, 1244, 1172 cm-1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.41 (3H, s), 1.80 (3H, s), 2.43 (3H, s), 3.06 (1H, dd, J = 15.3, 4.3), 3.32 (1H, dd, J = 15.3, 12.4), 
3.75 (1H, A part of AB system, J = 14.7 Hz), 3.81 (3H, s), 4.62 (1H, B part of AB system, J = 14.7 
Hz),5.38 (1H, dd, J = 12.4, 4.3), 6.20-6.60 (2H, m), 6.41 (1H, dd, J = 7.9, 1.1 Hz), 6.80-7.10 (1H, m), 
7.09 (1H, ddd, J = 7.9, 7.6, 1.7 Hz), 7.11-7.15 (2H, m), 7.23 (1H, ddd, J = 7.6, 7.6, 1.1 Hz), 7.27-7.37 
(6H, m), 7.42-7.47 (2H, m), 7.55 (1H, dd, J = 7.6, 1.7 Hz). 
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.4 (q), 21.9 (q), 22.8 (q), 48.9 (t), 49.5 (t), 55.7 (q), 64.3 (d), 127.6 (d), 128.2 (d), 128.4 (d), 
128.8 (d), 129.2 (d), 129.8 (d), 130.1 (d), 131.2 (d), 131.8 (s), 132.0 (s), 133.3 (s), 133.6 (d), 134.1 
(s), 134.2 (s), 136.6 (s), 136.9 (s), 144.0 (s), 158.9 (s), 168.0 (s).  
 
HRMS (ESI +): Calcd. for C34H34N2NaO4S (M+Na














Yield: 61%.  
Colorless oil. 




 Experimental Section  
1H-NMR: (400 MHz, CDCl3) 
δ: 1.38 (3H, s), 1.81 (3H, s), 2.43 (3H, s), 3.10 (1H, dd, J = 15.3, 4.2), 3.34 (1H, dd, J = 15.3, 12.5 Hz), 
3.79 (1H, A part of AB system, J = 14.7 Hz), 3.94 (3H, s), 4.61 (1H, B part of AB system, J = 14.7 Hz), 
5.39 (1H, dd, J = 12.5, 4.2 Hz), 6.29 (1H, d, J = 8.0 Hz), 6.52 (1H, s br), 7.02 (1H, ddd, J = 8.0, 7.6, 1.7 
Hz), 7.10-7.15 (2H, m), 7.22 (1H, ddd, J = 7.7, 7.6, 1.0 Hz), 7.27-7.37 (5H, m), 7.40-7.47 (2H, m), 
7.54 (1H, dd, J = 7.7, 1.7 Hz), 7.50-7.85 (2H, m), 8.05-8.35 (1H, m).  
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.4 (q), 21.9 (q), 22.7 (q), 48.9 (t), 49.5 (t), 52.4 (q), 64.0 (d), 127.6 (d), 128.3 (d), 128.6 (d), 
128.9 (d), 129.0 (s), 129.2 (d), 130.1 (d), 130.2 (d), 131.4 (d), 132.1 (s), 133.1 (s), 133.2 (d), 133.8 
(s), 134.0 (s), 136.3 (s), 136.8 (s), 144.2 (s), 144.9 (s), 167.4 (s), 167.9 (s).  
 
HRMS (ESI +): Calcd. for C35H34N2NaO4S (M+Na















Yield: 71%.  
Colorless oil. 
IR (neat) 1652, 1518, 1346 cm-1. 
  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.39 (3H, s), 1.81 (3H, s), 2.44 (3H, s), 3.12 (1H, dd, J = 15.3, 4.2 Hz), 3.33 (1H, dd, J = 15.3, 12.6 
Hz), 3.82 (1H, A part of AB system, J = 14.7 Hz), 4.61 (B part of AB system, J = 14.7 Hz), 5.39 (1H, 
dd, J = 12.6, 4.2 Hz), 6.30 (1H, dd, J = 8.0, 1.0 Hz), 6.38-6.95 (1H, m), 7.05 (1H, ddd, J =8.0, 7.6, 1.6 
Hz), 7.11-7.15 (2H, m), 7.21-7.45 (6H, m), 7.40-7.45 (2H, m), 7.57 (1H, dd, J = 7.6, 1.6 Hz), 7.59-
8.65 (3H, m)  
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.5 (q), 22.0 (q), 22.8 (q), 48.8 (t), 49.6 (t), 63.9 (d), 127.6 (d), 128.3 (d), 128.7 (d), 128.9 (d), 
129.3 (d), 130.2 (d), 130.4 (d), 131.4 (d), 132.3 (s), 132.8 (d), 133.1 (s), 133.7 (s), 134.1 (s), 136.0 
(s), 136.7 (s), 144.4 (s), 147.3 (s), 167.7 (s).  
 
HRMS (ESI +): Calcd. for C33H31N3NaO5S (M+Na

















Yield: 68%.  
Colorless oil. 
IR (neat) 1682, 1650, 1350, 1158, 714, 660 cm-1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.39 (3H, s), 1.81 (3H, s), 2.43 (3H, s), 2.62 (3H, s), 3.11 (1H, dd, J = 15.2, 4.2 Hz), 3.34 (1H, dd, J 
= 15.2, 12.5 Hz), 3.79 (1H, A part of AB system, J = 14.6 Hz), 4.61 (1H, B part of AB system, J = 14.6 
Hz), 5.39 (1H, dd, J = 12.5, 4.2 Hz), 6.26 (1H, dd, J = 8.1, 0.9 Hz), 6.40-6.75 (1H, br s), 6.99 (1H, ddd, 
J = 8.1, 7.6, 1.7 Hz), 7.13 (2H, m), 7.22 (1H, ddd, J = 7.6, 7.6, 0.9 Hz), 7.27-7.38 (5H, m), 7.41-7.46 
(2H, m), 7.55 (1H, dd, J = 7.6, 1.7 Hz), 7.55-7.80 (2H, br s), 7.80-8.30 (1H, s br).  
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.4 (q), 21.9 (q), 22.7 (q), 27.0 (q), 48.9 (t), 49.5 (t), 64.0 (d), 127.6 (d), 128.3 (d), 128.6 (d), 
128.9 (d), 129.2 (d), 130.1 (d), 130.2 (d), 131.2 (d), 132.1 (s), 133.1 (d), 133.8 (s), 134.1 (s), 136.0 
(s), 136.3 (s), 144.2 (s), 145.2 (s), 167.8 (s), 198.2 (s).  
 
HRMS (ESI +): Calcd. for C35H34N2NaO4S (M+Na












Yield: 67%.  
White oil.  
IR (neat) 1651, 1351, 1160, 703, 658 cm-1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.40 (3H, s), 1.82 (3H, s), 2.43 (3H, s), 3.08 (1H, dd, J = 15.3, 4.2), 3.35 (1H, ddd, J = 15.3, 12.4, 
0.8), 3.75 (1H, A part of AB system, J = 14.7 Hz), 4.62 (1H, B part of AB system, J = 14.7 Hz), 5.40 
(1H, dd, J = 12.4, 4.2 Hz), 6.30 (2H, dd, J = 8.1, 1.1 Hz), 6.45 (1H, s br), 6.90-7.05 (1H, m), 7.03 (1H, 
 Experimental Section  
ddd, J = 8.1, 7.6, 1.7 Hz), 7.11-7.16 (2H, m), 7.18-1.25 (1H, m), 7.21 (1H, ddd, J = 7.6, 7.6, 1.1),7.27-
7.37 (5H, m), 7.42-7.60 (4H, m), 7.54 (1H, dd, J = 7.6, 1.7 Hz);  
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.4 (q), 21.9 (q), 22.8 (q), 48.9 (t), 49.5 (t), 64.2 (d), 127.0 (d), 127.6 (d), 128.2 (d), 128.8 (d), 
129.2 (d), 129.8 (d), 130.1 (d), 131.2 (d), 131.4 (s), 133.5 (d), 133.8 (s), 134.0 (s), 136.6 (s), 137.0 
(s), 139.7 (s), 144.0. (s), 168.0 (s).  
 
HRMS (ESI +): Calcd. for C33H32N2NaO3S (M+Na














Colorless oil.  
IR (neat) 1651, 1351, 1159, 712, 658 cm-1.  
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.40 (3H, s), 1.81 (3H, s), 2.43 (3H, s), 3.10 (1H, dd, J = 15.3, 4.2), 3.25-3.33 (1H, m), 3.86 (1H, A 
part of AB system, J = 14.7 Hz), 4.59 (1H, B part of AB system, J = 14.7 Hz), 5.34-5.40 (1H, m), 6.32 
(1H, s br), 7.08-7.14 (3H, m), 7.17-7.40 (8H, m), 7.41-7.48 (2H, m), 7.51-7.58 (1H, m), 7.60-8.40 
(1H, m), 8.52 (1H, d, J = 4.3 Hz).  
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.5 (q), 21.9 (q), 22.9 (q), 48.7 (t), 49.6 (t), 63.9 (d), 127.6 (d), 128.3 (d), 128.2 (d), 128.8 (d), 
129.1 (s), 129.3 (d), 130.2 (d), 130.3 (d), 130.4 (d), 131.2 (s), 131.5 (d), 132.8 (s), 133.0 (s), 133.7 
(d), 134.0 (s), 134.4 (s), 136.1 (s), 136.7 (s), 144.3 (s), 167.8 (s).  
 
HRMS (ESI +): Calcd. for C32H31N3NaO3S (M+Na











 Experimental Section  
Yield: 75%.  
Colorless oil.  
IR (neat) 1651, 1351, 1162, 700, 658 cm-1. 
 
1H-NMR: (400 MHz, CDCl3) 
δ: 1.48 (3H, s), 1.57 (3H, s), 1.95 (3H, s), 2.32 (3H, s), 2.46 (3H, s), 3.00 (1H, dd, J = 15.2, 3.7), 3.18 
(1H, A part of AB system, J = 14.9 Hz), 3.59 (1H, dd, J = 15.2, 12.2 Hz), 4.69 (1H, A part of AB 
system, J = 14.9 Hz), 5.36 (1H, dd, J = 12.2, 3.6 Hz), 6.40-6.80 (1H, m), 6.90-7.05 (2H, m), 7.10-7.15 
(2H, m), 7.16-7.22 (1H, m), 7.23-7.35 (6H, m), 7. 38 (2H, d, J = 8.2 Hz), 7.50-7.55 (1H, m), 7.63 (2H, 
d, J = 8.2 Hz)  
13C-NMR (100 MHz, CDCl3) 
δ: 18.7 (q), 20.2 (q), 21.4 (q), 21.9 (q), 23.6 (q), 48.8 (t), 49.8 (t), 64.6 (d), 128.1 (d), 128.4 (d), 
128.5 (d), 128.7 (d), 129.1 (d), 130.2 (d), 132.3 (s), 133.8 (s), 134.1 (s), 134.6 (d), 135.0 (s), 136.1 
(s), 136.8 (s), 137.0 (s), 143.5 (s), 144.1 (s), 168.5 (s).  
 
HRMS (ESI +): Calcd. for C35H36N2NaO3S (M+Na
+): 587.23388, found: 587.23221 
 
 








To a solution of NH-Boc derivative XY (1 equiv.) in CH3CN were added chlorotrimethylsilane (2 
equiv.) and sodium iodide (2 equiv.) at room temperature. After complete disappearance of 
starting material (TLC plate, about 3 hours), methanol was added (4 equiv.). The reaction mixture 
was stirred for 2 hours, filtered on a celite pad and the volatile compounds were removed under 
reduced pressure. Purification over silica gel column (pentane/diethyl ether 6:4) or treatment of 
the crude product in acidic conditions (see text in the article) gave product XY in yields varying 
from 75% to 92%. 
 
Yellow oil.  
IR (neat) 3323, 1617, 1478, 749, 701 cm-1.  
 
1H-NMR (400 MHz, CDCl3) 
δ: 1.47 (3H, d, J = 1.3 Hz), 1.66 (3H, d, J = 1.3 Hz), 3.14 (1H, dd, J = 15.0, 3.4 Hz), 3.42 (1H, dd, J = 
15.0, 9.6 Hz), 3.60 (1H, s br), 4.16 (1H, ddd, J = 9.6, 9.6, 3.4 Hz), 4.61 (1H, A part of AB system, J = 
14.7 Hz), 5.03-5.08 (1H, m), 5.06 (1H, B part of AB system, J = 14.7 Hz), 5.06 (1H, m), 6.63 (1H, d, J 
= 8.0 Hz), 6.91 (1H, ddd, J = 8.0, 7.8, 0.8 Hz), 7.24 (1H, ddd, J = 8.0, 8.0, 1.6 Hz), 7.28-7.42 (m, 5H), 
7.85 (1H, dd, J = 7.8, 1.6 Hz).  
 
 Experimental Section  
13C-NMR (100 MHz, CDCl3) 
δ: 18.2 (q), 26.0 (q), 50.4 (t), 51.8 (t), 58.7 (d), 120.2 (d), 120.3 (d), 123.6 (s), 123.7 (d), 127.9 (d), 
128.8 (d), 129.0 (d), 132.1 (d), 132.5 (d), 136.0 (s), 137.6 (s), 143.8 (s), 170.2 (s).  
 
HRMS: Calcd. For C20H23ON2 (M+H











To a solution of 23c (1 equiv.) in DMF (0,1 M) were added PhSH (1.2 equiv.) and potassium 
carbonate (3 eq.) at room temperature. The reaction mixture was stirred at 40°C overnight. The 
mixture was treated with brine and extracted twice with ethyl acetate. It was then concentrated 
in vacuo and purified over silica gel column (pentane/diethyl ether 6:4).  
 
Yield: 13% 
White oil.  
IR (neat) 3320, 1613, 751, 700 cm-1.  
 
1H-NMR (400 MHz, CDCl3) 
δ: 1.43 (3H, s), 1.63 (3H, s), 2.27-2.32 (1H, m), 2.29 (3H, s), 3.14 (1H, dd, J = 14.9, 2.6 Hz), 3.46 (1H, 
dd, J = 14.9, 10.3 Hz), 4.62 (1H, d, J = 10.3 Hz), 4.69 (1H, A part of AB system, J = 14.8 Hz), 4.93 (1H, 
B part of AB system, J = 14.8 Hz), 6.18 (1H, d, J = 7.8 Hz), 6.73-6.81 (3H, m), 7.03-7.10 (3H, m), 
7.27-7.45 (5H, m), 7.77 (1H, dd, J = 7.8, 1.6 Hz).  
 
13C-NMR (100 MHz, CDCl3) 
δ: 19.8 (q), 21.4 (q), 22.9 (q), 50.0 (t), 51.9 (t), 60.9 (d), 119.0 (s), 119.3 (d), 121.6 (s), 121.9 (s), 
127.9 (d), 128.8 (d), 129.1 (d), 129.4 (d), 129.7 (d), 132.3 (d), 133.0 (s), 135.3 (s), 136.4 (s), 136.8 
(d), 137.6 (s), 170.0 (s), 172.0 (s).  
 
HRMS: Calcd. For C27H29ON2 (M+H
+): 397.22744, found: 397.22648. 
 
 Experimental Section  
4) Exploiting the anthranilic scaffold, back to allenamides – 










DCC (10 mmol), N-propargyl amine (8.3 mmol)108 and DMAP (0.125 mmol) were added to a 
solution of Boc-anthranilic acid (10 mmol) in CH2Cl2 (60 mL, 0 °C). The mixture reacted for 2 d at 
r.t., then was filtered on a silica gel path. The solvent was removed under reduced pressure and 
the crude purified by flash chromatography (light petroleum/AcOEt 7:3). 
 
 











Yellow solid. M. p. 76°C 
IR: 1715, 1640 cm-1 
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.50 (9H, s), 2.34 (1H, s), 3.12 (3H, s), 3.95-4.50 (2H, m), 7.03 (1H, ddd, J = 1.0, 7.2, 8.1 Hz), 7.36-
7.41 (2H, m), 7.96 (1 H, b), 8.13 (1H, d, J = 8.4 Hz) 
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.2 (q), 33.8 (t), 54.0 (q), 75.0 (d), 78.1 (s), 80.4 (s), 120.9 (d), 121.9 (d), 122.8 (s), 127.3 (d), 
130.9 (d), 137.4 (s), 152.8 (s), 170.0 (s). 
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 Except for commercial N-methyl-propargyl amine, all other amines were prepared according to: E. M. 
Beccalli, A. Bernasconi, E. Borsini, G. Broggini, M. Rigamonti, G. Zecchi J. Org. Chem. 2010, 75, 6923. 
 Experimental Section  






IR: 1713, 1641 cm-1 
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.53 (9H, s), 2.01 (1H, s), 3.12 (2H, d, J = 7.2 Hz), 4.94 (2H, s), 7.03 (1H, ddd, J = 1.1, 6.5, 7.6 Hz), 
7.36 – 7.41 (3H, m), 7.44 – 7.48 (2H, m), 7.74 (1H, br s), 7.79 – 7.82 (4H, m), 8.13 (1H, dd, J = 0.4, 
8.2 Hz). 
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.3 (q), 29.7 (t), 52.4 (t), 71.9 (d), 78.3 (s), 80.6 (s), 117.0 (d), 121.5 (d), 122.4 (d), 123.6 (s), 
125.5 (d), 126.2 (d), 126.4 (d), 126.9 (d), 127.7 (d), 127.8 (d), 128.8 (d), 131.1 (d), 133.0 (s), 133.3 
(s), 137.2 (s), 148.0 (s), 153.0 (s), 170.4 (s). 
 
















IR: 1718, 1645 cm-1 
  
1H-NMR (400 MHz, CDCl3)  
δ: 1.53 (9H, s), 2.37 (1H, s), 4.02 (2H, s), 4.94 (2H, s), 6.95-6.98 (1H, m), 7.04-7.08 (2H, m), 7.26-
7.38 (1H, m), 7.39-7.42 (2H, m), 7.80 (1H, br s), 8.10 (1H, d, J = 8.6 Hz). 
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.3 (q), 36.9 (t), 46.6 (t), 72.0 (d), 78.3 (s), 80.4 (s), 121.4 (d), 122.3 (d), 123.6 (s), 126.1 (d), 
126.7 (d), 126.9 (d), 127.5 (d), 131.1 (d), 137.2 (s), 138.3 (s), 152.9 (s), 170.0 (s). 
 
MS: m/z 370 (M+). Anal. calcd for C20H22N2O3S: C, 64.84; H, 5.99; N, 7.56. Found C, 64.80; H, 5.91; 
N, 7.70. 
 
 Experimental Section  










Yellow solid (M. p. 95°C) 
IR: 1720, 1640 cm-1 
 
1H-NMR (CDCl3)  
δ: 1.53 (9H, s), 2.35 (1H, s), 3.95 (2H, s), 4.83 (2H, s), 7.05 (1H, d, J = 6.8), 7.03-7.42 (7H, m), 7.87 
(1H, br s), 8.10 (1H, d, J = 8.4) 
 
13C-NMR (CDCl3)  
δ: 28.3 (q), 36.9 (t), 51.9 (t), 72.3 (d), 78.2 (s), 80.6 (s), 121.5 (d), 122.3 (d), 123.5 (s), 126.8 (d), 
127.9 (d), 128.5 (d), 128.8 (d), 131.0 (d), 136.4 (s), 137.1 (s), 152.9 (s), 170.0 (s). 
 










IR: 1700, 1650 cm-1 
 
1H-NMR (CDCl3)  
δ: 1.27 (1H, s), 1.52 (9H, s), 2.32 (1H, s), 4.30 (2H, s), 4.85 (2H, s), 7.00-7.04 (2H, m), 7.12-7.14 (3H, 
m), 7.35-7.39 (2H, m), 7.85 (1H, br s), 8.10 (1H, d, J = 8.3). 
 
13C-NMR (CDCl3)  
δ: 21.1 (q), 28.3 (q), 38.7 (t), 47.0 (t), 73.5 (d), 78.3 (s), 80.4 (s), 121.4 (d), 122.3 (d), 123.7 (s), 
126.6 (d), 128.0 (d), 129.5 (d), 130.9 (d), 132.5 (s), 137.1 (s), 137.5 (s), 152.9 (s), 170.1 (s). 
 





 Experimental Section  






IR: 1703, 1651 cm-1 
 
1H-NMR (CDCl3)  
δ: 1.52 (9H, s), 2.34 (1H, s), 3.59-3.72 (2H, m), 3.81 (3H, s), 4.50-4.78 (2H, br s), 6.87 (2H, d, J = 8.5 
Hz), 7.03-7.42 (5H, m), 7.83 (1H, br s), 8.10 (1H, d, J = 8.4 Hz). 
 
13C-NMR (CDCl3)  
δ: 28.3 (q), 30.9 (t), 55.2 (q),64.4 (t), 73.5 (d), 78.3 (s), 80.5 (s), 114.2 (d), 121.4 (d), 122.3 (s), 126.9 
(d), 130.9 (d), 137.1 (s), 152.9 (s), 159.3 (s), 170.1 (s). 
 














2-amino-5-chloro-N-methyl-N-(prop-2-ynyl)benzamide109 (3.15 mmol) was dissolved in EtOH (15 
mL). (Boc)2O (14 mmol) was added and the reactino was stirred at 50 °C for 6 d. The solvent  was 
then evaporated under reduced pressure and the residue was purified by flash column 
cromatography (light petroleum/EtOAc 4:1). 
 
Yield: 73%. 
White solid. M.p. 147 °C.  
IR:  1705, 1658 cm-1 
 
1H-NMR (CDCl3)  
δ: 1.51 (9H, s), 2.37 (1H, s), 3.13 (3H, s), 3.90-4.50 (2H, m), 7.20-7.37 (2H, m), 7.85 (1H, br s), 8.11 
(1H, d, J = 9.0) 
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 G. Broggini, G. Molteni, A. Terraneo, G. Zecchi, Tetrahedron, 1999, 55, 14803. 
 Experimental Section  
13C-NMR (CDCl3)  
δ: 28.4 (q), 37.0 (q), 42.0 (t), 73.2 (d), 79.5 (s), 80.9 (s), 122.4 (d), 124.2 (s), 127.1 (d), 130.9 (d), 
134.0 (s), 136.1 (s), 152.7 (s), 168.7 (s). 
 














t-BuOK (2.5 mmol) in THF (10 mL) was added to a solution of 28 (1 mmol). The resulting solution 
was stirred at r.t. for 1 min, then filtered on silica gel (AcOEt). The solvent was evaporated under 
reduced pressure and the residue was used without further purification for the next step. 
 
 













IR:  1701, 1652 cm-1 
 
1H-NMR (400 MHz, CDCl3):  
δ: 1.52 (9H, s), 3.13 (3H, s), 5.40 (2H, d, J = 6.3 Hz), 6.78 (1H, br s), 7.04 (1H, ddd, J = 1.2, 6.5, 7.9 
Hz), 7.28 (1H, dd, J = 1.5, 7.7 Hz), 7.39 (1H, ddd, J = 1.6, 6.2, 7.9 Hz), 7.90 (1H, br s), 8.16 (1H, dd, J 
= 1.0, 8.4 Hz)  
 
13C-NMR (100 MHz, CDCl3):  
δ: 28.3 (q), 30.3 (q), 80.6 (s), 87.3 (t), 103.3 (d), 115.8 (s), 121.0 (d), 121.7 (d), 128.7 (d), 131.3 (d), 
137.9 (s), 152.8 (s), 168.4 (s), 200.1 (s). 
 





 Experimental Section  





Orange oil.  
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.51 (9H, s), 5.08 (2H, s), 5.30 (2H, s), 7.06 (1H, br s), 7.42 – 7.54 (5H, m), 7.77 – 7.85 (5H, m), 
8.04 (1H, br s), 8.18 (1H, d, J = 8.1 Hz) 
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.3 (q), 48.0 (t), 80.6 (s), 87.6 (t), 102.5 (d), 117.2 (d), 121.3 (d), 122.0 (d), 125.1 (d), 125.9 (d), 
126.2 (d), 127.0 (s), 127.3 (d), 127.7 (d), 127.8 (d), 128.4 (d), 129.5 (s), 131.4 (d), 132.7 (s), 133.4 
(s), 134.5 (s), 152.9 (s), 168.3 (s), 200.6 (s). 
 


















1H-NMR (400 MHz, CDCl3)  
δ: 1.53 (9H, s), 5.02 (2H, s), 5.45 (2H, d, J = 6.3 Hz), 6.70 (1H, br s), 6.95 – 7.05 (3H, m), 7.23 – 7.32 
(2H, m), 7.39 – 7.43 (1H, m), 7.95 (1H, br s), 8.13 (1H, d, J = 8.4 Hz)  
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.3 (q), 42.5 (t), 80.5 (s), 88.2 (t), 101.6 (d), 121.2 (d), 121.9 (d), 125.5 (d), 126.4 (d), 127.4 (d), 
128.4 (d), 129.0 (s), 131.4 (d), 137.7 (s), 139.0 (s), 152.8 (s), 168.0 (s), 200.1 (s). 
 






 Experimental Section  







1H-NMR (400 MHz, CDCl3)  
δ: 1.53 (9H, s), 4.90 (2H, s), 5.29 (2H, d, J = 6.1 Hz), 6.73 (1H, br s), 7.00 – 7.42 (8H, m), 7.97 (1H, br 
s), 8.15 (1H, d, J = 8.2 Hz)  
 
13C-NMR (CDCl3)  
δ: 28.3 (q), 47.7 (t), 80.6 (s), 87.6 (t), 102.4 (d), 121.3 (d), 126.6 (d), 127.3 (s), 127.8 (d), 128.5 (d), 
128.6 (d), 128.8 (d), 131.3 (d), 137.1 (s), 137.6 (s), 152.8 (s), 168.4 (s), 200.5 (s). 
 












δ: 1.54 (9H, s), 2.34 (3H, s), 4.86 (2H, br s), 5.30 (2H, d, J = 6.0 Hz), 6.71 (1H, br s), 7.04 – 7.42 (7H, 
m), 7.97 (1H, br s), 8.14 (1H, d, J = 8.3 Hz)  
 
13C-NMR (CDCl3)  
δ: 21.1 (q), 28.3 (q), 47.7 (t), 80.5 (s), 87.5 (t), 102.4 (d), 121.2 (d), 122.0 (d), 126.8 (s), 127.8 (d), 
128.5 (d), 129.0 (d), 131.3 (d), 134.1 (s), 136.9 (s), 137.7 (s), 152.8 (s), 168.3 (s), 200.5 (s). 
 







 Experimental Section  







1H-NMR (400 MHz, CDCl3) 
δ: 1.51 (9H, s), 3.79 (3H, s), 4.83 (2H, br s), 5.32 (2H, d, J = 6.3 Hz), 6.55 – 7.45 (7H, m), 7.94 (1H, br 
s), 8.13 (1H, d, J = 8.3 Hz)  
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.3 (q), 47.1 (t), 55.2 (q), 80.5 (s), 87.5 (t), 102.3 (d), 113.9 (d), 121.2 (d), 123.0 (d), 128.5 (d), 
129.4 (d), 131.3 (d), 137.6 (s), 152.8 (s), 158.8 (s), 168.3 (s), 200.5 (s). 
 










K2CO3 (4 mmol), the appropriate aryl iodide (1.5 mmol) and Pd(PPh3)4 (2%) in DMF (10 mL) were 
added to a solution of 2 (1 mmol). The resulting solution was heated at 100 °C for 2 h, then was 
cooled, diluted with brine and extracted with AcOEt (3 x 20 mL). The resulting crude was purified 









White solid. M.p.: 165°C 
 
 Experimental Section  
1H-NMR (400 MHz, CDCl3)  
δ: 1.41 (9H, s), 3.27 (3H, s), 5.03 (1H, d, J = 1.4 Hz), 5.24 (1H, d, J = 1.7 Hz), 6.67 (1H, br s), 7.16-
7.22 (4H, m), 7.27-7.29 (3H, m), 7.36 (1H, ddd, J = 1.6, J = 7.2, 8.8 Hz), 8.01 (1H, dd, J = 1.1, 7.8 Hz)  
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.0 (q), 33.9 (q), 70.7 (s), 82.7 (d), 116.6 (t), 123.6 (s), 124.4 (d), 124.9 (d), 127.0 (d), 127.3 (d), 
127.9 (s), 128.1 (d), 131.7 (d), 137.0 (s), 139.0 (s), 143.9 (d), 145.5 (s), 163.1 (s). 
 















Brown oil.  
 
1H-NMR (CDCl3)  
δ: 1.01 (9H, s), 4.80 (1H, br s), 5.18 (1H, d, J = 1.7 Hz), 5.24 (1H, d, J = 1.4 Hz), 5.91 (1H, br s), 6.62 
(1H, br s), 7.07 – 7.09 (2H, m), 7.24 – 7.27 (4H, m), 7.40 – 7.54 (5H, m), 7.82 – 7.85 (4H, m), 8.12 
(1H, d, J = 7.6 Hz) 
 
13C-NMR (100 MHz, CDCl3) 
δ: 27.9 (q), 48.8 (t), 82.2 (s), 102.5 (d), 116.9 (t), 119.0 (d), 123.5 (s), 124.2 (d), 124.8 (d), 126.2 (d), 
126.3 (d), 126.5 (d), 127.3 (d), 127.7 (d), 127.8 (d), 127.9 (d), 128.1 (d), 128.8 (d), 132.2 (d), 133.1 
(s), 133.4 (s), 134.2 (s), 135.0 (d), 137.1 (s), 139.4 (s), 143.8 (s), 150.9 (s), 163.0 (s). 
 


























Brown oil.  
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.53 (9H, s), 4.35 (1H, br s), 5.07 (1H, d, J = 1.4 Hz), 5.22 (1H, s), 5.75 (1H, br s), 6.70 (1H, br s), 
6.98 – 7.07 (2H, m), 7.11 – 7.14 (3H, m), 7.22 – 7.26 (2H, m), 7.27 – 7.35 (2H, m), 7.41 – 7.47 (2H, 
m), 8.06 (1H, d, J = 7.2 Hz) 
 
13C-NMR (100 MHz, CDCl3)  
δ: 27.6 (q), 44.0 (t), 68.4 (d), 82.3 (s), 116.9 (t), 120.0 (d), 121.3 (d), 124.2 (s), 124.8 (d), 126.6 (d), 
127.3 (d), 127.6 (d), 127.9 (d), 128.5 (d), 136.7 (s), 137.0 (s), 138.1 (s), 143.7 (s), 151.0 (s), 162.9 
(s). 
 














Yellow oil.  
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.17 (9H, s), 3.94 (1H, br s), 5.13 (1H, d, J = 1.6 Hz), 5.24 (1H, s), 5.80 (1H, br s), 6.49 (1H, br s), 
7.06-7.09 (2H, m), 7.22 – 7.28 (5H, m), 7.34 – 7.44 (6H, m), 8.08 (1H, d, J = 7.6 Hz)  
 
13C-NMR (100 MHz, CDCl3)  
δ: 27.6 (q), 44.0 (t), 68.4 (d), 82.3 (s), 116.9 (t), 120.0 (d), 121.3 (d), 124.2 (s), 124.8 (d), 126.6 (d), 
127.3 (d), 127.6 (d), 127.9 (d), 128.5 (d), 128.9 (d), 132.1 (d), 136.7 (s), 137.0 (s), 138.1 (s), 143.7 
(s), 151.0 (s), 162.9 (s). 
 
 Experimental Section  

















1H-NMR (CDCl3)  
δ: 1.47 (9H, s), 2.36 (3H, s), 3.87 (1H, br s), 5.12 (1H, d, J = 1.6 Hz), 5.23 (1H, s), 5.73 (1H, br s), 6.47 
(1H, br s), 7.07-7.12 (3H,m), 7.18-7.30 (8H, m), 7.65 (1H, d, J = 2.6 Hz), 8.08 (1H, d, J = 7.7 Hz) 
 
13C-NMR (CDCl3)  
δ: 21.1 (q), 28.3 (q), 48.0 (t), 68.2 (d), 82.2 (s), 116.9 (t), 123.5 (s), 124.1 (d), 124.8 (d), 126.8 (s), 
127.3 (d), 127.6 (d), 127.9 (d), 128.1 (d), 128.6 (d), 129.3 (s), 129.5 (d), 132.1 (s), 133.6 (s), 137.0 
(s), 137.6 (d), 152.1 (s), 162.9 (s). 
 



















 Experimental Section  
1H-NMR (400 MHz, CDCl3, 50 °C)  
δ: 1.23 (9H, s), 3.70-3.90 (2H, m), 3.81 (3H s), 5.11 (1H, d, J = 1.2 Hz), 5.20 (1H, d, J = 1.2 Hz), 6.57 
(1H, br s), 6.89-7.43 (11H m), 8.05-8.09 (1H, m). 
 
 13C-NMR (100 MHz, CDCl3, 50 °C)  
δ: 27.6 (q), 55.3 (q), 68.1 (t), 116.9 (t), 124.8 (d), 127.6 (d), 127.7 (d), 127.9 (d), 128.0 (d), 128.9 
(d), 129.3 (d), 129.9 (d), 130.0 (s), 137.0 (s), 143.8 (s), 159.4 (s), 162.8 (s) 
 










Yellow solid. M.p.: 115°C  
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.40 (9H, s), 3.28 (3H, s), 5.01 (1H, d, J = 1.8 Hz), 5.29 (1H, d, J = 1.8 Hz), 6.68 (1H, br s), 7.17-
7.35 (6H, m), 7.98 (1H, d, J = 7.1 Hz), 8.01 (1H, dd, J = 1.1, J = 7.8 Hz)  
 
13C-NMR (CDCl3)  
δ: 28.0 (q), 34.0 (q), 70.0 (d), 83.1 (s), 116.9 (t), 124.6 (s), 125.8 (d), 126.8 (d), 126.9 (d), 128.1 (d), 
128.6 (d), 130.5 (s), 131.7 (d), 135.5 (s), 138.0 (s), 143.8 (s), 152.5 (s), 162.0 (s). 
 













 Experimental Section  
1H-NMR (CDCl3)  
δ: 1.40 (9H, s), 1.40 (3H, t, J = 7.1 Hz), 3.29 (3H, s), 4.39 (2H, q, J = 7.1 Hz), 5.10 (1H, s), 5.34 (1H, s), 
6.67 (1H, br s), 7.22-7.28 (4H, m), 7.32-7.42 (1H, m), 7.96-8.01 (3H, m) 
 
13C-NMR (CDCl3)  
δ: 14.3 (q), 28.0 (q), 33.9 (q), 61.0 (t), 82.9 (s), 92.2 (d), 117.9 (t), 123.5 (s), 124.4 (d), 125.0 (d), 
126.9 (d), 127.4 (d), 129.4 (d), 130.0 (s), 131.8 (d), 136.8 (s), 142.7 (s), 143.5 (s), 155.0 (s), 163.0 
(s), 166.2 (s). 
 










Orange solid. M.p.: 140°C. 
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.41 (9H, s), 2.61 (3H, s), 3.30 (3H, s), 5.12 (1H, d, J = 1.8), 5.36 (1H, s), 6.68 (1H, br s), 7.21-7.39 
(5H, m), 7.88-7.90 (2H, m), 8.01 (1H, dd, J = 1.3, 7.8 Hz)  
 
13C-NMR (100 MHz, CDCl3)  
δ: 26.6 (q), 28.0 (q), 39.9 (q), 82.9 (s), 96.2 (d), 114.9 (s), 118.0 (t), 123.1 (s), 123.5 (d), 124.4 (d), 
125.1 (d), 127.4 (d), 128.2 (d), 131.8 (d), 136.5 (s), 136.8 (s), 143.0 (s), 143.3 (s), 163.0 (s), 197.5 
(s). 
 









 Experimental Section  
4) Exploiting the anthranilic scaffold, back to allenamides – B) a 








General procedure for the Au-catalyzed hydroamination 
 
To a solution of 26 (0.48 mmoli) in MeCN (8 mL) add AuCl3 (0.029 mmoli). Let the mixture react 
under stirring for one night (60 °C). 




Procedure for the Ru-catalyzed hydroamination 
 
Dissolve 26 (0.21 mmol) in MeCN (2 mL). Add RuCl3•2.4 H2O (0.002 mmol), dppe (0.002 mmol), 
K2CO3 (0.42 mol) and CuCl2 (0.21 mmol). Leave the mixture under stirring at 60°C for 2h. 
Evaporate the solvent under reduced pressure. 
 
 




Yield: 45% (Au), 90% (Ru). 
White solid (M.p.: 122 °C) 
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.50 (9H, s), 3.15 (3H, s), 5.20 (2H, dd, J = 0.7, 6.8 Hz), 5.64-5.73 (1H, m), 6.11 (1H, d, J = 3.7 Hz), 
7.18 (1H, ddd, J = 1.0, 6.8, 7.7 Hz), 7.43 (1H, ddd, J = 1.4, 6.8, 8.2 Hz), 7.50 (1H, d, J = 6.0 Hz), 8.01 
(1H, dd, J = 1.0, 7.7 Hz)  
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.2 (q), 32.9 (q), 70.9 (d), 83.0 (s), 118.6 (t), 122.4 (s), 123.7 (d), 124.5 (d), 127.7 (d), 131.6 (d), 
132.2 (d), 137.5 (s), 155.0 (s), 162.3 (s). 
 
MS: m/z 288 (M+). Anal. calcd for C16H20N2O3: C, 66.65; H, 6.99; N, 9.72. Found C, 66.70; H, 6.81; N, 
9.81. 
tert-butyl 6-chloro-3-methyl-4-oxo-2-vinyl-3,4-dihydroquinazoline-1(2H)-carboxylate (30b) 





White solid (M.p.: 120 °C)  
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.53 (9H, s), 3.15 (3H, s), 5.15-5.21 (2H, m), 5.66 (1H, ddd, J = 3.6, 10.3, 15.5 Hz), 6.05 (1H, br s), 
7.38 (1H, dd, J = 2.5, 8.7 Hz), 7.50 (1H, d, J = 6.3 Hz), 7.97 (1H, d, J = 2.8 Hz)  
 
13C-NMR (100 MHz, CDCl3)  
δ: 28.2 (q), 33.1 (q), 70.0 (d), 83.4 (s), 118.9 (t), 123.7 (s), 125.2 (d), 127.5 (d), 130.2 (s), 131.3 (d), 
131.9 (d), 136.0 (s), 151.4 (s), 161.3 (s). 
 












1H-NMR (400 MHz, CDCl3)  
δ: 1.20 (9H, s), 4.12 (1H, br s), 5.15-5.24 (2H, m), 5.68-5.76 (1H, m), 5.74 (1H, br s), 6.12 (1H, d, J = 
5.3 Hz), 7.23 – 7.27 (1H, m), 7.44 – 7.49 (5H, m), 7.79 – 7.83 (4H, m), 8.11 (1H, dd, J = 1.3, 7.7 Hz)  
 
13C-NMR (100 MHz, CDCl3)  
δ: 27.6 (q), 48.2 (t), 79.8 (s), 82.5 (d), 118.7 (t), 122.4 (d), 123.5 (s), 124.6 (d), 126.1 (d), 126.5 (d), 
127.3 (d), 127.7 (d), 127.8 (d), 127.9 (d), 128.1 (d), 128.8 (d), 129.8 (d),  131.8 (d), 133.1 (s), 133.4 
(s), 137.7 (s), 151.1 (s), 162.3 (s), 164.0 (s). 
 





tert-butyl 3-benzyl-4-oxo-2-vinyl-3,4-dihydroquinazoline-1(2H)-carboxylate (30d) 





Yellow oil.  
 
1H-NMR (400 MHz, CDCl3)  
δ: 1.34 (9H, s), 3.90 (1H, br s), 5.17-5.21 (2H, m), 5.59 (1H, br s), 5.70 (1H, ddd, J = 5.4, 8.9, 16.8 
Hz), 6.05 (1H, br s), 7.21-7.25 (2H, m), 7.31-7.37 (4H, m), 7.47 (1H, ddd, J = 1.6, 6.0, 7.5 Hz), 7.60 
(1H, br s), 8.07 (1H, dd, J = 1.5, 7.8 Hz) 
   
13C-NMR (100 MHz, CDCl3)  
δ: 27.9 (q), 47.7 (t), 68.3 (d), 82.6 (s), 118.6 (t), 122.0 (d), 123.6 (s), 124.5 (d), 127.8 (d), 128.1 (d), 
128.8 (d), 129.8 (d), 131.8 (d), 132.3 (d), 136.6 (s), 137.6 (s), 152.0 (s), 164.9 (s). 
 











1H-NMR (400 MHz, CDCl3)  
δ: 1.34 (9H, s), 2.33 (3H, s), 2.41 (3H, s), 3.88 (1H, br s), 5.16-5.20 (2H, m), 5.56 (1H, br s), 5.64-
5.75 (1H, m), 6.03 (1H, br s), 7.13-7.33 (4H, m), 7.45 (1H, d, J = 7.3 Hz), 7.59 (1H, br s), 8.05 (1H, d, 
J = 7.6 Hz) 
 
13C-NMR (100 MHz, CDCl3)  
δ: 18.3 (q), 27.9 (q), 47.7 (t), 68.3 (d), 82.6 (s), 118.6 (t), 122.0 (d), 123.6 (s), 124.5 (d), 127.8 (d), 
128.1 (d), 128.8 (d), 129.8 (d), 131.8 (d), 132.3 (d), 136.6 (s), 137.6 (s), 152.0 (s), 164.9 (s). 
 





tert-butyl 3,8-dimethyl-4-oxo-2-vinyl-3,4-dihydroquinazoline-1(2H)-carboxylate (30f) 







1H-NMR (400 MHz, CDCl3)  
δ: 1.52 (9H, s), 3.79 (3H, s), 4.54-4.62 (1H, m), 5.14-5.20 (1H, m),5.59-5.64 (1H, m), .95-6.02 (1H, 
m),6.85 – 7.42 (6H, m), 8.04 (1H, d, J = 1.2 Hz), 8.38-8.43 (1H, m) 
  
13C-NMR (CDCl3) 
δ: 27.4(q), 54.8 (q), 59.9 (t), 67.8 (d), 113.9 (d), 118.0 (t), 119.2 (d), 120.7 (d), 124.1 (d), 126.9 (d), 
127.6 (d), 128.8 (d), 129.4 (d), 131.8 (d), 170.5 (s).  
 











1H-NMR (400 MHz, CDCl3)  
δ: 1.52 (9H, s), 3.79 (3H, s), 4.54-4.62 (1H, m), 5.14-5.20 (1H, m),5.59-5.64 (1H, m), .95-6.02 (1H, 
m),6.85 – 7.42 (6H, m), 8.04 (1H, d, J = 1.2 Hz), 8.38-8.43 (1H, m) 
  
13C-NMR (CDCl3) da verificare 
δ: 27.4(q), 54.8 (q), 59.9 (t), 67.8 (d), 113.9 (d), 118.0 (t), 119.2 (d), 120.7 (d), 124.1 (d), 126.9 (d), 
127.6 (d), 128.8 (d), 129.4 (d), 131.8 (d), 170.5 (s).  
 
MS: m/z 394 (M+). Anal. calcd for C23H26N2O4: C, 70.03; H, 6.64; N, 7.10. Found C, 70.07; H, 6.71; N, 
7.01. 
 
 
 
 
 
